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Abstract 
 
Nucleosome positioning is involved in a variety of cellular processes, and it provides a 
likely substrate for species evolution and may play roles in human disease. However, many 
fundamental aspects of nucleosome positioning remain controversial, such as the relative 
importance of underlying sequence features, genomic neighbourhood and trans-acting 
factors.  
In this thesis, I have focused on analyses of the divergence and conservation of 
nucleosome positioning, associated substitution spectra, and the interplay between them. I 
have investigated the extent to which nucleosome positioning patterns change following the 
duplication of a DNA sequence and its insertion into a new genomic region within the same 
species, by assessing the relative nucleosome positioning between paralogous regions in both 
the human (using in vitro and in vivo datasets) and yeast (in vivo) genomes. I observed that 
the positioning of paralogous nucleosomes is generally well conserved and detected a strong 
rotational preference where nucleosome positioning has diverged. I have also found, in all 
datasets, that DNA sequence features appear to be more important than local chromosomal 
environments in nucleosome positioning evolution, while controlling for trans-acting factors 
that can potentially confound inter-species comparisons.  
I have also examined the relationships between chromatin structure and DNA sequence 
variation, with a particular focus on the spectra of (germline and somatic) substitutions seen 
in human diseases. Both somatic and germline substitutions are found to be enriched at 
sequences coinciding with nucleosome cores. In addition, transitions appear to be enriched in 
germline relative to somatic substitutions at nucleosome core regions. This difference in 
transition to transversion ratio is also seen at transcription start sites (TSSs) genome wide. 
However, the contrasts seen between somatic and germline mutational spectra do not appear 
to be attributable to alterations in nucleosome positioning between cell types. Examination of 
multiple human nucleosome positioning datasets shows conserved positioning across TSSs 
and strongly conserved global phasing between 4 cancer cell lines and 7 non-cancer cell 
lines. This suggests that the particular mutational profiles seen for somatic and germline cells 
occur upon a common landscape of conserved chromatin structure.  
I extended my studies of mutational spectra by analysing genome sequencing data from 
various tissues in a cohort of individuals to identify human somatic mutations. This allowed 
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an assessment of the relationship between age and mutation accumulation and a search for 
inherited genetic variants linked to high somatic mutation rates. A list of candidate germline 
variants that potentially predispose to increased somatic mutation rates was the outcome.  
Together these analyses contribute to an integrated view of genome evolution, 
encompassing the divergence of DNA sequence and chromatin structure, and explorations of 
how they may interact in human disease. 
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Lay Summary 
 
Nucleosome positioning defines the locations and patterns of nucleosome occupancy 
across the genome and is a universal feature of eukaryotic chromatin structure. The 
properties of this fundamental layer of chromatin organisation have important implications 
since nucleosomes prevent bound DNA from being accessed by a wide range of cellular 
machinery. Nucleosome positioning has been shown to regulate a variety of cellular 
p r o c e s s e s ,  a n d  c o n t r i b u t e s  t o  s p e c i e s  e vo l u t i o n  a n d  h u ma n  d i s e a s e s .  
Due to its functional importance, nucleosome positioning itself has to be precisely 
regulated. Certain factors are known to regulate how and where nucleosomes are organised 
in the genome, including the differential affinities of particular DNA sequences and physical 
barriers provided by proteins. However, the relative importance of these different factors to 
the fine tuning of nucleosome positioning remains controversial. 
In this thesis, I have studied the relationships between chromatin structure and underlying 
DNA sequences, by exploring the factors that affect nucleosome positioning and the impacts 
of nucleosome positioning on the patterns of mutations seen in DNA sequences. I have 
investigated the extent to which nucleosome positioning patterns change following the 
duplication of a DNA sequence and its insertion into a new genomic region within the same 
genome, a process called segmental duplication which creates two regions of high sequence 
identity (paralogous regions) for each duplication event. I assessed the differences in 
nucleosome positioning between paralogous regions in both the human (using datasets 
resulting from in vitro and in vivo experiments) and yeast (using in vivo data) genomes. I 
observed that most nucleosomes tend to occupy similar places following the duplication of 
paralogous regions, but detected a strong preference for positional shifts in multiples of 10 
bp in the regions nucleosome positioning has diverged. The 10 bp preference is related to the 
increased binding affinity between nucleosome core histones and DNA sequences that show 
10 bp periodicity with respect to AA/TT/AT dinucleotides. I have also found, in all datasets, 
that DNA sequence composition is more important in nucleosome positioning evolution than 
features of local chromosomal environments, such as whether the duplication event happens 
between different chromosomes or within the same chromosome and whether the chromatin 
states of duplicated regions are the same or not. Importantly, the analysis of duplicated 
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regions within the same cells controls for the influence of trans-acting factors (such as 
transcription factors) that have potentially confounded previous inter-species comparisons.  
I have also examined the relationships between nucleosome positioning and the patterns 
of germline and somatic DNA substitutions seen in human diseases, including cancers. Both 
somatic and germline substitutions were found to be enriched in nucleosome occupied DNA 
sequences (at the nucleosome core). In addition, specific transition substitutions of A<->T or 
C<->G appear to be enriched in germline (inherited from parents) sequence variants relative 
to somatic variants (not inherited from parents but acquired in somatic tissues) at 
nucleosome core regions. This difference in mutational spectra is also seen at transcription 
start sites (TSSs) genome wide. Thus the different profiles observed for germline and 
somatic mutations suggest that different underlying molecular mechanisms are involved. 
However, the contrasts seen between somatic and germline mutational profiles do not appear 
to be attributable to alterations in nucleosome positioning between cell types, as indicated by 
the broadly conserved nucleosome positioning I have identified between 4 cancer cell lines 
and 7 non-cancer cell lines. This suggests that the particular mutational profiles seen for 
somatic and germline cells occur upon a common landscape of conserved chromatin 
structure.  
Mutations in somatic tissues accumulate as people age, as well as in diseases such as 
cancers. Using large collections of genomic sequencing data I detected somatic mutations in 
normal somatic tissues to explore how age and germline variants affect mutation 
accumulation in normal somatic tissues. I have shown, for the first time, that DNA mutations 
have accumulated in normal human cells as a linear function of age and also identified a list 
of potential germline variants that appear to accelerate the accumulation of DNA mutations 
in somatic normal tissues.   
Together these analyses contribute to an integrated view of genome evolution, 
encompassing the fundamental relationships between DNA sequence and chromatin 
structure, and explorations of how they may interact in human disease. 
 
vi 
 
Acknowledgements 
 
Firstly, I would like to acknowledge and thank my supervisors Colin Semple, James 
Prendergast and Martin Taylor for their guidance and support throughout the course of my 
PhD. I feel extremely lucky to have three supervisors and their student friendly supervision 
styles and considerations hugely mitigate my stress during my whole PhD. I would also like 
to thank the members of my thesis committee panel, Susan Farrington and Richard Meehan 
for their helpful suggestions, and the members of Evogen for all their help and advice. I 
particularly thank Alison Meynert for her help with variant calling and Bioinformatics 
advice. 
Special sorry goes to James for my bombardment of all sorts of stupid questions (at least 
10 per day) during the first two years of my PhD, ranging from the basic usage of the Linux 
operating system, to programming languages like PERL and R, and to many basic concepts 
in computational biology and bioinformatics.   
Finally, I would like to thank all my family members, especially my mother and 
grandmother, and friends for their support. 
 
vii 
 
 
Contents 
 
Declaration of Authorship ...................................................................................................... i 
Abstract ................................................................................................................................... ii 
Lay Summary ........................................................................................................................ iv 
Acknowledgements ............................................................................................................... vi 
List of Figures ......................................................................................................................... x 
List of Tables ........................................................................................................................ xii 
Abbreviations ...................................................................................................................... xiii 
Chapter 1: Introduction ........................................................................................................ 1 
1.1 Chromatin structure and the nucleosome ................................................................. 1 
1.1.1 Different layers of chromatin structure in eukaryotes .................................... 1 
1.1.2 Nucleosome structure and its biological importance ..................................... 1 
1.1.3 Determinants of nucleosome positioning ....................................................... 3 
1.1.4 Personal summary ........................................................................................ 18 
1.2 Mutation spectra and chromatin structure .............................................................. 18 
1.2.1 Central importance of mutations in the evolutionary process and human 
diseases ......................................................................................................... 18 
1.2.2 Variations in mutation spectra ...................................................................... 20 
1.2.3 Chromatin structure and mutation rates ....................................................... 21 
1.2.4 Personal summary ........................................................................................ 23 
1.3 Goals of investigation ............................................................................................. 23 
Chapter 2: Nucleosome Positioning Dynamics in Evolution ............................................ 25 
2.1 Introduction ............................................................................................................ 25 
2.2 Materials and Methods: .......................................................................................... 30 
2.2.1 Bioinformatics tools used ............................................................................. 30 
2.2.2 Summary of datasets used ............................................................................ 31 
2.2.3 Analysis procedure ....................................................................................... 34 
2.3 Results .................................................................................................................... 41 
2.3.1 Translational positioning between in vitro and in vivo nucleosomes ........... 41 
2.3.2 Translational positioning between paralogous nucleosomes within both in 
vitro and in vivo human samples .................................................................. 46 
2.3.3 No obvious effect of the difference in mapping stringency and mapping 
software on the inference of nucleosome positions and the pattern of 
paralogous nucleosome positioning ............................................................. 59 
2.4 Discussion............................................................................................................... 62 
 
viii 
 
Chapter 3: Conserved Determinants of Nucleosome Positioning Evolution across 
Eukaryotes ............................................................................................................................ 65 
3.1 Introduction ............................................................................................................ 65 
3.2 Materials and Methods: .......................................................................................... 66 
3.2.1 Summary of datasets and software used....................................................... 66 
3.2.2 Analysis procedure ....................................................................................... 68 
3.3 Results .................................................................................................................... 69 
3.3.1 Nucleosome positioning is well conserved following yeast and human 
duplications .................................................................................................. 69 
3.3.2 Yeast nucleosome positioning divergence shows strong periodicity ........... 69 
3.3.3 Long range correlations in nucleosome positioning evolution in human and 
yeast genomes .............................................................................................. 70 
3.3.4 The local DNA composition bias is associated with nucleosome positioning 
evolution ....................................................................................................... 71 
3.3.5 Sequence divergence and the nucleosome repositioning ............................. 74 
3.3.6 The local genomic environment affects positioning between paralogous 
nucleosomes ................................................................................................. 75 
3.3.7 Integrative analysis of paralogous nucleosome divergence covariates by 
multiple linear regression and relative importance test ................................ 78 
3.4 Discussion............................................................................................................... 81 
Chapter 4: Nucleosome Positioning Dynamics and Interplay with Mutational Spectra 
in Disease .............................................................................................................................. 83 
4.1 Introduction ............................................................................................................ 83 
4.2 Methods and materials ............................................................................................ 85 
4.2.1 ENCODE source data to call nucleosome positions .................................... 85 
4.2.2 Reads mapping and nucleosome positions calling ....................................... 85 
4.2.3 TCGA dataset and overview of variant calling ............................................ 88 
4.2.4 Simultaneous per-patient variant calling and mutation rate calculation....... 88 
4.3 Results .................................................................................................................... 90 
4.3.1 Nucleosome phasing is well conserved among different human cell lines .. 90 
4.3.2 Nucleosome positioning around FANTOM5 TSSs is moderately conserved 
among different human cell lines ................................................................. 92 
4.3.3 Mutation spectra around FANTOM5 TSSs.................................................. 96 
4.3.4 Composition is distinct between germline and somatic substitutions around 
FANTOM5 TSSs ......................................................................................... 98 
4.3.5 Mutation spectra around nucleosome dyads .............................................. 100 
4.3.6 Composition of substitutions is distinct between germline and somatic 
substitutions around nucleosome dyads ..................................................... 103 
4.4 Discussion............................................................................................................. 106 
Chapter 5: Genetic Determinants of Somatic Mutation Rates in Blood Cells ............. 107 
5.1 Introduction .......................................................................................................... 107 
5.2 Methods ................................................................................................................ 110 
5.2.1 Patient selection and raw variant calling .................................................... 110 
5.2.2 Variants filtering and mutation rate calculation ......................................... 111 
5.2.3 Genome-wide association study (GAWS) for genetic determinants of normal 
cells specific somatic mutation rates .......................................................... 112 
 
ix 
 
5.3 Results and discussions ........................................................................................ 114 
5.3.1 The overall somatic mutation rate and age ................................................. 114 
5.3.2 Genetic determinants of somatic mutation rate .......................................... 115 
Chapter 6: Discussion ........................................................................................................ 119 
Bibliography ....................................................................................................................... 122 
Appendix ............................................................................................................................. 143 
 
 
x 
 
List of Figures 
 
Figure 1.1. Illustration of the concept of nucleosome positioning and nucleosome occupancy
 ....................................................................................................................................... 8 
Figure 1.2. Illustration of the concept of rotational positioning and translational positioning. 9 
Figure 1.3. Illustration of the concept of “statistical positioning”. ........................................ 18 
Figure 2.1. Size distributions of average paralogous duplicons in the human genome. ........ 31 
Figure 2.2. Schematic description on defining paralogous nucleosomes. ............................. 35 
Figure 2.3. Correction of the inflated divergence of in vitro nucleosome positioning between 
paralogous regions due to the iNPS rounding approach. ............................................. 36 
Figure 2.4. Schematic drawing to show that the DNA motif is absent in one duplicon. ....... 40 
Figure 2.5. Comparison of translational positioning between in vitro and in vivo nucleosomes.
 ..................................................................................................................................... 43 
Figure 2.6. Translational nucleosome positioning is associated with underlying sequence 
composition. ................................................................................................................ 43 
Figure 2.7. Comparison of translational positioning between in vitro and in vivo nucleosomes 
in different chromatin states. ....................................................................................... 44 
Figure 2.8. Comparison of translational positioning between in vitro and in vivo nucleosomes 
in the context of individual chromatin states. .............................................................. 45 
Figure 2.9. Nucleosome positioning is generally conserved between paralogous regions.. .. 48 
Figure 2.10. Shifts among proximal paralogous nucleosome pairs are correlated. ............... 49 
Figure 2.11. Nucleosome positioning divergence is associated with underlying sequence 
composition. Nucleosome pairs were classified into two approximately equal sized 
groups based on their observed shift............................................................................ 52 
Figure 2.12. Sequence divergence (number of base changes) is correlated with divergence in 
positioning between paralogous nucleosomes (unsinged shift) in vivo and in vitro. ... 54 
Figure 2.13. Local chromatin states affect divergence in positioning between paralogous 
nucleosomes in vivo but not in vitro. ........................................................................... 55 
Figure 2.14. Local chromosomal environments affect divergence in positioning between 
paralogous nucleosomes in vivo and in vitro. .............................................................. 56 
Figure 2.15. Relative importance analysis of local sequence and chromosomal environment 
features on positioning divergence in vivo and in vitro. .............................................. 58 
Figure 2.16. CDX2 and TEAD2 binding motifs affect nucleosome positioning between 
paralogous regions in vivo but not in vitro. ................................................................. 59 
Figure 2.17. Comparison of in vivo nucleosomes derived from differently mapped pair-end 
reads. ............................................................................................................................ 60 
Figure 2.18. Pattern of nucleosome positioning between paralogous regions derived from 
paired-end reads that mapped to the human reference genome with default parameter 
and by BWA. ............................................................................................................... 61 
 
xi 
 
Figure 3.1. Size distributions of average paralogous duplicons   in the human genome. ...... 67 
Figure 3.2. Nucleosome positioning is generally conserved between paralogous regions in 
human and yeast .......................................................................................................... 70 
Figure 3.3. Shifts among proximal paralogous nucleosome pairs are correlated. ................. 71 
Figure 3.4. Nucleosome positioning divergence is associated with underlying sequence 
composition. ................................................................................................................ 73 
Figure 3.5. Sequence divergence is associated with divergence in nucleosome positioning 
between paralogous regions in human and yeast. ........................................................ 75 
Figure 3.6. Local chromosomal environments affect divergence in positioning between 
paralogous nucleosomes .............................................................................................. 77 
Figure 3.7. The effects of linker region AT content on nucleosome repositioning in human 
and yeast genomes. ...................................................................................................... 80 
Figure 4.1. Workflow to derive positions of nucleosomes carrying a specific histone 
modification and all nucleosomes carrying any examined histone modifications....... 86 
Figure 4.2. Nucleosome phasing is conserved among different cell lines. ............................ 90 
Figure 4.3. Nucleosome phasing is globally conserved between normal and cancer genomes.
 ..................................................................................................................................... 91 
Figure 4.4. Global nucleosome phasing is relatively conserved between GM12878 normal 
and K562 cancer cell lines. .......................................................................................... 92 
Figure 4.5. Nucleosome positioning around FANTOM5 TSSs. ............................................ 94 
Figure 4.6. Variable positioning of nucleosomes downstream of TSSs in different cell types.
 ..................................................................................................................................... 95 
Figure 4.7. Nucleosome positioning around FANTOM5 TSSs in normal and cancer cell lines.
 ..................................................................................................................................... 95 
Figure 4.8. Number of valid sites at each position relative to FANTOM5 TSSs. ................. 96 
Figure 4.9. Substitution density (original and 20bp sliding window) from -500bp to +500bp 
relative to FANTOM5 TSSs between germline and somatic mutations. ..................... 97 
Figure 4.10. Transition and transversion biases between germline and somatic substitutions 
in the region from -500bp to +500bp relative to FANTOM5 TSSs as a whole. ........ 100 
Figure 4.11. Substitution frequency (original and 20bp sliding window) from -500bp to 
+500bp relative to nucleosome dyad between germline and somatic mutations. ...... 102 
Figure 4.12. Transition and transversion biases between germline and somatic substitutions 
on the region from -125bp to +125bp relative to the nucleosome dyad. ................... 105 
Figure 5.1. Work flow for calling normal cells specific somatic variants and germline 
variants. ...................................................................................................................... 112 
Figure 5.2. Relationship between age and the somatic mutation rates in blood derived normal 
cells in 372 TCGA patients. ....................................................................................... 115 
 
xii 
 
List of Tables 
 
Table 2.1. 15 chromatin states inferred in (Ernst et al. 2011) ................................................ 33 
Table 2.2. Summary of human in vivo and in vitro datasets .................................................. 34 
Table 2.3. Relative effects of chromatin state and DNA compositions on positioning between 
in vitro and in vivo nucleosomes by multiple linear regression. .................................. 45 
Table 2.4. Relative effects of DNA local sequences and chromosomal environments on 
positioning between paralogous nucleosomes by multiple linear regression. ............. 58 
Table 3.1. Relative effects of DNA local sequences and chromosomal environments on 
positioning between paralogous nucleosomes according to optimised multiple linear 
regression models. ....................................................................................................... 79 
Table 3.2:  Relative importance analysis of DNA local sequences and chromosomal 
environments on positioning between paralogous nucleosomes. ................................ 79 
Table 4.1. The list of cell lines used for detecting nucleosome positioning .......................... 86 
Table 4.2. Summary of number of nucleosomes called from histone modifications and 
variants data in this study. ........................................................................................... 87 
Table 4.3. List of disease in the study. ................................................................................... 89 
Table 4.4. Observed frequency of substitutions in germline and somatic substitutions in the 
region from -500bp to +500bp relative to FANTOM5 TSSs as a whole. .................... 99 
Table 4.5. Observed frequency of substitutions in germline and somatic substitutions on the 
region from -125bp to +125bp relative to nucleosome dyads. .................................. 104 
Table 5.1:  List of patient numbers whose control tissues are from blood derived normal cells.
 ................................................................................................................................... 111 
Table 5.2. Summary of genes harbouring germline variants associated with variation in 
somatic mutation rates. .............................................................................................. 117 
 
 
xiii 
 
Abbreviations 
 
TF Transcription factor 
TSS Transcription start site 
NDR Nucleosome depleted region  
MNase Micrococcal Nuclease 
TTS Transcription termination site  
Pol II RNA polymerase II  
Indel Insertion/deletion 
DHS DNase I hypersensitive site 
  
  
  
  
 
 
 
 
1 
 
Chapter 1: Introduction 
 
 
1.1 Chromatin structure and the nucleosome  
1.1.1 Different layers of chromatin structure in eukaryotes 
The eukaryotic genome is packed into the nucleus in the form of chromatin, a DNA-
protein complex (Kornberg 1977; Igo-Kemenes et al. 1982), and compaction of genomic 
DNA can be achieved at multiple levels, corresponding to the different layers of chromatin 
structure. The primary level involves DNA packaged into nucleosomes, generating a 10 nm 
fibre and the resulting nucleosome arrays look like “beads on a string” under an electron 
microscope (Thoma et al. 1979; Richmond and Davey 2003). Nucleosomes are further 
condensed into a 30 nm chromatin fibre through interaction with nearby nucleosomes and 
through linker histone H1 binding to DNA sequences that lie between successive 
nucleosomes and core histones (Tremethick 2007; van Steensel 2011; Fudenberg and Mirny 
2012). However, there are debates on this pervasive presence of the 30 nm fibre (Tremethick 
2007; Eltsov et al. 2008; Maeshima and Eltsov 2008; Maeshima et al. 2010; Fussner et al. 
2011). The highest levels of chromatin structure determine the spatial organization of the 
genome in nucleus. For example, the human genome can be arranged into functionally 
distinct domains at mega-base scales, and show different degrees of accessibility to trans-
acting factors. One of the indicators for genome accessibility is sensitivity to DNase I 
cleavage, and regions that show high sensitivity are called DNase hypersensitive sites (DHSs) 
(Birney et al. 2007; Bell et al. 2011; Thurman et al. 2012: 1). The genome accessibility is 
usually lower in heterochromatin than in euchromatin; heterochromatin is preferentially 
distributed at the periphery of the nucleus and interacts with nuclear lamins while 
euchromatin is more likely to locate in the centre, thus away from the periphery (Van Bortle 
and Corces 2012).  
 
1.1.2 Nucleosome structure and its biological importance  
Nucleosomes form the basic repeating unit of chromatin structure and provide the basis for 
all other higher orders of chromatin structure. The discovery and confirmation of the 
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existence of nucleosome and that nucleosome is the repeating unit of chromatin, as 
summarised in Kornberg (1977), came from different lines of evidences. Several studies 
using X-ray diffraction technique observed the multiple levels of folding of genomic DNA 
(Luzzati et al. 1961; Bram and Ris 1971; Pardon and Wilkins 1972), and the work from 
Olins and Olins (1974) showed that chromatin appeared as chains of particles under the 
electron microscope. Based on the finding from X-ray diffraction and biologicals results 
(Kornberg and Thomas 1974), Kornberg proposed that nucleosome was the repeating unit of 
chromatin, made of “eight histone molecules and about 200 DNA base pairs” (Kornberg 
1974). Subsequently, the crystal structure of nucleosome core particle with different 
resolutions was provided by Klug and his colleagues (Finch et al. 1977; Richmond et al. 
1984). 
A nucleosome consists of 147 bp of DNA wrapped ~1.7 times around an octameric core 
complex of histone proteins, made up of two copies for each of H2A, H2B, H3 and H4 
canonical histones (Luger et al. 1997; Luger et al. 1997; Richmond and Davey 2003; Cutter 
and Hayes 2015). The interaction between DNA and core histones is not static; rather 
nucleosomes undergo constant unwrapping and rebinding from core histones, with the time 
required for DNA at the edge of the histone octamer to unwrap and rebind far shorter than 
that observed for DNA at the centre position (Polach and Widom 1995). Linker histones bind 
linker DNA between adjacent nucleosomes, interact with core histones, and play important 
roles in further chromatin folding. Another function for the linker histone is regulation of 
nucleosome spacing, and the difference in the length of linker DNA seen across different 
species and cell types correlates with the linker histone expression levels. For example, the 
linker DNA is ~20 bp in yeast and ~50 bp in human (Valouev et al. 2011; Brogaard et al. 
2012), and the abundance of linker histone Hho1p in yeast is about 1 molecule per 4 ~ 40 
nucleosomes while the abundance of linker histone H1 in human is approximately 1 
molecule per nucleosome (Bates and Thomas 1981; Freidkin and Katcoff 2001; Downs et al. 
2003). Nucleosome spacing is shorter and correspondingly H1 linker histone expression is 
lower in human primary granulocytes than CD4+ T cells (Valouev et al. 2011). 
In addition to compaction of DNA, nucleosomes decrease the accessibility of DNA to 
trans-acting proteins, including transcription factors (TFs), chromatin remodelling 
complexes, polymerases, and DNA mutagens and repair enzymes. The accessibility of linker 
DNA is much higher than that of nucleosomal DNA, and DNA located at nucleosome 
entry/exit points is more accessible than DNA close to nucleosome centre (dyad). Motifs that 
sit on major grooves that face towards the histone octamer surface are generally not available 
for trans-acting factors while those that sit on the major grooves exposed to the solvent are 
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more accessible. Because of the reduced accessibility of the nucleosomal DNA, the 
nucleosome provides an extra layer for the regulation of genome functions and nucleosome 
positioning has been observed to be involved in a variety of nuclear processes that use DNA 
as template, including gene transcription, DNA replication, and DNA damage and repair (Li 
et al. 2007; Clapier and Cairns 2009; Rando and Winston 2012; Hughes and Rando 2014). 
Nucleosomes are generally thought to have a repressive effect on gene expression 
through blocking the access of cis-regulatory sites to TFs and RNA polymerase, and thus 
preventing the assembly of bulk transcription machinery at promoters which are immediately 
upstream of transcription start sites (TSSs) during transcription initiation; nucleosomes could 
also block the passage of the RNA polymerase during transcription elongation (Bondarenko 
et al. 2006; Jiang and Pugh 2009; Kulaeva et al. 2010; Radman-Livaja and Rando 2010; 
Valouev et al. 2011; Hughes and Rando 2014). Indeed, ubiquitously expressed promoters are 
usually depleted of nucleosomes and enriched with unstable nucleosomes which are easily 
digested by MNase, and display a nucleosome depleted region (NDR) at promoters, such as 
in growth genes (ribosomal genes) in yeast and housekeeping genes in human (Sekinger et al. 
2005; Weiner et al. 2010; Vavouri and Lehner 2012). The local chromatin architecture at 
promoters has been demonstrated to strongly affect both the baseline gene expression level 
and the ability to change gene expression under environmental change (expression plasticity) 
in both yeast and human species, leading to differential strategies for gene expression 
regulation (Tirosh and Barkai 2008). In addition, Vaillant et al. (2010) have also observed a 
novel strategy for transcription regulation in yeast mediated by the nucleosome ordering 
pattern in coding regions. Interestingly, nucleosomes can also activate gene expression by 
different mechanisms as summarised in Hughes and Rando (2014). 
 
1.1.3 Determinants of nucleosome positioning 
Unlike sequence specific DNA binding proteins such as TFs, core histones do not have 
sequence-specific DNA binding domains and the wrapping of DNA around the nucleosome 
octamer is mediated by the direct charge-charge interactions of core histones with DNA 
backbone phosphates at minor grooves (Luger et al. 1997; Davey et al. 2002; Cutter and 
Hayes 2015). The physical properties of DNA thus have important roles in determining the 
overall affinity between histone octamer and nucleosomal DNA, such as the ability of DNA 
to bend and curve around the histone octamer surface. Indeed, even though the histone can 
bind to almost any DNA sequence, nucleosome formation has significant sequence 
preferences and the affinity between DNA sequences and the histone octamer can vary over 
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more than three orders of magnitude (Struhl and Segal 2013). Similarly, even though 
nucleosomes can occupy all possible positions along a stretch of DNA sequences, positions 
with the minimum free energy for DNA-histone interactions are occupied at the highest 
frequencies by nucleosomes (Kornberg 1981; Drew and Travers 1985; Zhurkin 1985; 
Kornberg and Stryer 1988; Lowary and Widom 1997; Becker 1999; Thåström et al. 1999; 
Widom 2001). A change in the properties of either histones or DNA, such as DNA 
methylation and the replacement of canonical histones with variants and histones carrying 
post-translational modifications can also affect intrinsic histone-DNA interaction affinity or 
provide docking sites for the recruitment of other trans-acting factors like chromatin 
remodelling complexes, thus leading to differential positioning of nucleosomes on a given 
genome. Transcription factors have long been observed to be able to compete with the 
nucleosomes for DNA with variable abilities, and notably a subset of special TFs called 
“pioneer factors” can invade the nucleosomal DNA (Tims et al. 2011; Zaret and Carroll 2011; 
Struhl and Segal 2013). 
The pattern of the genome-wide nucleosome organization on a given genome can be 
summarised and described by nucleosome occupancy, nucleosome positioning (translational 
and rotational), and nucleosome phasing (Albert et al. 2007; Mavrich et al. 2008; Hughes et 
al. 2012; Hughes and Rando 2014). There is a long standing dispute about whether local (cis- 
acting) DNA sequences or (trans-acting) proteins play the dominant role in nucleosome 
positioning (Zhang et al. 2009; Tirosh et al. 2010; Zhang et al. 2010; Hughes et al. 2012). 
Several studies have attempted to dissect the effects of DNA sequences from that of trans- 
acting proteins with one approach being the comparison of nucleosome positioning in vivo 
and in vitro using experimental reconstructions of nucleosome formation by mixing histone 
proteins and genomic DNA (Kaplan et al. 2009; Zhang et al. 2009; Valouev et al. 2011). 
Tirosh et al. (2010) compared inter-species difference in nucleosome positioning between S. 
cerevisiae and S. paradoxus with that of their hybrid. Differences maintained in the hybrid 
being inferred to be largely the result of cis-acting DNA sequences, and not trans-acting 
proteins that are expected to be distinct in different species. Other efforts have combined 
genetic and evolutionary approaches to study the relative contributions of cis and trans 
determinants. For example, Hughes et al. (2012) introduced yeast artificial chromosomes 
(YAC) containing genomic DNA from other yeast species into S. cerevisiae, and compared 
the nucleosome positioning between these yeast artificial chromosomes and the same regions 
in their native, donor species. Schones et al. (2008) have suggested that nucleosome 
positioning at non-regulatory regions is largely determined by DNA sequence preferences 
but that at regulatory regions it is mainly governed and regulated by trans-acting factors.  
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It is now accepted that nucleosome organization is not random and is determined by the 
interplay of sequence preferences, trans factors and statistical positioning principles 
(Kornberg and Stryer 1988; Segal et al. 2006; Mavrich et al. 2008; Struhl and Segal 2013; 
Hughes and Rando 2014). 
1.1.3.1 Sequence preference in nucleosome occupancy 
Various in vivo genome-wide nucleosome positioning maps of differential resolutions in 
yeast have observed a decrease in nucleosome occupancy at promoters and at transcription 
termination sites (TTSs), with much stronger depletion in promoter regions, compared to that 
over coding regions (Yuan et al. 2005; Mavrich et al. 2008; Shivaswamy et al. 2008; Kaplan 
et al. 2009; Fan et al. 2010; Brogaard et al. 2012). For example, different groups have 
studied the average nucleosome positioning pattern around genes and observed a classical 
nucleosome depletion region (NDR) of ~150 bp just upstream of transcription start sites, 
immediately flanked by two well positioned nucleosomes with the downstream nucleosome 
called +1 nucleosome and the upstream nucleosome called -2 nucleosome; while in a subset 
of genes, including some stress genes in yeast and tissue specific genes in human, a 
nucleosome called -1 nucleosome was observed to occupy the region between -2 and +1 
nucleosomes that coincides with NDR (Jansen and Verstrepen 2011; Hughes and Rando 
2014). In addition, nucleosome depletion has been observed at many of the transcription 
factor binding sites (Segal et al. 2006; Kaplan et al. 2009).  
The observed phenomena mentioned above caused efforts to dissect the relative 
importance of DNA sequence and other factors in genome wide nucleosome organization 
patterns. Since it is hard if not impossible to disentangle the effects of trans mechanisms 
from that of cis-acting DNA sequence preference, several labs have contrasted in vivo 
genome-wide nucleosome positioning maps to in vitro maps. These maps are generated by 
assembling recombinant histone octamers of canonical histones purified from other species 
on genomic DNA, which only reflect the role of DNA sequence preference in nucleosome 
occupancy (Segal et al. 2006; Kaplan et al. 2009; Zhang et al. 2009; Valouev et al. 2011; 
Struhl and Segal 2013). For example, similar global nucleosome occupancy patterns 
observed both in vivo and in vitro, with correlations as high as 0.74 in genome-wide per base 
pair nucleosome occupancy and almost a perfect correlation (0.98) in 5mer nucleosome 
occupancy, and the accuracy of separation of nucleosome enriched regions from nucleosome 
depleted regions in vivo based on the in vitro data is high (Segal et al. 2006; Kaplan et al. 
2009). 
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One of the mechanisms for low nucleosome occupancy are intrinsic histone-DNA 
interaction preferences, as observed in HIS3-PET56 and DED1 promoter regions in yeast 
(Sekinger et al. 2005). Sequence analysis found that the low preference for nucleosome 
occupancy in yeast promoters is mainly shaped by enrichment of the antinucleosomal AT 
rich DNA sequence such as poly(dA:dT) homo-polymeric stretches, which are found in the 
promoters of about 95% of yeast genes (Mavrich et al. 2008). Most of the genes with 
poly(dA:dT) rich promoters are growth genes, which are usually deprived of TATA boxes 
and show high baseline expression level and low transcriptional plasticity (Tirosh and Barkai 
2008). Another class of genes are stress genes which feature low basal transcription levels 
and high transcription plasticity; promoters of genes in this class commonly possess TATA 
boxes and show deficiencies of poly(dA:dT) stretches, concurrent with high nucleosome 
occupancy and more fuzzily localized and evenly distributed nucleosomes (Mavrich et al. 
2008; Tirosh and Barkai 2008; Rando and Winston 2012).   
Homo-polymeric poly(dA:dT) stretches are intrinsically stiff and have low binding 
affinity with histone octamers (McCall et al. 1985; Nelson et al. 1987; Suter et al. 2000; 
Segal and Widom 2009; Struhl and Segal 2013). The affinity of poly(dA:dT) to histone 
octamers has been thought to be length dependent, and ploy(dA:dT) stretches with length of 
4bp or greater have low affinity with histone octamers (Anderson and Widom 2001; Scipioni 
et al. 2004; Thåström et al. 2004; Jansen and Verstrepen 2011). The depletion of 
nucleosomes due to poly(dA:dT) is independent of transcription activity and is observed in 
vivo under different growth conditions, including YPD, ethanol and galactose (Sekinger et al. 
2005; Kaplan et al. 2009). Raveh-Sadka et al. (2012) managed to alter nucleosome 
organization in promoters and their transcription levels through manipulating poly(dA:dT) 
tracts. Hughes et al. (2012) found that the NDR has been maintained in gene promoters of 
foreign species after being introduced into the budding yeast and maintenance is through 
poly(dA:dT) tracts.  
In contrast, GC rich sequences are intrinsically nucleosome favouring. Human promoters 
are generally GC rich and are occupied by nucleosomes (Hughes and Rando 2009; Tillo et al. 
2010; Valouev et al. 2011). High nucleosome occupancy in human promoters has been 
observed in vitro and in a subset of unexpressed genes in vivo which feature the absence of 
CpG island in their promoters (Valouev et al. 2011; Vavouri and Lehner 2012). More than 
50% of human genes contain a CpG island in their promoter and most of the genes in this 
class are constitutively expressed genes such as housekeeping genes (Vavouri and Lehner 
2012). CpG promoters are less likely to contain a TATA box while human genes that lack 
CpG island promoters are more likely to contain a TATA box and associate with tissue-
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specific genes (Davuluri et al. 2001; Carninci et al. 2006; Saxonov et al. 2006; Vavouri and 
Lehner 2012). Interestingly, CpG promoters have a constitutive NDR which seems to be 
independent of transcription activity, and thus can still be observed in unexpressed genes 
(Vavouri and Lehner 2012). The low nucleosome occupancy in CpG promoters has been 
shown to be linked to the assembly of CpG islands into unstable nucleosomes, preoccupation 
and pausing of RNA polymerases, and high levels of CTCF binding (Tirosh and Barkai 2008; 
Ramirez-Carrozzi et al. 2009; Vavouri and Lehner 2012). Nonetheless, sequence preference 
is at least partially responsible for the assembly of CpG island into unstable nucleosomes: 
tetramers of high GC content associate with high nucleosome core coverage, such that the 
tetramers of 100% GC content are associated with the highest nucleosome core occupancy. 
The CpG dinucleotide tetramer (CGCG) shows a 30% reduction in nucleosome occupancy in 
vitro (Valouev et al. 2011); in addition, the non-CpG island sequences outperform the CpG 
island sequences in associating with purified recombinant histone octamers from Xenopus 
laevis. Interestingly the famous Widom601 CpG island sequence that has periodic A/T 
dinucleotides also shows greater affinity with histone octamers than CpG island sequences 
that lack properly phased A/T dinucleotides, suggesting that these histone-DNA interaction 
preferences are also affected by the rotational positioning of the A/T dinucleotides at the 
histone octamer surface (Lowary and Widom 1997; Lowary and Widom 1998; Thåström et 
al. 1999; Ramirez-Carrozzi et al. 2009). A/T dinucleotides are bendable and their periodic 
arrangement along the nucleosome DNA, featuring repeating occurrence every ~10.2 bp, has 
been shown to be favourable for nucleosome positioning (Struhl and Segal 2013). However, 
it has also been shown that the sequence-directed nucleosome occupancy signals are mainly 
realized through that of poly (dA:dT) and GC content, rather than that of rotational 
preference of dinucleotides (Tillo and Hughes 2009).   
 
1.1.3.2 Sequence bias in nucleosome positioning 
Beside the involvement in nucleosome occupancy, the DNA sequence preference has also 
been shown to play important roles in nucleosome positioning which is similar to but distinct 
from nucleosome occupancy (Pugh 2010; Struhl and Segal 2013; Figure 1.1). Nucleosome 
occupancy (or density) describes the fraction of cells in a population in which a given 
genomic region is occupied by a nucleosome. Nucleosome positioning with respect to a 
given genomic region can be represented by the consensus primary position plus the average 
deviation from the primary position such as standard deviation (Pugh 2010). A nucleosome 
occupying the same genomic region with small standard deviation is said to be well 
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positioned. In extreme cases, a nucleosome is said to be perfectly positioned if the 
nucleosome binds to the same genomic region in every cell in the population, and a 
nucleosome taking up variable positions with no preference in the cell population is defined 
as poorly positioned or fuzzily positioned (Mavrich et al. 2008; Struhl and Segal 2013). 
Regions with similar occupancy level might be covered by well or poorly positioned 
nucleosomes and the indiscriminate usage of nucleosome occupancy and nucleosome 
positioning underlies some disputes on whether the DNA sequence preference is the primary 
determinant of genomic nucleosome organization or not (Segal et al. 2006; Kaplan et al. 
2009; Zhang et al. 2009; Kaplan et al. 2010; Pugh 2010; Zhang et al. 2010; Struhl and Segal 
2013). 
 
 
 
Figure 1.1. Illustration of the concept of nucleosome positioning 
and nucleosome occupancy. Region A and B are of 147 bp on a 
genome. Region A: partial positioning but higher occupancy; 
Region B: perfect positioning but lower occupancy. Each black 
horizontal line represents a nucleosome core which is 147 bp.   
 
 
Two related concepts with respect to nucleosome positioning are translational positioning 
and rotational positioning (Figure 1.2), and they both describe the preference of certain 
positions over others. While translational positioning defines the specific genome region of 
147 bp that the histone octamer binds, rotational positioning describes a set of translational 
positions separated by distances of multiple complete helical turns that are more preferable 
than other positions (Thåström et al. 1999; Albert et al. 2007; Brogaard et al. 2012; Gaffney 
et al. 2012). 
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Figure 1.2. Illustration of the concept of rotational positioning and translational positioning. The dyad 
of a nucleosome in a given genomic region can occupy every position allowed, but with different 
probabilities, and this phenomenon is called translational positioning. The position of highest 
probability to be occupied is called main position and positions around it are called alternative 
positions. Rotational positioning means that not all alternative positions are of equal probabilities to 
be occupied by a dyad, and those with distances of multiple of ~10.5 bp to the main position have 
higher probability to be occupied than other alternative positions. The structural basis for rotational 
positioning is the periodic organization of dinucleotides on nucleosome core. 
 
 
Tirosh et al. (2010) estimated that about 70% of inter-species difference in nucleosome 
positioning is due to DNA sequences. They suggested that the divergence of inter-species 
nucleosome positioning could be explained by the divergence in AT-rich nucleosome 
disfavouring but not the nucleosome favouring sequences. In addition, these authors found 
that nucleosome positioning divergence was able to propagate to multiple adjacent 
nucleosomes either side of the NDR but could not cross the NDR and concluded that the 
NDR, rather than the +1 nucleosome serves as the barrier, in direct contradiction with what 
was found by Zhang et al. (2009) that the strongly positioning of the +1 nucleosome is due to 
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the binding of the transcription factors and the assembly of the transcriptional machinery in 
promoters. Valouev et al. (2011) observed that sequence driven nucleosome positioning 
signals are involved in the translational positioning of nucleosomes at many genomic sites. 
From highly positioned nucleosomes, these authors also extracted another type of sequence-
directed nucleosome positioning signal that is different from the 10 bp dinucleotide 
frequency for rotational positioning: “container sites”. These sites are characterised by the 
central GC-rich nucleosome favouring sequence and boundaries set out by the AT-rich 
nucleosome repelling sequences. Using more accurate nucleosome positioning data obtained 
from lymphoblastoid cell lines from 7 human individuals, Gaffney et al. (2012) observed 
non-random translational positioning for about 84% of nucleosomes, with stronger 
translational positioning than expected by chance and 8.7% of total nucleosomes detected 
seen to be strongly positioned. One example, a 76 kb region near the centromere on 
chromosome 12 has been observed to contain phased arrays of highly positioned 
nucleosomes, featuring high GC content in core and high AT content in linker (Gaffney et al. 
2012).  
DNA methylation involves the addition of a methyl group to the cytosine (C) nucleotide, 
and this feature of the epi-genome has also been shown in vitro to increase the stability of 
nucleosomes (Collings et al. 2013). 
The sequence basis for rotational positioning has been linked to the rotational preference 
of nucleosomal DNA, which is characterised by a distinct 10 bp dinucleotide frequency: 
AA/TT/AT/TA dinucleotides are favoured at minor grooves that are ~10 bp apart from each 
other, and face inwards towards and are in direct contact with the histone cores; set off by 5 
bp, GG/CC/GC/CG dinucleotides are favoured at major grooves that face towards the 
histone cores; and A/T dinucleotide has high bendability and the nucleosome formation is 
more stable when it is in direct contact with histone (Segal et al. 2006; Albert et al. 2007; 
Brogaard et al. 2012; Gaffney et al. 2012; Cutter and Hayes 2015). This 10 bp periodicity 
has been observed in the dinucleotide frequency along the nucleosomal DNA by different 
groups. Kaplan et al. (2009) observed that nucleosomal DNA has the characteristic 10 bp 
periodicity in yeast nucleosomes both in vivo and in vitro, with the signal much stronger in 
vitro; a similar difference between in vivo and in vitro in terms of rotational positioning and 
the rotational preference of nucleosomal DNA has also been observed by Zhang et al. (2009). 
In addition, based on a nucleosome positioning map with base pair accuracy in yeast, 
Brogaard et al. (2012) observed that more stable nucleosomes in yeast are associated with 
stronger signal for periodic dinucleotide frequency, and also the corresponding rotational 
positioning that features the 10 bp periodicity in the distance between nucleosome centres in 
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the redundant map. Valouev et al. (2011) observed a much stronger signal of 10 bp 
periodicity in nucleosomal DNA in vitro than in human granulocytes. Gaffney et al. (2012) 
observed the rotational preference of nucleosomal DNA and the rotational positioning, 
indicated by a clear 10 bp periodicity in both the dinucleotide frequency, the DNase I 
cleavage frequency and the MNase midpoint distribution. Taken together, these studies 
suggest that rotational positioning of nucleosomes is primarily determined by the rotational 
preference of the DNA helix on the histone octamer surface in both yeast and humans. 
 
1.1.3.3 Trans-determinants of nucleosome organization 
Evidence mentioned above clearly shows the importance of DNA sequence preferences in 
nucleosome organization. However, it is also clear that nucleosome organization in vivo 
cannot be perfectly recapitulated by that in vitro, strongly arguing for the role of trans-acting 
factors in determining in vivo genome-wide nucleosome positioning (Hughes and Rando 
2014). For example, reduced nucleosome occupancy was observed in yeast promoters in 
vitro, but the depletion is much more profound in vivo (Hughes and Rando 2009; Kaplan et 
al. 2009; Zhang et al. 2009). The opposite nucleosome occupancy pattern exists in human 
promoters between in vitro and in vivo, especially for CpG promoters where nucleosome 
occupancy in vitro is 5 times as high as in vivo (Valouev et al. 2011; Vavouri and Lehner 
2012). Nucleosome depletion at yeast terminators, with a well-positioned nucleosome just 
upstream of transcription termination sites, has proven not to be intrinsic but instead related 
to the transcriptional mechanism (Mavrich et al. 2008; Shivaswamy et al. 2008; Fan et al. 
2010). In addition, the most important determinant of cell identity is the differential 
expression profiles of all genes in a given genome since the sequence of the genome is the 
same for all cells with different identities, a particular cell identity must be encoded by trans-
acting factors that fine-tune gene expression by regulating nucleosome positioning (Thurman 
et al. 2012; Hughes and Rando 2014). 
Choi and Kim (2009) observed stably positioned nucleosomes at sites that show high 
propensities for DNA binding and periodic occurrence of dinucleotides. These sites also 
coincide with TATA boxes and transcription terminator sites in the variably expressed genes, 
suggesting that altered transcription activity is realized by evicting or repositioning 
nucleosomes from their original sites through trans mechanisms. Unlike in human CpG 
promoters, nucleosome occupancy in non-CpG promoters is dependent on the transcription 
rate. Unexpressed non-CpG promoters display high nucleosome occupancy which is 
consistent with high nucleosome affinity of GC rich sequence, whereas promoters become 
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depleted of nucleosomes in actively transcribed genes, showing the classical NDR, and 
during transcription activation, nucleosomes have to be cleared from promoters to allow the 
assembly of the transcription machinery either through nucleosome eviction or translocation 
which inevitably involves trans-acting factors (Clapier and Cairns 2009; Ramirez-Carrozzi et 
al. 2009; Vavouri and Lehner 2012; Hughes and Rando 2014). 
 
1.1.3.4 Importance of transcription factors 
Transcription factors (TFs) are proteins that read signals for transcription initiation 
encoded in cis-regulatory sequences located in core promoters immediately upstream of 
TSSs and position transcription machinery over TSSs by associating with components of 
transcription preinitiation complexes (PIC) that control gene expression (Zaret and Carroll 
2011). Though the accessibility of nucleosomal DNA is significantly reduced for most TFs, a 
special class of TFs have strong DNA-binding activity and can invade nucleosome 
embedded DNA motifs, open up local chromatin either by the direct competition against 
nucleosomes or by recruiting chromatin remodelling complexes, and enhance the binding of 
other TFs and the assembly of bulk transcription machinery. Examples include the pioneer 
factors such as general TFs Abf1 and Reb1 in yeast and FoxA (the FoxA family includes 
FoxA1, FoxA2, and FoxA3) and GATA TFs in human (Kaplan et al. 2008; Zhang et al. 2009; 
Zaret and Carroll 2011; Rando and Winston 2012). Abf1 and Reb1 binding sites are 
intrinsically nucleosome favouring; however, Abf1 and Reb1 expel nucleosome formations 
in the vicinity of their binding sites and their loss leads to increased nucleosome occupancy 
in vivo (Kaplan et al. 2009). The power of pioneer factors to open closed chromatin was 
supported by the crystal structure of the FoxA1 pioneer factor, which revealed a DNA 
binding domain (DBD) showing high similarity with that of the linker histone that could also 
displace linker histone, and a C-terminal domain which binds to the core histones; FoxA1 
can open up local chromatin by disrupting the interaction between nearby nucleosomes 
(Clark et al. 1993; Ramakrishnan et al. 1993; Cirillo et al. 2002; Zaret and Carroll 2011). 
It has long been verified that TFs compete against nucleosomes for binding to DNA 
sequence, and the direct competition mechanism is consistent with the observation in yeast 
that the transcription factor binding sites are preferentially located at the entry/exit sites than 
dyad positions of nucleosomes and the entry/exist sites have far shorter exposure time 
compared to sites close to dyads (Polach and Widom 1995; Albert et al. 2007; Tims et al. 
2011). The NDR in CLN2 promoter has eight conserved transcription factor binding sites 
and lacks the homo-polymeric poly(dA:dT) stretch; the complete NDR is maintained when 
 
13 
 
promoter sequences containing all of the eight conserved factor binding sites is inserted into 
new nucleosome favouring sites, but lost after some of the conserved transcription factor 
binding sites were mutated, clearly supporting the role of TFs in nucleosome positioning 
(Bai et al. 2011). The authors also noticed that TFs seem to work in synergy with 
poly(dA:dT) in the establishment of the NDR in yeast promoters, indicated by the 
observation that the NDRs are most enriched with nucleosome-depleting factors binding 
sites and poly(dA:dT). This is consistent with findings that nucleosome depletion at many of 
the transcription factor binding sites is encoded intrinsically into the yeast genome, as 
revealed by in vitro genome-wide nucleosome reconstruction  (Kaplan et al. 2009; Bai et al. 
2011). The dominance of trans-acting proteins over sequence preferences was also seen in 
the comparison of nucleosome positioning patterns around NRSF and CTCF protein binding 
sites between in vitro and in vivo data (Valouev et al. 2011). The NRSF binding site is within 
nucleosome favouring sequence and was occupied in vitro by nucleosomes through the 
“container site” mechanism mentioned above. In contrast, NRSF bound to DNA in vivo and 
occluded nucleosomes from their original sites, leading to that nucleosomes were well 
positioned both upstream and downstream of the bound NRSF protein (Valouev et al. 2011). 
Gaffney et al. (2012) have also confirmed the nucleosome excluding role of CTCF and also 
notified a similar effect for other TFs like GABP and C-fos.  
 
1.1.3.5 RNA polymerase and the transcription machinery in nucleosome organization 
To transcribe a gene, the transcription initiation complex (PIC) has to assemble at the 
core promoter in the vicinity of TSSs. During transcription elongation, RNA polymerase has 
to move along the DNA which is embedded in nucleosomes. Nucleosomes act as a barrier in 
both transcription initiation and elongation, and thus histone-DNA interaction has to be 
disrupted, either through nucleosome eviction or sliding, to allow for the assembly of PIC at 
promoters during transcription activation and the passage of RNA polymerase during 
transcription elongation (Weiner et al. 2010; Hughes and Rando 2014). RNA polymerase has 
been tested experimentally in vitro showing that it can invade DNA located at the edges of 
the histone octamer, and loosen the binding of DNA to the histone octamer, which is 
followed by subsequent rebinding of the histone octamer to DNA upstream (Studitsky et al. 
1994; Studitsky et al. 1997; Kulaeva et al. 2010). Nucleosome organization in both yeast and 
human species correlates with transcriptional activity: genes that are highly active display 
greater nucleosome depletion at promoters, terminator sites, and possess densely packaged 
nucleosomes at coding regions showing shorter inter-nucleosomal spacing (Albert et al. 2007; 
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Mavrich et al. 2008; Shivaswamy et al. 2008; Valouev et al. 2011; Vavouri and Lehner 2012; 
Hughes and Rando 2014).  
A study on the transcription coupled regulation of nucleosome positioning compared the 
positions of individual nucleosomes at promoters before and after heat shock (Shivaswamy 
et al. 2008)  and found that genes usually react to transcriptional perturbation by changing 
nucleosome occupancy and positioning, and that binding sites for TFs that mediate 
transcriptional activation become more accessible. RNA polymerase II has been observed to 
evict nucleosomes from promoters and shift nucleosomes upstream during transcriptional 
elongation, and the loss of function for RNA polymerase resulted in a decreased NDR width 
and downstream nucleosome shifting, a nucleosome positioning pattern which is more 
similar to that observed in vitro in yeast (Weiner et al. 2010). Schones et al. (2008) found 
that the extent to which nucleosomes are depleted at core promoter regions in CD4+ T cells 
is directly dependent on RNA polymerase II (Pol II) binding level. Stalled promoters which 
feature relatively high levels of Pol II binding but very low gene expression levels display 
significantly reduced nucleosome occupancy which is similar to that of active genes. In 
addition, a subset of repressed genes showed a significant decrease in Pol II binding, 
accompanied by significantly increased nucleosome occupancy at promoters, suggesting that 
changes in transcription levels might be achieved by fine-tuning nucleosome organization at 
promoters and variable levels of Pol II binding (Schones et al. 2008).  
Interestingly, the positioning of the +1 nucleosome of stalled promoters is different from 
that in elongation promoters, and the difference seems not to be dependent on the amount of 
Pol II binding but the function of the bound Pol II. Promoters activated by TCR signalling 
show the same positioning of the +1 nucleosome as in expressed genes, concurrent with the 
conversion of hypo-phosphorylated Pol II to ser5-phosphorylated Pol II (Schones et al. 2008). 
This relationship between the +1 nucleosome position and TSS activation is observed in 
human and many other species, suggesting that the transcriptional machinery itself is a 
general mechanism for transcription coupled fine-tuning of nucleosome positioning (Jiang 
and Pugh 2009; Zhang et al. 2009; Valouev et al. 2011; Hughes et al. 2012).  
 
1.1.3.6 Chromatin remodelling complexes 
Chromatin remodelling complexes consist of multiple protein subunits and can be divided 
into to four different families: SWI/SNF, ISWI, CHD and INO80 (Clapier and Cairns 2009). 
All four families of remodelling complexes contain a catalytic ATPase subunit of 
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SWI2/SNF2 subfamily and non-catalytic attendant subunits. Each ATPase subunit contains 
an ATPase domain that is split into DExx and HELICc, and unique flanking domains. 
ATPase domain is conserved in all four families and across eukaryotes, and each family is 
distinguished from others by unique domains within and flanking the ATPase domain 
(Clapier and Cairns 2009). The ATPase domain uses the energy generated from dialysing 
ATP to disrupt the histone-DNA interaction and translocate DNA, and distinct combinations 
of non-catalytic subunits, as well as flanking domains in the ATPase subunits, detect unique 
targeting signals and regulate the remodelling activities of individual complexes (Clapier and 
Cairns 2009; Längst and Manelyte 2015). The targeting signals include DNA 
sequence/structure, RNA molecules, histone variant and post-translational modification, and 
TFs (Längst and Manelyte 2015). Eventual outcomes of remodelling activity can be 
nucleosome sliding, partial or complete nucleosome eviction, and nucleosome restricting 
such as the replacement of canonical H2A/H2B by H2A.Z/H2B (Hughes and Rando 2014).  
SWI/SNF family remodelling complexes preferentially target acetylated lysine residues 
on the histone tails through bromo-domains, and can slide or evict nucleosomes but have no 
role in chromatin assembly (Hassan et al. 2002; Kassabov et al. 2003). The SWI/SNF 
remodelling complex has been shown to regulate nucleosome positioning at promoters of 
yeast ribosomal genes and non-CpG promoters in humans (Shivaswamy et al. 2008; 
Ramirez-Carrozzi et al. 2009). The SANT domain together with SLIDE domain in the 
ATPase subunit of ISWI family remodellers can bind to linker DNA and unmodified H4 tails, 
and thus many complexes from this family have a role in nucleosome spacing and chromatin 
assembly (Strohner et al. 2004; Clapier and Cairns 2009; Längst and Manelyte 2015). Zhang 
et al. (2009) used the chromatin assembly factor ACF to assemble nucleosome arrays on the 
yeast genome and found that both the translational and rotational positioning were 
diminished compared to the in vitro reconstruction by salt dialysis, suggesting that chromatin 
remodelling complexes can overcome the sequence preference and translocate nucleosomes 
to sequences that are less nucleosome favourable. The chromo-domain defines the CHD 
family complexes, and the Chd1 complex specifically interacts with methylated histone tails 
through the chromo-domain to regulate gene expression in yeast (Pray-Grant et al. 2005; 
Marfella and Imbalzano 2007). The INO80 complex has been found to be important in the 
dynamics of the H2A.Z histone variant at yeast promoters and the deletion of the INO80 
complex disrupts the link between H2A.Z level and transcriptional activity (Papamichos-
Chronakis et al. 2011; Längst and Manelyte 2015).   
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1.1.3.7 Histone modifications and histone variants  
The four core histones consist of an N-terminal tail domain and a C-terminal histone fold 
domain (Cutter and Hayes 2015). The post-translational modifications affect either domain, 
and can either directly affect the interaction affinity with DNA and/or function indirectly by 
providing docking signals for the recruitment of other effect proteins, including TFs and 
chromatin remodelling complexes (Taverna et al. 2007; Musselman et al. 2012; Zentner and 
Henikoff 2013; Tessarz and Kouzarides 2014). Acetylation neutralizes the positive charge of 
lysine residues, and thus interferes with the electrostatic interaction between positively 
charged lysine residue and the negatively charged phosphates on the DNA backbone, leading 
to reduced stability of nucleosome formation (Hong et al. 1993). Histone acetylation is 
involved in a variety of cellular processes (Xu et al. 2005; Hu et al. 2011; Vavouri and 
Lehner 2012; Zentner and Henikoff 2013; Tessarz and Kouzarides 2014). Methylation does 
not affect the charge of the lysine residue and up to three methyl groups can be added to the 
lysine residue. In addition to lysine residues, histones can also be mono- or di-methylated on 
arginine residues (Zentner and Henikoff 2013; Tessarz and Kouzarides 2014). While histone 
acetylation is usually associated with transcriptional activation (Vavouri and Lehner 2012), 
histone lysine methylation can be associated with both transcription activation and repression 
(Barski et al. 2007; Valouev et al. 2011; Thurman et al. 2012; Vavouri and Lehner 2012).  
Histone variant H2A.Z containing nucleosomes have been shown to be preferentially 
located at promoters in both yeast and human species, and the H2A.Z level is associated with 
transcription rate, suggesting the H2A.Z containing nucleosomes are less stable (Albert et al. 
2007; Barski et al. 2007; Ramirez-Carrozzi et al. 2009; Vavouri and Lehner 2012). 
H3.3/H2A.Z containing nucleosomes are observed to be preferentially located at active 
promoters and other cis-regulatory sites in humans (Jin et al. 2009a).   
 
1.1.3.8 Nucleosome phasing and “statistical positioning” 
In contrast to nucleosome occupancy and positioning, the mechanisms by which 
eukaryotic genomes are compacted into regularly ordered arrays of nucleosomes 
(nucleosome phasing) are exclusively regulated by trans-acting factors, including linker 
histones and chromatin remodelling complexes, and positioning constraints such as the 
“statistical principle” (Kornberg 1981; Kornberg and Stryer 1988; Mavrich et al. 2008; 
Zhang et al. 2009; Valouev et al. 2011; Zhang et al. 2011). Kornberg and his colleague 
(Kornberg 1981; Kornberg and Stryer 1988) suggested that nucleosome formation on DNA 
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was decided by the difference in the sequence specificity of DNA for nucleosome histones 
and other non-histone regulatory proteins and proposed the statistical model for nucleosome 
position and distribution (Figure 1.3). In this model, nucleosomes cannot form on DNA 
associated with other proteins that set the boundary or barrier for the nucleosomes, whose 
positions are then restricted to the regions of DNA between the boundaries. Nucleosomes 
close to the boundary are well positioned and show clear periodicity in flanking regions up to 
1 kb (equivalent to about 5 nucleosomes), but this decreases and eventually disappears as the 
distance increases. A study from Fu et al. (2008) has revealed that the insulator CTCF can 
actually affect nucleosome positioning in this way. Nucleosomes cannot overlap with each 
other, and if the distance between the boundaries is less than 166 bp nucleosomes cannot 
form inside this region; thus the periodic pattern of nucleosome positioning can be affected 
by the concentration of core histones and the length of available DNA sequences (Kornberg 
1981; Kornberg and Stryer 1988; Mavrich et al. 2008; Vaillant et al. 2010). The barriers 
producing a boundary effect can be sequence-specific binding to DNA by cis-acting proteins 
including TFs and CTCF (Fu et al. 2008; Cuddapah et al. 2009; Valouev et al. 2011), the 
transcription coupled nucleosome depleted regions located at both 5’ and 3’ termini of genes 
(Kornberg and Stryer 1988; Mavrich et al. 2008; Vaillant et al. 2010), and the strongly 
positioned nucleosomes observed at “container sites” (Valouev et al. 2011; Gaffney et al. 
2012). The nucleosome phasing around “container sites” was only observed in vivo but not 
in vitro, which confirms the role of trans-acting factors and the “statistical principle” in 
establishing the regular spacing between nucleosomes (Valouev et al. 2011). 
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Figure 1.3. Illustration of the concept of “statistical 
positioning”. The probability of a nucleosome positioning 
at a certain place was shown as vertical arrows and the 
linear distance from the boundaries at two ends of a region 
was shown as horizontal arrows.  
1.1.4 Personal summary 
Though some labs used different approaches and came to different conclusions in terms 
of whether cis or trans factors are the major determinants of nucleosome positioning (Tirosh 
et al. 2010; Hughes et al. 2012), my opinion on this is that both the DNA sequences and 
trans factors such as TFs are essential. While DNA sequence determines the baseline 
nucleosome organization in a given genome other factors including TFs, regulate the genome 
functions, such as the cell identity, through affecting nucleosome positioning. 
 
1.2 Mutation spectra and chromatin structure 
1.2.1 Central importance of mutations in the evolutionary process and human 
diseases 
Mutation provides raw materials required for evolution to occur both at organism level 
and cell level. While mutation contributes to biological diversity on earth, it also contributes 
to human heritable diseases, since mutations that occur in germ cells are passed on from 
generation to generation (germline mutations). In non-heritable disease, mutations can 
accumulate in the genomes of dividing cells in somatic tissues as people age (somatic 
mutations). Mutations may have functional consequences by affecting gene expression 
patterns (mutation in ci-regulatory sites), and/or protein structural changes (such as loss of 
function and gain-of-function mutations in coding regions), which underlie human diseases 
including cancer. Cancer can be regarded as a disease of the genome and is the result of an 
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evolutionary process within populations of cells (Crespi and Summers 2005; Jones et al. 
2008; Ye et al. 2009; Heng et al. 2010; Heng et al. 2011). Driver mutations in a certain 
subset of important genes like tumour suppressor genes (loss-of-function mutations) and/or 
oncogenes (gain-of-function mutations) confer proliferation and survival advantages to 
carrier cells over their neighbours. As a result of this evolutionary process, positively 
selected cells with increased fitness are clonally expanded and acquire increased ability to 
survive and invade proximal and distal organs through blood and lymphatic vessels, leading 
to cancer development and progression (Ye et al. 2009; Heng et al. 2010; Talavera et al. 
2010; Chaffer and Weinberg 2011; Lawrence A. Loeb 2011; Valastyan and Weinberg 2011). 
Passenger mutations happen by chance with no effect on cell fitness and only expand in cell 
populations because of driver mutations (Pon and Marra 2015). Talavera et al. (2010) 
showed that mutations are not evenly distributed across coding sequences, with driver 
mutations concentrated in conserved functional domains while the passenger mutations are 
more evenly dispersed. Indeed, the main goal of The Cancer Genome Atlas (TCGA) 
consortium was to catalogue the driver mutations, identifying targets for the delivery of 
better personalized medical service.   
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1.2.2 Variations in mutation spectra 
Due to the central importance of mutations in both evolutionary biology and the aetiology 
of human diseases, great efforts have been focused on understanding the mechanisms 
underlying variation in the mutation rate. The distribution of mutations of different types is 
not random and variation in mutation rates is a general feature across the genome (Baer et al. 
2007). The rate of mutations, both germline and somatic, vary from chromosome to 
chromosome and from region to region within a given chromosome measured at different 
scales, ranging from single nucleotide to mega-base scales (Gaffney and Keightley 2005; 
Hellmann et al. 2005; Spencer et al. 2006; Hodgkinson and Eyre-Walker 2011; Hodgkinson 
et al. 2012; Schuster-Böckler and Lehner 2012; Makova and Hardison 2015; Polak et al. 
2015). It has been observed that germline mutation rate is higher in sex chromosome than 
autosomal chromosome and higher in male than female, due to the phenomenon of male 
mutation bias where, compared to the eggs in female, sperm cells in male have increased 
numbers of cell divisions (Crow 2000; Conrad et al. 2011; Wilson Sayres and Makova 
2011). Since DNA replication is not a perfect process the increased cell divisions lead to a 
higher accumulation of mutations in sperm. Kong et al. (2012) found that the rate of de novo 
germline mutations could be explained by the father’s age when children were conceived, 
showing a linear relationship with an increase of two mutations per year. Genomic context 
also affects the mutation rate. At the lowest single base pair scale, the mutation rate is 
affected by the neighbouring nucleotide composition, exemplified by the increased rate of C-
>T base changes (both germline and somatic) at CpG sites, due to the methylation of 
cytosine (C) in the context of CpG dinucleotide and conversion of methylated cytosine to 
thymine (T) through deamination (Hwang and Green 2004; Lee et al. 2010; Pleasance et al. 
2010; Chapman et al. 2011; Hodgkinson and Eyre-Walker 2011). In contrast, 
hydroxymethylated cytosines were observed to preferentially mutate to guanine (G) (Supek 
et al. 2014), although interestingly mutation rate is significantly decreased at promoter CpG 
islands (Polak and Arndt 2008; Cohen et al. 2011; Hodgkinson and Eyre-Walker 2011). 
Sequence comparison between human and chimpanzee has shown that the SNPs in human 
are excessively enriched at the sites where there are also chimpanzee SNPs and the base 
substitution rate increases around insertions and deletions (Indels) (Tian et al. 2008; 
Hodgkinson and Eyre-Walker 2011; Johnson and Hellmann 2011).  
In addition to the variation in the mutation rate across the genome, heterogeneity has been 
also observed between cancer cells and normal somatic cells, and also between different 
cancer types (Greenman et al. 2007; Salk et al. 2010; Lawrence et al. 2013). Various studies 
have clearly shown that mutation spectra are tumour specific and show differential degrees 
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of heterogeneity across different cancer types, different tumours of a given cancer type, and 
different cell populations within a single tumour (Salk et al. 2010; Lawrence A. Loeb 2011; 
Gerlinger et al. 2012; Helleday et al. 2014). In the past few years, increasing efforts have 
been made to explain these varying mutation spectra (Nik-Zainal et al. 2012; Ludmil B. 
Alexandrov et al. 2013; Helleday et al. 2014). For example, based on a non-negative matrix 
factorization algorithm (NMF), the landscapes of somatic mutations seen in different 
tumours can be considered to be the total sums of products of the exposure rates and 
signatures of individual mutational processes, which in turn are determined by distinct 
mutagenesis pathways and deficits in DNA repair systems (Ludmil B. Alexandrov et al. 
2013; Helleday et al. 2014).  
 
1.2.3 Chromatin structure and mutation rates  
Every nuclear process involving genomic DNA happens in the context of chromatin, and 
both genome landscape features and chromatin structure have been observed to be closely 
associated with regional variation in mutation rates (Makova and Hardison 2015). For 
example, Hellmann et al. (2005) have found that genomic features, including GC and CpG 
content, recombination rates, and the distance to the centromere and telomere, are associated 
with both sequence diversity within human species and the sequence divergence between 
human and chimpanzee. Hodgkinson et al. (2012) have observed significant variations in 
somatic mutation density at mega-base scales, which are correlated with both genomic and 
epi-genomic features, including GC content, nucleosome occupancy, and other factors. DNA 
replication timing has also been found to be correlated with the rate of single nucleotide 
substitutions in cancer genomes (Liu et al. 2013).   
Chromatin structure, from three-dimensional nuclear organisation, to nucleosome 
positioning and occupancy at primary level, have proved to be important determinants of the 
variation in mutation spectra (Makova and Hardison 2015). Human-chimpanzee sequence 
divergence has been found to be relatively higher in regions of closed chromatin than that of 
open chromatin (Prendergast et al. 2007). Analyses to assess the impact of higher order 
chromatin structure on somatic mutational spectra at 1 Mb scale in human cancers have 
shown that the somatic mutation rate is mainly determined and shaped by chromatin 
organization (Schuster-Böckler and Lehner 2012; Polak et al. 2015). Schuster-Böckler and 
Lehner (2012) found that even though other features, including GC content, are associated 
with mutational rate at 1 Mb scale, the single feature H3K9me3 that is associated with 
heterochromatin can account for more than 40% of the variation seen in mutation rate and 
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combined features related to chromatin organization explain more than 55% of the variation 
in somatic mutation rates. In addition, when regressing the somatic mutation rate at 1 Mb 
scale against the genomic and epi-genomic features from the same cell type, Polak et al. 
(2015) found that chromatin accessibility and modification, together with replication timing, 
explain up to 86% of the variation in mutation rates across 173 genomes from 8 cancer types.  
The relationship between the openness of chromatin (accessibility) and base substitution 
rate often seems to be contradictory between studies: some have found that the base mutation 
rate is elevated in closed heterochromatin while others found that the base mutation rate is 
actually elevated in the open chromatin (Birney et al. 2007; Haygood et al. 2007; 
Prendergast et al. 2007; Taylor et al. 2008: 11). For example, while Prendergast et al. (2007) 
observed higher human-chimpanzee sequence divergence in closed chromatin and Thurman 
et al. (2012) found the mutation rate at open chromatin (DHS) was lower than 4-fold 
degenerate sites, previous work has suggested that primate promoter regions are subject to 
higher mutation rates than other regions of the genome (Taylor et al. 2006; Taylor et al. 
2008). The observation of higher mutation rates in both closed and open chromatin was 
confirmed in two multivariate analyses: canonical correlation analysis (CCA) and hidden 
Markov model genome segmentation analysis (Ananda et al. 2011; Don et al. 2013). On one 
hand, the base substitution rate was observed to be elevated at regions harbouring nuclear 
lamina binding sites in closed chromatin; on the other hand, along with insertions and 
deletions, base substitutions were seen to be highly elevated at open chromatin (Ananda et al. 
2011; Don et al. 2013). The base substitution rate has also been shown to be elevated at sites 
surrounding insertions and deletions (Tian et al. 2008) and the intervals with elevated 
insertion, deletion and substitution rates were located in open chromatin with reduced lamina 
interactions and enriched with DHS and H3K4me1 marks, making up about 8% of the 
genome. In contrast, intervals characterised by mildly elevated deletion and substitution rates 
were associated with closed chromatin featuring high number of nuclear lamina binding sites 
and low DHS and H3K4me1 levels, making up 18% of the genome.  
At the primary level of chromatin structure, the linkage between nucleosome positioning 
and sequence divergence is well supported (Gilbert et al. 2004; Gazave et al. 2007; 
Prendergast et al. 2007; Washietl et al. 2008; Semple and Taylor 2009; Prendergast and 
Semple 2011). Higasa and Hayashi (2006) found that the distribution of human SNPs shows 
a 146bp periodicity around CpG but not nonCpG TSSs. Also, Sasaki et al. (2009)
 
observed a 
200bp periodicity of mutation rates around TSSs in Medaka fish and found that this 
periodicity is associated with nucleosome positioning. However, Tolstorukov et al. (2011) 
have not found any significant correlation between nucleosome occupancy level and SNP 
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frequency around TSSs in humans. Several groups have noted a higher rate of sequence 
variation at nucleosome cores relative to linker DNA, which could be explained by 
differential mutation rates, or by alterations in the modes and strength of selection between 
core and linker regions. Prendergast and Semple (2011) have shown that both mutation rates 
and patterns of selection observed in the human lineage are correlated with nucleosome 
positioning. Furthermore the direction and strength of selection observed was predicted to 
maintain the optimal variation in local GC content for nucleosome positioning. In yeast, the 
variation in GC content between nucleosome core and linker regions has been linked to 
mutational bias, and the presence of nucleosomes has been shown to preferentially suppress 
certain types of spontaneous single base mutations (Chen et al. 2012; Xing and He 2015). 
 
1.2.4 Personal summary 
Mutations is of central importance of mutations in the evolutionary process and human 
diseases. In addition, mutational spectra is linked with different levels of chromatin structure, 
both at mega-base and  nucleosome level. Thus a potential confounding factor to affect the 
mutational spectra across different cells is whether global nucleosome positioning is 
massively altered  across cells.  
 
1.3 Goals of investigation 
In this thesis, I am interested in nucleosome positioning dynamics in evolution and 
disease, and the interplay between mutational spectra and nucleosome structure. 
I firstly focused on nucleosome positioning evolution in the human genome. To better 
understand the role of DNA sequence in nucleosome positioning dynamics in vivo, Chapter 2 
is focused on the effect of genetic changes on nucleosome locations between paralogous 
regions, where a genomic segment is copied and inserted into a new genomic region within 
the same sample (using in vitro and in vivo datasets). The levels of trans-acting factors are 
inherently controlled for by comparing paralogous regions in vivo, and all broad features of 
the cellular environment (the expression of chromatin binding proteins etc.) should be 
consistent between regions. However duplicated region pairs will share different levels of 
sequence similarity, allowing us to assess the role of sequence changes in altering 
nucleosome structure. Also comparisons of duplicons between in vivo and in vitro samples, 
where trans factors are completely absent, allows one to study the roles of trans factors in 
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positioning. In Chapter 3, I directly compared nucleosome positioning evolution between 
paralogous regions in human and yeast genomes side by side to investigate whether the 
sequence related mechanisms in nucleosome positioning evolution were conserved between 
these two eukaryotes which are separated by over 1 billion years.  
In Chapter 4, I investigated nucleosome positioning in human diseases and the interplay 
between mutational spectra and nucleosome structure. Previous evidence suggests that the 
positioning of nucleosomes and the patterns of histone modifications or variants they carry 
may differ between cancer and normal cell lines (Fraga et al. 2005; Barski et al. 2007; 
Esteller 2007; Lin et al. 2007; Zhang et al. 2008; Jin et al. 2009a; Chodavarapu et al. 2010; 
Portela and Esteller 2010; Brait and Sidransky 2011; Wilson and Roberts 2011; Collings et 
al. 2013). Thus I directly compared nucleosome positioning across 4 cancer and 7 non-
cancerous cell lines, aiming to investigate whether the nucleosome organization seen in 
cancer cell lines is altered compared to that in non-cancerous cell lines. I then analysed the 
interplay of mutational spectra (germline and somatic) with nucleosome structure and 
concluded that the profiles seen for somatic and germline cells depend upon a common 
landscape of conserved chromatin structure, since nucleosome positioning was conserved 
across all 11 cell lines examined. 
Finally in Chapter 5, I extended our studies of mutational spectra by comparing genome 
sequencing data from various tissues in a cohort of individuals to identify human somatic 
mutations. This allowed me to explore the relationships between age and mutation number 
and to seek inherited genetic variants linked to high somatic mutation rates. I identified a list 
of candidate germline variants that potentially predispose to increased somatic mutation rates. 
Together these analyses contribute to an integrated view of genome evolution, encompassing 
the divergence of DNA sequence and chromatin structure, and how they may interact in 
human disease. 
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Chapter 2: Nucleosome Positioning Dynamics 
in Evolution 
 
 
2.1 Introduction 
Nucleosome positioning is involved in a variety of cellular processes and provides a 
likely important substrate for species evolution; the positions of nucleosomes have been 
shown to be relatively well conserved between species, in particular around promoters (Jiang 
and Pugh 2009; Hughes and Rando 2014). Nucleosome positioning is generally considered 
to be determined by the combined effects of DNA sequence preference, steric constraints 
from neighbouring nucleosomes which can be explained by statistical positioning, and trans-
acting factors (Kornberg and Stryer 1988; Segal et al. 2006; Mavrich et al. 2008; Struhl and 
Segal 2013). However, many fundamental aspects of nucleosome positioning remain 
controversial, such as the relative importance of underlying sequence features, genomic 
neighbourhood and trans-acting factors (Kaplan et al. 2008; Zhang et al. 2009; Stein et al. 
2010; Tirosh et al. 2010; Hughes et al. 2012). For example, homo-polymeric poly(dA:dT) 
sequences that are intrinsically nucleosome repelling are enriched in yeast promoters, and 
associated with the classical nucleosome depleted region (NDR) upstream of transcription 
start sites (TSSs); in contrast, the NDR observed in human promoters is generally GC rich in 
sequence and GC rich sequences have been shown to be intrinsically nucleosome favouring, 
directly arguing for the formation of NDR in human promoters by trans-acting factors (Tillo 
et al. 2010; Valouev et al. 2011; Struhl and Segal 2013).  
Investigations into nucleosome positioning can be categorised into single-locus scale, 
large-scale, and genome-wide scale (Jansen and Verstrepen 2011). Large-scale studies of 
nucleosome positions in both yeast and human genomes started with the chromatin 
immunoprecipitation followed by DNA microarray (ChIP-chip) technology (Bernstein et al. 
2004; Lee et al. 2004; Yuan et al. 2005; Heintzman et al. 2007; Lee et al. 2007; Ozsolak et al. 
2007). However, only thanks to the advance in next generation sequencing (NGS) 
technologies in the past decade, which all feature low per-base cost and massively parallel 
sequencing ability (Mardis 2008; Liu et al. 2012; Koboldt et al. 2013), the genome-wide 
nucleosome positions maps have been generated routinely to study the patterns and 
 
26 
 
determinants of positioning of bulk nucleosomes and/or subsets of functionally distinct 
nucleosomes, including H2A.Z and H3.3/H2A.Z containing nucleosomes which are enriched 
at promoters, and H3K4me3 containing nucleosomes around TSSs (Albert et al. 2007; 
Barski et al. 2007; Jin et al. 2009b; Thurman et al. 2012). Bulk chromatin in vivo or in vitro 
(resulted from the assembly of purified histone octamers on the genomic DNA are 
fragmented by either physical shearing, like sonication, or enzymatic digestion, such as 
micrococcal nuclease (MNase). Nucleosomal DNA is protected from digestion while linker 
DNA is preferentially digested by MNase (Chung et al. 2010; Jansen and Verstrepen 2011; 
Allan et al. 2012). Mono-nucleosome sized DNA fragments are extracted and purified from 
PCR gel. In chromatin immunoprecipitation followed by next generation sequencing (ChIP-
Seq), the genomic DNA is firstly covalently cross-linked to core histones and fragmented by 
physical or nuclease methods as mentioned above, then nucleosome bound DNA fragments 
are then pulled down and enriched by chromatin immunoprecipitation (ChIP) with antibodies 
against the specific residues in the core histones which can be either residues of the 
canonical histone or variant, or post-translationally modified residues (Barski et al. 2007; 
Anon 2011; Tollefsbol 2011). Enriched and purified nucleosome-protected DNA fragments 
are finally sequenced by different NGS sequencing platforms. The ChIP-Seq protocol was 
widely applied in Encode project to identify and annotate the functional elements including 
chromatin states (Consortium 2004).  
The genome-wide pattern of nucleosome positions in a given genome can be described by 
related but distinct entities, including nucleosome occupancy, nucleosome transitional and 
rotational positioning, and nucleosome spacing. Empowered by the high throughput of the 
NGS technologies and due to its biological importance, great interest has been focused on 
linking the specific aspects of nucleosome positioning with individual determinants, aiming 
to better understand the mechanisms governing nucleosome positioning in detail. For 
example, building on the knowledge from biochemical studies that poly(dA:dT) has low 
affinity with core histones, (Raveh-Sadka et al. 2012) have demonstrated that manipulating a 
poly(dA:dT) tract can cause change in gene expression in a predictable way, corroborating 
former claims from the same group on the role of DNA sequences in nucleosome positioning 
(Anderson and Widom 2001; Segal et al. 2006; Kaplan et al. 2008; Segal and Widom 2009). 
The causal effect of RNA polymerase on regulating nucleosome occupancy and transitional 
positioning has been demonstrated in a study from Weiner et al. (2010) which compared 
both nucleosome occupancy and transitional positioning around promoter and TSS regions 
before and after the induction of the loss of function of RNA polymerase. The central 
importance of chromatin remodelling complexes in nucleosome positioning has been shown 
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by Zhang et al. (2011). In the in vitro nucleosome reconstruction by mixing genomic DNA 
and purified histones plus the whole cell extract (WCE), the Adenosine triphosphate (ATP), 
but no other nucleoside triphosphates, is required to well match the in vivo nucleosome 
organization pattern around 5’ end of genes (Zhang et al. 2011), confirming the ability of 
chromatin remodelling complex, using energy produced by the hydrolysis of ATP to evict or 
slide nucleosomes from their original positions, in organizing nucleosomes at 5’ of genes 
alone (Clapier and Cairns 2009). In addition, the sufficiency of chromatin remodelling 
complexes in uniformly placing nucleosomes into an array has been shown to be 
independent of statistical positioning, indicated by the observation of the regular spacing 
between nucleosomes with low histone concentration while the high nucleosome 
concentration was required by statistic principle (Zhang et al. 2011).  
However, disentangling effects of individual factors on nucleosome positioning is far 
from simple and straightforward when it comes to differentiating whether the nucleosome 
positioning is primarily determined by cis-acting DNA sequence preferences, as shown by 
the contradicting conclusions reached by different studies after comparing genome-wide 
nucleosome positioning maps in yeast generated by different approaches (Kaplan et al. 2008; 
Zhang et al. 2009; Tirosh et al. 2010; Hughes et al. 2012). Both Kaplan et al. (2008) and 
Zhang et al. (2009) have contrasted in vitro and in vivo genome-wide nucleosome maps but 
came to opposite conclusions. A joint review by these studies’ authors, published in 2013 
(Struhl and Segal 2013), attributed the discrepancy to the fact that, nucleosome occupancy 
was chosen to represent the genome-wide nucleosome positioning in Kaplan et al. (2008); 
while in Zhang et al. (2009), nucleosome positioning was strictly interpreted to be the exact 
nucleosome translational positioning (Kaplan et al. 2010; Pugh 2010; Zhang et al. 2010). 
The comparison of in vitro and in vivo nucleosome maps has been used in other studies to 
deduce the relative contribution of DNA sequence to nucleosome positioning. The 
comparison of in vitro and in vivo human nucleosome positioning maps from three primary 
blood cell lines enabled Valouev et al. (2011) to deduce a sequence preference driven 
nucleosome positioning signal called the “container site”, which is distinct from the 
rotational preference and was formed by the synergic effects of GC rich sequence in core and 
AT rich sequence in linker. The “container site” was later observed in a region of 76 kb 
around the centromere on chromosome 12 in Gaffney et al. (2012). Other efforts have 
combined genetic and evolutionary approaches to study the relative contributions of cis and 
trans determinants. For example, Tirosh et al. (2010) compared the inter-species difference 
in nucleosome positioning between S. cerevisiae and S. paradoxus with that of their hybrid. 
Differences maintained in the hybrid were inferred to be largely the result of cis-acting DNA 
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sequences, rather than the presence of trans-acting chromatin binding proteins that are 
expected to be distinct in different species. These authors estimated that about 70% of inter-
species divergence in nucleosome positioning is due to DNA sequences, which is mainly 
realised by the anti-nucleosomal 5-mers of AT nucleotides rather than the GC rich 
nucleosome favouring sequences. The features chosen to represent nucleosome positioning 
include both nucleosome occupancy and nucleosome translational positioning, thus arguing 
for the role of DNA sequence in nucleosome translational positioning in contradiction to 
Zhang et al. (2009). A different experimental approach (Hughes et al. 2012) introduced yeast 
artificial chromosomes (YACs) containing genomic DNA from other yeast species into S. 
cerevisiae cells, and compared the nucleosome positioning between these yeast artificial 
chromosomes and the same regions in their native, donor species. In contrast to the findings 
of Tirosh et al. (2010), they observed that the only feature that is invariant between native 
and donor species is the nucleosome depletion due to the poly(dA:dT), but other features, 
including nucleosome spacing and the translational positioning of the +1 nucleosome, 
differed notably between the same DNA sequences in YACs and their native species, 
suggesting trans- acting factors are in fact the primary determinants of nucleosome 
translational positioning. 
One limitation of these previous studies is that the levels of trans-acting chromatin 
binding factors are expected to vary widely between cell types, replicates and organisms. To 
better understand the role of DNA sequence in in vivo nucleosome positioning, ideally one 
would investigate the effect of sequence changes on nucleosome locations within the same 
organism and within the same sample of cells. To achieve this, we have investigated the 
extent to which nucleosome positioning patterns change following the duplication of a DNA 
sequence and its insertion into a new genomic region within the same species, by assessing 
the relative nucleosome positioning between paralogous regions in the human genome (using 
in vitro and in vivo datasets). Within in vivo samples, broad features of the global cellular 
environment (the expression of chromatin binding proteins etc.) should be consistent and 
controlled for, but duplicated regions will share different levels of sequence similarity. The 
effects of changes in the DNA sequence between duplicons, including the birth or death of 
binding sites (motifs), can therefore be studied while controlling for global levels of the 
relevant trans factors. Comparisons to duplicons within in vitro samples, where trans factors 
are completely absent, allows one to distinguish divergence in nucleosome positioning where 
trans factors play no role at all. 
The studies of duplicated regions have already provided numerous insights into genome 
evolution (Zheng 2008; Lorente-Galdos et al. 2013; Prendergast et al. 2014). Duplication 
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events, transferring copies of one genomic region to a new location, being considered a key 
driving force for the creation of new genes in eukaryotic genomes (Wolfe and Shields 1997; 
Koszul et al. 2004; Dehal and Boore 2005; Aarts et al. 2014). It has been estimated that 
approximately 5% of the human genome has arisen from a recent duplication event, 
corresponding to around 150 Mb of sequence (Marques-Bonet et al. 2009). Although the 
evolving DNA sequences of sister duplicons have been explored in detail since the 
publication of the yeast genome (LangkjAEr et al. 2003; Papp et al. 2003; Kellis et al. 2004), 
their epi-genomic divergence is under studied. Recent work has shown that human DNA 
methylation patterns appear to be well conserved following a duplication event (Prendergast 
et al. 2014), but Zheng (2008) have also observed that histone modifications show 
asymmetric patterns between duplicons. However, the evolution of nucleosome positioning, 
though fundamental to chromatin structure, has not been studied between duplicated sister 
regions across the human genome. 
In this chapter, we have focused on the analyses of the divergence and conservation of 
nucleosome positioning, and investigated the potential roles of both DNA sequence features 
and local chromosomal environments in nucleosome positioning evolution, by investigating 
the correspondence between the positions of in vivo and in vitro nucleosomes, and also by 
comparing genome-wide nucleosomes between human paralogous regions in vitro and in 
vivo. We observed significant correspondences between the positions of in vivo and in vitro 
nucleosomes and detected the DNA composition and local chromatin state related 
nucleosome positioning signals. In addition, the positioning of paralogous nucleosomes is 
generally well conserved and we detected a strong rotational preference where nucleosome 
positioning has diverged. Though both DNA sequence features and local chromosomal 
environments are significantly associated with nucleosome positioning evolution between 
paralogous regions, DNA sequence features appear to be more important than local 
chromosomal environments both in vivo and in vivo. 
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2.2 Materials and Methods:  
2.2.1 Bioinformatics tools used  
2.2.1.1 Bowtie1 and Bowtie2 
Though there are several short read aligners available, we chose Bowtie1 and Bowtie2 in 
this study (Langmead et al. 2009; Langmead and Salzberg 2012). Bowtie1 and Bowtie2 are 
both ultrafast and memory efficient in mapping reads to long sequences such as the human 
genome. The pre-built human genomes (hg18) were downloaded from the Bowtie1 website 
(http://bowtie-bio.sourceforge.net/manual.shtml#paired-end-alignment). Bowtie1 was used 
to map single-end reads (33 bp) in colour space generated for the in vitro human dataset and 
Bowtie2 was used to map paired-end reads (25 bp each) for the in vivo human sample 
respectively. We used Bowtie1 for mapping in vitro reads because only Bowtie1 supports 
alignment of reads in colour space. 
 
2.2.1.2 iNPS  
Improved nucleosome-positioning algorithm (iNPS) was used to called nucleosomes in 
vitro (Chen et al. 2014). To infer nucleosome positions, iNPS extends each MNase-seq tag 
from the 5' end by 150 bp towards the 3' position, the middle 75 bp is then selected to infer 
the nucleosomes position, iNPS then detects the inflection start and end points, which 
represent the borders of nucleosomes, from the smoothed nucleosome occupancy profile, and 
defines dyads as the midpoints of the paired inflection points. Nucleosomes called by iNPS 
have a 10 bp resolution, an uncertainty of 10 bp in nucleosome’s real positions.  
 
2.2.1.3 PERL and R  
PERL (version 5.14.1, https://www.perl.org/) is a high-level and general purpose 
programming language and has been used for the daily data handling and manipulation. Data 
manipulation for statistical analysis and all the statistical analyses were carried out in R 
(version 3.1.0, https://www.rproject.org/) using its standard functions and extension 
packages including Reshape and Plyr for data manipulation and ggplot2 for data 
visualization (Wickham 2014; Wickham 2015; Wickham and Chang 2015: 2). 
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2.2.2 Summary of datasets used 
2.2.2.1 The paralogous regions 
The list of paralogous segments (sequence identity ≥ 90%; length ≥ 1 kb), that are 
enriched in telomere and centromere related regions and comprise 159 Mb of the human 
genome (based on hg18), was obtained from http://humanparalogy.gs.washington.edu/ (She 
et al. 2004). We identified a total of 53,626 pairs of paralogous regions in the human genome, 
with a median average size of 3 kb. The size distribution is plotted in Figure 2.1. 
 
 
 
Figure 2.1. Size distributions of average paralogous 
duplicons in the human genome. 
 
2.2.2.2 Sequencing reads for human in vivo sample 
The paired-end sequencing reads to infer human nucleosome positions in vivo were 
obtained from (Gaffney et al. 2012). The authors studied genome-wide nucleosome 
organization in lymphoblastoid cell lines belonging to seven Yoruba individuals from the 
HapMap project, generated by MNase digestion of chromatin, size selection of mono-
nucleosomal DNA fragments, and both single-end and paired-end sequencing. The data 
included in this analysis were based on the paired-end reads  
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2.2.2.3 Sequencing reads for human in vitro sample 
The in vitro nucleosomes were generated through the reconstruction of recombinant 
Xenopus histones onto human genomic DNA derived from neutrophil granulocytes (Valouev 
et al. 2011). Briefly, purified naked genomic DNA was sheared by sonication and fragments 
of length ranging from 850 bp to 2000 bp were selected to be mixed with approximately 
equal molar of histone octamers to ensure that on average one nucleosome was found every 
850 bp. The resulting nucleosomes in six replicate experiments were then digested with 
MNase, and mono-nucleosomal DNA fragments were retrieved by size selection and 
sequenced from one-end (single-end sequencing) using the SOLiD technology to generate 
reads of 35 bp in colour space. 
 
2.2.2.4 HOMER genome-wide motifs 
The list of genome-wide motifs predicted by the HOMER program was downloaded from 
the HOMER website 
(http://homer.salk.edu/homer/data/motifs/homer.KnownMotifs.hg19.bed.gz, (Heinz et al. 
2010). The genome-wide sequence scanning and motif prediction was based on the known 
motifs for different factors in the HOMER motif database which is collated from different 
sources. Motifs that are deposited in the HOMER database include transcription factor 
motifs from ChIP-Seq data, promoter related motifs which are preferentially enriched in 
promoters as compared against random genomic regions, and general factor motifs which are 
observed to bind to factors in different studies but lacking information on the direct 
association between DNA binding domains and motifs. Generally, screening for binding 
motif for a particular factor consists of two main steps: generating a position-specific weight 
matrix (PSWM) where each row (corresponding to one position) represents the observed 
frequencies of four nucleotides A, T, C, and G based on DNA sequences bound by a given 
factor. Query sequences are compared against these PSWM to assess how likely the query 
sequence matches the PSWM for a particular factor (Stormo 2000; Heinz et al. 2010). 
 
2.2.2.5 Chromatin state data 
Chromatin state data for the lymphoblastoid cell line GM12878 was downloaded from the 
UCSC genome browser (Kent et al. 2002; Ernst et al. 2011). The study generated density 
maps for nine histone marks by ChIP-Seq and an input control from whole cell extract (WCE) 
of 9 cell lines including GM12878, resulting in 90 maps in total. Multivariate Hidden 
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Markov Model (HMM) was applied to learn the chromatin state for each 200 bp interval 
across the human genome in 9 cell lines based on the combinations of the signal density 
from 9 histone marks and input control. Consecutive intervals of 200bp with the same state 
were concatenated to generate final chromatin state maps for each cell line. A total of 15 
chromatin states were inferred (Table 2.1), including states corresponding to promoters, 
enhancers, insulators, actively transcribed regions, and repressed and inactive domains (Ernst 
and Kellis 2010; Ernst et al. 2011).  
 
                    Table 2.1. 15 chromatin states inferred in (Ernst et al. 2011) 
Chromatin states Function domains 
State 1 Active Promoter 
State 2 Weak Promoter 
State 3 Inactive/poised Promoter 
State 4 Strong enhancer  
State 5 Strong enhancer 
State 6 Weak/poised enhancer 
State 7 Weak/poised enhancer 
State 8 Insulator  
State 9 Transcriptional transition  
State 10 Transcriptional elongation  
State 11 Weak transcribed  
State 12 Polycomb-repressed  
State 13 Heterochromatin; low signal  
State 14 Repetitive/Copy Number Variation  
State 15 Repetitive/Copy Number Variation  
 
2.2.2.6 Uniqueness data 
Uniqueness data (hg18) based on reads of 35 bp (wgEncodeDukeUniqueness35bp table) 
was downloaded from UCSC genome browser to gauge the uniqueness (or mappability) of a 
given genomic position in the sense that whether a read can be unambiguously mapped back 
to its originating genomic position (Kent et al. 2002; Ernst et al. 2011; Derrien et al. 2012). 
The mappability of a given genome region depends on its sequence complexity, read length, 
and the number of mismatches allowed during mapping. We chose the uniqueness data for 
35 bp reads to approximately match the length of 33bp for single-end reads in vitro. Though 
reads are of 25 bp in vivo, it is far less of a problem for paired-end reads since both reads for 
a nucleosome fragment have to be uniquely mapped to two positions of 147 bp apart.  
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2.2.3 Analysis procedure 
2.2.3.1 Reads mapping 
To obtain nucleosome positions in the human genome, paired-end sequencing reads were 
obtained from (Gaffney et al. 2012) for the in vivo dataset, and single-end sequencing reads 
from (Valouev et al. 2011) for the in vitro analysis (Table 2.2). Sequence similarity is high 
between paralogous regions by definition, and therefore it was important to only analyse 
those regions where it was possible to unambiguously determine the locations of 
nucleosomes. For this reason when mapping reads to the genome with Bowtie2 for in vivo 
and Bowtie1 for in vitro datasets (Langmead et al. 2009; Langmead and Salzberg 2012), no 
mismatches in the entire read length (25 bp for paired-end reads and 33 bp for single-end 
reads) were allowed and only uniquely mapped reads were kept. Uniquely mapped reads 
from different sequencing runs were combined prior to determining nucleosome positions. 
The in vivo dataset was restricted to those reads derived from fragments of exactly 147 bp, 
and therefore expected to provide base-pair resolution nucleosome locations. The usage of 
the strictest parameters for mapping reads in our study resulted in ~45 million uniquely 
mapped and properly paired fragments of 147 bp in vivo from 16 replicate experiments and 
~408 million unambiguously mapped single-end reads in vitro from 6 replicates, compared 
to a total of ~124 million and ~996 million reads respectively in their corresponding original 
studies.  
 
 
Table 2.2. Summary of human in vivo and in vitro datasets 
Datasets 
Sequencing  
strategy 
Read 
length 
Total  
reads 
Nucleosomes  
called 
Source 
in vivo Paired-end 25 bp 90,243,756 3,039,065 Gaffney et al. 2012 
in vitro Single-end 33 bp 408,543,428 11,947,675 Valouev et al. 2011 
 
 
2.2.3.2 Nucleosome positioning inference 
To determine dyad positions in vivo, genome-wide midpoint profile was first generated, 
and a 150 bp sliding window with a 10 bp step was run on the midpoint profile, with the 
locations in each window with the highest fragment midpoint count identified, and annotated 
as nucleosome dyad if containing at least 4 midpoints. Consecutive dyad calls were not 
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allowed to overlap by more than 40 bp, by checking whether there was a dyad called in the 
upstream 107 bp interval, as done in Brogaard et al. (2012). I identified 3,039,065 
nucleosomes in vivo in total by this method. Due to the single-end sequencing for in vitro 
dataset, nucleosome positions were determined using the iNPS software described above 
using default parameters (Chen et al. 2014).with a total of 11,947,675 nucleosomes called at 
a resolution of 10 bp in vitro. 
 
2.2.3.3 Defining paralogous nucleosomes 
Nucleosomes located in each duplicated region were selected and assigned a relative 
position with respect to the start of the corresponding duplicated region in both in vivo and in 
vitro datasets. Reciprocally closest nucleosome pairs on each duplicate were defined as 
paralogous nucleosomes, as illustrated by a dummy example shown in Figure 2.2, for 
nucleosome A1 on paralog A, B1 is the corresponding nucleosome on paralog B that is 
closest to the location of A1; in turn the nucleosome on paralog A which is closest to B1 is 
A1. In this case, A1 and B1 are said to be reciprocally closest to each other and are defined 
as paralogous nucleosomes, and for the same reasoning nucleosomes A4 and B3 are also 
considered as a paralogous pair. However, though the closest nucleosome for A2 is B2 on 
paralog B, A2 and B2 are not reciprocally closest to each other because the closest 
nucleosome for B2 on paralog A is A3; instead, A3 and B2 are considered as paralogous 
nucleosomes.  
 
 
 
Figure 2.2. Schematic description on defining paralogous nucleosomes. 
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Due to the rounding strategy adopted by iNPS that each position is rounded down (in a 5 
prime direction) to the nearest 10n+1, all dyad positions in vitro end either with a 1 or 6, and 
there is risk of introducing an extra 10 bp bias between paralogous nucleosomes if one 
duplicon is aligned on the plus strand while the other is on a minus strand for a given pair of 
paralogous regions. As a result each nucleosome call had to be shifted 10 bp 3 prime if the 
containing duplicon was on the minus strand and the other on the plus strand. This is 
explained schematically in Figure 2.3. 
 
 
 
 
Figure 2.3. Correction of the inflated divergence of in vitro nucleosome 
positioning between paralogous regions due to the iNPS rounding approach. 
Correction of the inflated divergence of in vitro nucleosome positioning 
between paralogous regions due to the iNPS rounding approach. The dyad 
position of a nucleosome is defined as the midpoint of the inflection start 
and end positions by iNPS. Due to the strategy adopted by iNPS that each 
position is rounded down (in a 5 prime direction) to the nearest 10n+1, the 
inflection start position is rounded down to genomic coordinate 41 if the 
position is in the range [41, 50] (A and B). Similarly, the inflection end 
position is rounded down to genomic coordinate 81 if in the range [81, 90] 
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(A) and to 91 if in the range [91, 100] (B). Where the duplicons are inverted 
(paralog 2 on minus strand) this will lead to the divergence in nucleosome 
positioning being inflated by 10 bp, as indicated by the distance between 
nucleosomes coloured by blue and red. To correct this bias, 10 bp was 
added to the dyad position if the nucleosome is on the minus strand and its 
paralogous counterpart is on the plus strand, indicated by nucleosomes with 
green colours. 
 
2.2.3.4 Permutation to assess the conservation in nucleosome positioning 
To show whether there was conservation in nucleosome positioning between paralogous 
regions, I also compared the observed shift against the permuted shift for both in vivo and in 
vitro datasets (for Figure 2.9A page 59, page 46 of main text). In each pair of duplicons, I 
firstly retrieved reciprocally closest nucleosomes between duplicons, and the distance was 
calculated as the observed shift. To obtain permuted shift, I chose one duplicon by random as 
reference and randomly permute all nucleosomes while keeping the inter-nucleosome 
distance in the other duplicon. A random number between 1 and the duplicon length was 
generated and added to the genomic position of each nucleosome to be permuted. If the 
permuted genomic position of a nucleosome was X bp larger than the higher end point of the 
duplicon, it was projected at the X bp from the lower end point of the duplicon by 
considering the duplicon as circular. I then retrieved reciprocally closest nucleosomes 
between reference duplicon and permuted duplicon, and the distance was calculated as 
permuted shift. I repeated this permutation process for 1000 times and compared the 
distribution of observed shifts against that of the 97.5th percentile of permutation. 
To show whether there was conservation in positioning between in vivo and in vitro 
nucleosomes (for Figure 2.5A, page 54, page 41 of main text), I adopted a similar 
permutation strategy as between paralogous nucleosomes mentioned above. Due to the size 
of human genome, I randomly chose a 1 Mb region from each chromosome and compared 
the observed shift between in vivo and in vitro nucleosomes against that from permutation. 
To obtain the permuted shift, I randomly permuted all in vitro nucleosomes and calculated 
the distance between in vivo and permuted in vitro nucleosomes as the permuted shift. 
 
2.2.3.5 Defining nucleosome core and linker regions 
The core region of nucleosomes was defined as from -73 to +73 bp relative to the 
reference dyad, which is the centre position of the nucleosomes located on the reference 
copy that was randomly selected from each pair. The reason for randomly choosing a 
 
38 
 
member from each duplicated region as the reference copy is due to the constraint of sample 
size; for example, the ancestral copy of only a very small proportion of duplicons (~ 2%) 
could be determined in the human genome, and even then the ancestral nucleosome position 
would be unknown. This is because the nucleosome on the ancestral duplicon may have 
moved more than its paralog. Linker regions have been estimated at approximately 50bp in 
humans (Valouev et al. 2011), and so 50bp at each side of the core regions was annotated as 
linker region. In addition, we set the maximum shift in humans as 100 bp, as similarly done 
in Kaplan et al. (2008).  
 
2.2.3.6 Permutation analysis to detect the correlation in positioning between proximal 
paralogous nucleosome pairs 
To assess whether the shifts between proximal paralogous nucleosome pairs are 
correlated or not, the observed frequency of the difference in shifts between proximal 
paralogous nucleosome pairs was compared to that expected by chance. Shifts between 
paralogous nucleosome pairs as well as at other nearby paralogous pairs (up to 1 kb) were 
first recorded and the observed shifts of proximal pairs were then shuffled genome wide and 
the frequency of individual differences in shifts between nearby nucleosome pairs 
recalculated, this being repeated 1000 times. If the observed frequency of nucleosome pairs 
shifting by distance X was greater than the 97.5 percentile of permutations it was deemed 
significant. Because of the 10 bp resolution of nucleosome positions in the in vivo sample 
due to iNPS, the count of proximal paralogous pairs were smoothed using a 10 bp moving 
average by R package “caTools” (R Development Core Team 2009; Tuszynski 2014) .  
2.2.3.7 Multiple linear regression and relative importance test 
The relative contributions of different DNA sequence related features and local 
chromosomal environment variables to the divergence in nucleosome positioning evolution 
between paralogous regions were assessed by multiple linear regression (glm() package in R) 
in all datasets. To find factors with the most influence on divergence in positioning between 
paralogous regions, step functions, according to Akaike information criterion (AIC), were 
applied for model selection in R (Venables and Ripley 2002; R Development Core Team 
2009). Additionally, the relative importance of different variables to the divergence in 
nucleosome positioning was investigated by relative importance analysis using the “lmg” 
method from “relaimpo” R package, which assesses the proportion of variations (relative 
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importance) in the dependent variable explained by individual regressors in the linear model 
(Lindeman and Merenda 1980; Ulrike 2006; Groemping and Matthias 2013). 
 
2.2.3.8 The divergence in the occupancy of dyads around motifs in human genome   
Motif locations (in hg19) were obtained from HOMER 
(http://homer.salk.edu/homer/motif/, (Heinz et al. 2010) and lifted to hg18 using default 
parameters with the UCSC genome browser utility liftOver (Kent et al. 2002). Only 
relatively short motifs (≤ 50 bp; 242 motifs in total) were kept and analysed. For any given 
motif, we recorded the midpoint positions of all of its occurrences on both duplicons in each 
pair of the paralogous regions. For each recorded midpoint position, if there was only one 
occurrence of this particular motif in the 1001 bp window centred at the midpoint position 
but none in the 1001bp window centred at the projected midpoint position on the paralogous 
duplicon then the recorded midpoint position is annotated as motif maintained and 
correspondingly the projected midpoint position as  motif lost. To exclude the possibility that 
any occupancy changes was due to the region being unmappable to in the original ChIP-seq 
experiments that defined the motifs, we calculated the number of unique sites in the 101 bp 
window centred at the recorded and projected midpoints using the 
wgEncodeDukeUniqueness35bp table (hg18) from the UCSC genome browser respectively 
(Kent et al. 2002; Derrien et al. 2012). Only pairs with at least 50 unique sites in the 101 bp 
window at both duplicons were kept and analysed. Positions between -20 bp to +20 bp 
relative to motif midpoints (observed and projected) were selected and analysed. For each 
motif, I then calculated a dyad frequency, from all occurrences of this particular motif, at 
each position selected (-20 to +20 bp relative to motif midpoints) as the ratio of the observed 
number of dyads to the total number of sites that can be uniquely mapped. Since the number 
of nucleosomes called in vivo is far less than in vitro (~3 million in vivo compared to ~12 
million in vitro) and to make the analyses comparable between in vivo and in vitro, at each 
position relative to any given observed or projected motif separately both in vivo and in vitro, 
I calculated a nucleosome dyad occupancy score, defined as log2(
𝑁
𝑀
), where N represents the 
dyad frequency at each relative position of a given observed or projected motif and M 
presents the median value of the dyad frequencies at all positions selected from 242 motifs. 
The difference in dyad occupancy scores between maintained and lost motifs was tested 
using both the Student’s t-test and Mann-Whitney test in vivo and in vitro.  
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Figure 2.4. Schematic drawing to show that the DNA motif is absent in one duplicon. This can 
be due to the loss of the motif in one duplicon (such as paralog B) or birth of the motif in the 
other duplicon (such as paralog A). To decreased the influence on the nucleosome occupancy of 
proximal occurrence from the same motif, a window of 1001 bp was centered at the midpoint of 
a given observed motif (on Paralog A) and the occupancy scores of nucleosome dyads from 
positions -20 to +20 relative to the midpoits of observed (solid red eclipse) and projected (red 
dashed line) motifs were contrasted in a given pair of paralogous regions only if 1) the observed 
motif is the only occurrence in this 1001 bp window; and 2) there are at least 50 positions that 
can be uniquely mapped in each window of 101 bp centered at observed and projected motif 
points respectively.  
 
 
41 
 
2.3 Results 
2.3.1 Translational positioning between in vitro and in vivo nucleosomes 
A widely accepted approach to study the importance of DNA sequence in nucleosome 
positioning has been the comparison of nucleosome positions maps generated in vitro and in 
vivo (Kaplan et al. 2008; Zhang et al. 2009; Valouev et al. 2011). To directly investigate the 
divergence of nucleosome positioning between in vitro and in vivo human samples, I 
retrieved 2,472,523 pairs of nucleosomes meeting the maximum inter-dyad distance of 100 
bp, as done in Kaplan et al. (2008). In vivo nucleosome positions (at up to 1 bp resolution) 
were called from a previous study that sequenced MNase digested DNA obtained from 5 
lymphoblastoid cell lines (Gaffney et al. 2012). The in vitro nucleosome positions (10 bp 
resolution) were determined from a second study that reassembled recombinant Xenopus 
histones onto human genomic DNA derived from neutrophil granulocytes (Valouev et al. 
2011).  
I observed a symmetry in the distribution of the signed distance around +4 bp, rather than 
0 bp as may be expected, due to the rounding strategy used by iNPS such that nucleosome 
dyad ends with either a 1 or 6 (Figure 2.5A). In addition, it clearly showed conservation in 
positioning between in vivo and in vitro nucleosomes (Figure 2.5A). To test whether the 
observed conservation in nucleosome positioning was significant, I compared the 
distribution of observed shifts against that from permutation based on a random 10 Mb 
region from each chromosome. As shown in Figure 2.5B, compared to permutation, the 
divergence in positioning between in vivo and in vitro nucleosomes was significantly lower. 
However, the direct comparison of translational positions in vitro against in vivo human 
samples might lack the power to detect DNA sequence driven nucleosome positioning 
signals, due to the potential technological variations in the generation of in vitro and in vivo 
nucleosome positions maps.  
Due to the 10 bp resolution issue associated with in vitro nucleosome positions map, I 
was unable to assess the nucleosome rotational positioning by searching for the classic ~10 
bp periodicity in the distance between in vivo and in vitro nucleosomes; instead I tested 
whether another set of sequence driven nucleosome positioning signal called “container site” 
by Valouev et al. (2011) was associated with the divergence of translational positioning 
between in vitro and in vivo nucleosomes, by comparing the GC content in nucleosome core 
and AT content in linker regions between nucleosomes showing low and high relative 
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distances. We divided nucleosome pairs into two equal sized groups based on the median 
distance of 39 bp.  
Figure 2.6 clearly shows that both the GC content in core and AT content in linker are 
significantly negatively correlated with the distance between the translational positions, 
suggesting that nucleosomes coinciding with sequences that are rich in GC in core and in AT 
in linker are more stable consistent with previous findings (Valouev et al. 2011; Gaffney et 
al. 2012). 
Among all factors that affect the nucleosome positioning is the local chromosomal 
environment (Thurman et al. 2012). By taking advantage of a recent genome-wide chromatin 
state map from the GM12878 human cell line that closely matches the cell line from which 
the in vivo nucleosomes were derived (Ernst et al. 2011), I compared the distribution of the 
signed distances between in vitro and in vivo nucleosomes in the context of individual 
chromatin states. The nucleosome positioning between in vitro and in vivo human samples 
was found to be least conserved at active promoters (chromatin state 1) but most conserved 
at repetitive/CNV regions (chromatin state 14 and 15), as shown by the detailed distribution 
of signed distances (Figure 2.7) and point estimation of unsigned distances in context of each 
chromatin state (Figure 2.8). It is consistent with previous studies suggesting that, in human, 
nucleosome positioning at cis-regulatory regions such as active promoters is mainly realized 
by trans-acting factors including chromatin remodelling complex and transcription factors 
while that at non-regulatory regions is primarily determined by DNA sequences (Schones et 
al. 2008).  
Finally, both effects of chromatin states and DNA sequences on the nucleosome 
positioning between in vitro and in vivo human samples were confirmed by the multiple 
linear regression analysis where the relative contributions of different factors were tested 
simultaneously (Table 2.3).   
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Figure 2.5. Comparison of translational positioning between in vitro and in vivo nucleosomes. (A). 
Distribution of signed differences in positions between in vitro and in vivo nucleosomes. Negative 
numbers in the X axis correspond to the situation that the in vivo nucleosome was located upstream of 
the in vitro nucleosome in each reciprocally closest in vitro and in vivo nucleosome pair. (B). 
Comparison of the distributions of observed signed differences in positions and that from permutation.  
The permutation is based on a randomly seletced 1 Mb region on each chromosome. Blue lines are 
observed signed differences in positions while red lines are permutated signed differences in positions 
(based on 1000 permutations) assuming independence between the positions of nucleosomes in vivo 
and in vitro. 
 
 
 
 
Figure 2.6. Translational nucleosome positioning is associated with underlying sequence 
composition. Nucleosome pairs were classified into two approximately equal sized groups based 
 
44 
 
on the median size of their observed distances. The mean and 95% confidence interval for both GC 
content in core and AT content in linker were plotted for the nucleosomes pairs with the “low” and 
“high” distances respectively. P values were obtained by the Mann-Whitney test: p < 2.2e-16 for 
both GC content in core and AT content in linker. 
 
 
Figure 2.7. Comparison of translational positioning between in vitro and in vivo nucleosomes in 
different chromatin states. Distribution of signed differences in positions between in vitro and in vivo 
nucleosomes was plotted in each chromatin state. Numbers (1-15) above each figure represent 
individual chromatin states and corresponding functional domains were also labelled below. CNV: 
copy number variation. 
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Figure 2.8. Comparison of translational positioning between in vitro and in vivo nucleosomes in the 
context of individual chromatin states. The mean and 95% confidence interval for estimated average 
unsigned distances were plotted within each chromatin state. Kruskal-Wallis rank sum test: p < 2.2e-
16. The post-hoc tests (105 tests in total) following kruskall-Wallis test were done by 
“posthoc.kruskal.nemenyi.test” function from R package “PMCMR” (Pohlert 2015). Post-hoc tests 
were significant for comparisons of chromatin state 1 (Active promoter) vs. all other states except 
chromatin state 3 (Inactive promoter, p=0.58). Comparisons of chromatin states 14 and 15 (both 
correspond to Repetitive/CNV regions) to all other chromatin states were significant while the 
comparison between chromatin state 14 and 15 was not (0.40). The corresponding functional domain 
for each chromatin state could be found in Table 2.1 and Figure 2.7. 
 
 
Table 2.3. Relative effects of chromatin state and DNA compositions on positioning between in vitro 
and in vivo nucleosomes by multiple linear regression. 
 Coefficient p value 
Chromatin State 2 (Weak promoter) -0.724154 0.04 
chromatin State 3 (Inactive/poised Promoter) -0.519146 0.36 
chromatin State 4 (Strong enhancer ) 0.09858 0.73 
chromatin State 5 (Strong enhancer ) -0.804442 0.01 
chromatin State 6 (Weak/poised enhancer) -1.632703 3.29e-06 
chromatin State7 (Weak/poised enhancer) -1.224527 9.70e-06 
chromatin State 8 (Insulator ) -1.834445 1.50e-06 
chromatin State 9 (Transcriptional transition ) -0.031133 0.92 
chromatin State 10 (Transcriptional elongation ) 0.392668 0.12 
chromatin State 11 (Weak transcribed ) 0.154951 0.53 
chromatin State 12 (Polycomb-repressed ) -0.16329 0.52 
chromatin State 13 (Heterochromatin; low signal ) 0.122605 0.61 
chromatin State 14 (Repetitive/Copy Number Variation ) -6.783459 <2.00e-16 
chromatin State 15 (Repetitive/Copy Number Variation ) -9.360009 <2.00e-16 
GC content in core -0.990708 <2.00e-16 
AT content in linker -0.991987 <2.00e-16 
 
Note: the reference level of chromatin states is chromatin state.1 (active promoter) and all of other 
chromatin states were tested against chromatin state 1 which corresponds to “Active promoter”. P 
values for chromatin state levels (2-15) show the probability to observe such a difference from 
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chromatin state 1 (active promoter) on nucleosome positioning divergence by chance under the null 
hypothesis that there is really no difference. Correspondingly, p value for GC and AT content means 
the probability to observe an effect on nucleosome positioning divergence by chance if there is really 
no effect. 
 
 
 
2.3.2 Translational positioning between paralogous nucleosomes within both 
in vitro and in vivo human samples 
2.3.2.1 Nucleosome positioning is generally well conserved following duplication events 
To investigate the positioning of nucleosomes following the duplication of a DNA 
sequence and its insertion into a new genomic region, I characterised the positioning of 
nucleosomes at paralogous segments of the human genome using publically available in vivo 
and in vitro datasets (Valouev et al. 2011; Gaffney et al. 2012). Since the focus was a 
comparison between homologous regions, a very stringent mapping approach was used in 
which no mismatches were permitted when mapping reads back to the reference genome. I 
identified 14,023 and 167,013 paralogous nucleosome pairs in a total of 53,626 segmental 
duplicates that are ≥ 90% in sequence identity and ≥ 1 kb in length in vivo and in vitro 
respectively.  
If chromosomal location or aspects of the broader chromatin environment are the primary 
determinants of nucleosome positioning we would expect to see little conservation in the 
positioning of nucleosomes following a duplication event in both the in vivo and in vitro 
samples. However, 35% (4,900 pairs) of the in vivo paralogous pairs of nucleosomes 
displayed no change in position following a duplication event (Figure 2.9A); whereas in 
vitro, 25% (42,263 pairs) of paralogous pairs of nucleosomes were observed to have shifted 
by less than 10 bp, the approximate resolution of the algorithm used to determine 
nucleosome positioning in this dataset (Chen et al. 2014). The median shift between 
paralogous nucleosomes was 20bp in vivo and 27bp in vitro; interestingly the median 
distance between in vitro and in vivo nucleosomes was 39 bp while the sequence is identical, 
suggesting that the comparison of paralogous regions within the same cells could indeed 
reduce the confounding effects of trans-acting factors and/or control for the technical 
variations in generation of nucleosome positions maps from different samples. I conclude 
that following the duplication of a region, nucleosomes in general assemble at broadly 
similar locations on the original and duplicated copies with a third assembling at identical 
positions in vivo. The broad similarity between in vivo and in vitro datasets suggests an 
important relative contribution of local DNA sequence to nucleosome positioning. 
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Nucleosomes are able to assemble at approximately the same location following the 
duplication of DNA sequences and their insertion into a new genomic location even in the 
absence of trans-acting factors. 
 
2.3.2.2 Nucleosome positioning divergence shows strong periodicity in vivo 
The in vivo nucleosome map used in this study allowed me to examine nucleosome 
divergence in detail, and investigate how nucleosome positioning diverges. As shown in 
Figure 2.9B, paralogous nucleosomes were observed to be preferentially shifted by a 
multiple of a complete DNA helical turn. The DNA double helix makes one complete turn 
every ~10.4 bp and it has been shown previously that the DNA sequences underlying 
nucleosomes have a distinct 10 bp dinucleotide periodicity (Albert et al. 2007; Mavrich et al. 
2008; Brogaard et al. 2012; Gaffney et al. 2012). Consequently shifts of complete helical 
turns between paralogous nucleosomes would be expected to maintain this dinucleotide 
periodicity relative to the dyad. As far as I am aware, this is the first time that a strong 
rotational preference in human nucleosome positioning evolution has been observed. Thus 
nucleosomes do not therefore appear to simply drift from their original locations; rather they 
preferentially relocate a full helical turn, which argues for important constraints imposed by 
the DNA helix on nucleosome positioning evolution. 
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Figure 2.9. Nucleosome positioning is generally conserved between paralogous regions. 
(A). Distribution of differences in positions (shift) between paralogous nucleosomes in 
vivo and in vitro respectively. Negative numbers in the X axis correspond to a shift 5 
prime relative to the randomly selected reference dyad. Blue lines are observed shifts 
between paralogous nucleosomes while red lines are permutated shifts (based on 1000 
permutations) assuming independence between the positions of nucleosomes across 
duplicons. (B). Observed periodicity in nucleosome positioning divergence of ~10 bp in in 
vivo dataset. A complete helical turn is approximately 10.4 bp, so the corresponding 
distances of 1 to 5 helical turns of 10, 21, 31, 42, and 52 are indicated. 
 
2.3.2.3 Correlated evolution among neighbouring nucleosomes 
Nucleosome positioning has been postulated to follow the “statistical principle”, in which 
the positioning of one nucleosome acts as a barrier and impacts the location of other 
neighbouring nucleosomes (Kornberg and Stryer 1988). I sought evidence for the influence 
of this phenomenon in nucleosome positioning evolution by investigating the correlations 
seen in shifts among proximal paralogous nucleosome pairs within a maximum distance of 
1000 bp. To assess the significance of any observations I permuted the positions of 
nucleosome pairs across the genome, disrupting the link between proximal nucleosome pairs 
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but maintaining the relationship between each nucleosome and its paralog (Figure 2.10A). I 
was then able to determine whether there were dependencies between the shifts in the 
positioning of neighbouring nucleosome pairs above what would be expected by chance, 
given the distribution of shifts between paralogous nucleosomes observed genome-wide. 
I found a significant enrichment of nucleosomes within close proximity that display 
approximately the same shifts relative to their corresponding paralogous nucleosome 
partners in both the in vivo and in vitro samples, indicated by the significantly higher 
frequency of zero differences in shift between paralogous nucleosomes in observed data than 
in the permutations (Figure 2.10B). I conclude that there are correlations between the extent 
of nucleosome repositioning following a duplication event and nearby nucleosomes (up to 1 
kb) are observed to often shift by approximately the same distance supporting a role for long 
range effects of nucleosome positioning evolution even in the absence of trans-acting factors. 
 
 
 
 
Figure 2.10. Shifts among proximal paralogous nucleosome pairs are correlated. (A). 
Schematic description of permutations. For any given paralogous nucleosome pair, the 
shift in their relative positioning was compared with that observed at pairs of 
paralogous nucleosomes within 1000 bp. To assess whether the observed shifts at 
neighbouring nucleosome pairs were correlated, pairs of nucleosomes were randomly 
shuffled 1000 times disrupting the link between neighbouring nucleosome pairs but 
maintaining the relationship between a nucleosome and its paralog. The difference in 
the shifts observed between neighbouring nucleosome pairs in the real data and 
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permuted data was then compared. For example in the left panel, to test whether a≈b 
and/or a ≈ c the difference in these shifts was compared to that observed at randomly 
selected pairs of paralogous nucleosomes (permutation; right panel). I repeated this 
process 1000 times. a and b were observed to more often be approximately the same in 
the real data than the permuted data highlighting that neighbouring pairs of 
nucleosomes display a correlation in their positioning divergence. (B). in vivo and in 
vitro samples. Because the resolution for in vitro nucleosome positioning is 10bp, data 
points were smoothed by a 10 bp moving average. 
 
 
2.3.2.4 Sequence level determinants of nucleosome positioning 
The conserved positioning of paralogous nucleosomes supports an important role for 
DNA sequence in nucleosome positioning (Segal et al. 2006; Kaplan et al. 2008; Valouev et 
al. 2011; Brogaard et al. 2012). To explore this relationship further, I investigated how 
various sequence features of duplicated regions are related to nucleosome positioning 
stability. It is thought that differential AT and GC base composition in core and linker 
regions is linked to nucleosome positioning, such that nucleosomes preferentially assemble 
at high GC content regions with relatively high AT content at their linker regions (Reynolds 
et al. 2010; Valouev et al. 2011). However it has been difficult to disentangle cause and 
effect for these associations, which may for example be a result of biased mutational spectra 
at core and linker regions, as hinted to be the case in yeast species by (Xing and He 2015). 
To investigate this further I compared the GC content in core and AT content in linker 
regions between nucleosomes showing conserved positions between paralogous regions with 
those showing larger relative shifts. To balance sample sizes, I divided the nucleosomes in 
both the in vivo and in vitro samples into two, approximately equal sized “high shift” and 
“low shift” groups based on the degree of their observed divergence in positioning. More 
stably positioned nucleosomes were observed to be associated with both a significantly 
higher average GC content in core regions and significantly elevated AT content in linker 
regions in both the in vivo and in vitro samples (Figure 2.11A). In addition, nucleosome 
positioning divergence was found to be significantly correlated with DNA composition by 
Spearman correlation tests (GC content in core, rho=-0.07 and p<2.2e-16 for in vivo, and 
rho=-0.07 and p<2.2e-16 for in vitro; AT content in linker, rho=-0.04 and p=1.3e-07 for in 
vivo, and rho=-0.03 and p<2.2e-16 for in vitro). I then tested whether changes in DNA 
composition between duplicons is associated with divergence in nucleosome positioning. As 
can be seen in Figure 2.11B, divergence in both the GC content in core regions and AT 
content in linker regions is significantly correlated with changes in positioning between 
paralogous nucleosomes in both the in vivo and in vitro samples, supported by correlation 
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tests (Divergence in DNA composition in core, rho=0.07 and p=8.9e-15 for in vivo, and 
rho=0.05 and p<2.2e-16 for in vitro; Divergence in DNA composition in linker: rho=0.09 
and p<2.2e-16 for in vivo, and rho=0.06 and p<2.2e-16 for in vitro). This suggests the 
strength of compositional bias generally associates with the stability of a nucleosome’s 
position. 
In addition to the role of DNA composition, I also examined the extent to which total 
DNA sequence divergence is correlated with nucleosome repositioning. Divergence in 
nucleosome positioning was found to be positively correlated with the amount of sequence 
divergence across the duplicated segments (Spearman test: in vivo, rho=0.15, p< 2.2e-16; in 
vitro, rho=0.09, p<2.2e-16). The divergence in nucleosome positioning between paralogous 
regions being significantly correlated with DNA sequence divergence in the nucleosome 
core, linker and whole nucleosome regions (core+linker) both in vivo and in vitro (Figure 
2.12, top panel). In addition, the strength of the correlation between sequence and 
nucleosome positioning divergence was observed to be linked to whether the sequence 
divergence changed DNA composition. Both in vivo and in vitro, the correlation between 
sequence divergence and nucleosome repositioning was higher when examining sequence 
divergence that changes DNA composition (AT <=> GC) relative to changes that do not (AT 
<=> TA or GC <=> CG) (Figure 2.12).  
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Figure 2.11. Nucleosome positioning divergence is associated with 
underlying sequence composition. Nucleosome pairs were classified into 
two approximately equal sized groups based on their observed shift. (A). 
Core GC and linker AT compositions associated with the “low” and 
“high” shift groups. GC content in core Mann-Whitney p=1.0e-11 for in 
vivo and p=1.5e-99 for in vitro samples; AT content in linker p=5.3e-09 
for in vivo and p=7.8e-30 for in vitro. (B). Divergence in DNA 
composition associated with the “low” and “high” shift groups. 
Divergence in DNA composition in core Mann-Whitney p=8.8e-13 for in 
vivo and p=1.8e-71 for in vitro samples; Divergence in DNA 
composition in linker p=2.0e-23 for in vivo and p=1.9e-97 for in vitro. In 
addition, to address the potential biases introduced by the arbitrary 
grouping of paralogous nucleosomes based on the median size of 
 
53 
 
unsigned shift, Correlation between the unsigned shift and DNA 
sequence composition was assessed by Spearman correlation tests. 
(A): GC content in core, rho=-0.07 and p<2.2e-16 for in vivo, and 
rho=-0.07 and p<2.2e-16 for in vitro; AT content in linker, rho=-
0.04 and p=1.3e-07 for in vivo, and rho=-0.03 and p<2.2e-16 for 
in vitro. (B): Divergence in DNA composition in core, rho=0.07 
and p=8.9e-15 for in vivo, and rho=0.05 and p<2.2e-16 for in 
vitro; Divergence in DNA composition in linker: rho=0.09 and 
p<2.2e-16 for in vivo, and rho=0.06 and p<2.2e-16 for in vitro. 
 
 
 
 
54 
 
 
Figure 2.12. Sequence divergence (number of base changes) is correlated with divergence in 
positioning between paralogous nucleosomes (unsinged shift) in vivo and in vitro. Sequence 
divergence was categorized into two types based on whether it changes DNA composition or 
not: DNA composition changed (AT <=> GC) and DNA composition unchanged (AT <=> TA 
or GC <=> CG). Correlation was then assessed in nucleosome core, linker and whole 
nucleosome regions (core+linker). Divergence in positioning between paralogous 
nucleosomes was tested using the Spearman non-parametric correlation. Correlation 
coefficients (rho) were plotted in the top panel and corresponding p values are shown in the 
bottom panel for both in vivo and in vitro samples. 
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2.3.2.5 The local genomic environment affects positioning between paralogous 
nucleosomes 
Though DNA composition and sequence divergence appear to be important determinants 
of nucleosome positioning, the different local chromosomal environments that duplicons 
occupy may also play important roles in divergence in positioning between paralogous 
nucleosomes. I first assessed whether the divergence in the chromatin states of nucleosomes 
in each paralogous pair is associated with the divergence in positioning. I found that the 
association only existed across in vivo paralogous nucleosomes: paralogous nucleosomes 
show a more conserved positioning if the chromatin state is the same (Figure 2.13). However, 
the absence of the effect of chromatin state on in vitro paralogous nucleosomes is not 
surprising, since the chromatin state is established by epigenetic marks and chromatin 
profiles, none of which would be expected to affect the positions of nucleosomes 
reconstructed in vitro that only involves the DNA sequence and canonical core histones from 
another species. 
In addition, the divergence in positioning between paralogous nucleosomes in 
duplications which have occurred between different chromosomes (inter-chromosomal) is 
significantly higher than those on the same chromosome (intra-chromosomal) in vivo and in 
vitro (Figure 2.14). Although inter-chromosomal duplications are generally older and 
therefore more divergent at the sequence level (Kimura 1983), changes in nucleosome 
positioning remain significantly larger between human inter-chromosomal duplicons having 
accounted for levels of sequence divergence (in vivo, p=7.3e-10; in vitro, p=3.4e-79).  
 
 
 
Figure 2.13. Local chromatin states affect divergence in positioning between paralogous 
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nucleosomes in vivo but not in vitro. The mean and 95% confidence interval were plotted for the 
shifts between paralogous nucleosomes that are either in the same chromatin (red) or different 
chromatin states (blue) for both in vitro and in vivo. P values obtained from the comparison of the 
unsigned shifts between paralogous nucleosomes by the Mann-Whitney test: in vitro, p=0.22; in 
vivo, p=1.3e-4.  
 
 
 
Figure 2.14. Local chromosomal environments affect divergence in positioning 
between paralogous nucleosomes in vivo and in vitro. Distribution of differences 
in positions (shift) between paralogous nucleosomes is plotted for both intra-
chromosomal (blue points) and inter-chromosomal duplications (red points). 
Negative numbers in the X axis correspond to a shift 5 prime relative to the 
randomly selected reference dyad. P values obtained from the comparison of the 
unsigned shifts between paralogous nucleosomes by the Mann-Whitney test: in 
vivo, p=1.3e-24; in vitro, p=5.4e-160. 
 
 
2.3.2.6 Strong agreement between role of sequence features in vivo and in vitro 
Thus I can discern the influence of many, doubtless inter-correlated, variables upon the 
divergence of nucleosome positioning, from sequence composition to various aspects of 
genomic function, including promoters and TSSs. Human promoters are GC rich and 
intrinsically nucleosome favouring but the nucleosome occupancy and positioning at 5’ 
prime of genes are under the dynamic regulation of transcription activity (Schones et al. 
2008; Tillo et al. 2010; Vavouri and Lehner 2012). To disentangle the relative contributions 
of these variables to nucleosome repositioning in both in vivo and in vitro samples, I 
included eight different variables in multiple linear regression models to assess their relative 
importance to nucleosome positioning in vivo and in vitro. The features linked to divergence 
in nucleosome positioning between paralogous regions were observed to be highly correlated 
 
57 
 
between in vivo and in vitro (Table 2.4, Figure 2.15). Not only was there a large overlap in 
the factors significantly linked to nucleosome position divergence in both species, but also 
the size and direction of their coefficients were generally similar, suggesting they have a 
similar impact on nucleosome positioning. Consequently the relative contribution of DNA 
sequence and chromosomal environment in nucleosome positioning appears to be largely 
consistent whether in the presence or absence of trans-acting chromatin binding factors. 
Relative importance analysis revealed that GC content at the nucleosome core appears to 
have a considerably stronger relative association with nucleosome positioning in vitro than 
in vivo (Figure 2.15). On the other hand sequence divergence in both linker and core regions 
appears more important in vivo. I hypothesised that this may be due to a role for DNA 
binding proteins in nucleosome positioning whose motifs may be disrupted through sequence 
divergence. The lack of these proteins in the in vitro sample would mean that sequence 
changes at their motifs would be irrelevant to nucleosome positioning in the resulting in vitro 
dataset.  
To explore this further I compared nucleosome occupancies between corresponding 
paralogous regions where a given motif is maintained in one duplicon but is lost in the other, 
encompassing 242 motifs (see Appendix). The loss of particular protein binding motifs was 
notably associated with changes in nucleosome occupancy between duplicons in vivo but not 
in vitro. For example disruption of CDX2 and TEAD2 binding motifs was associated with 
increased occupancy in vivo, but not in vitro, consistent with abrogated binding of this 
protein at these locations through the disruption of its motif, with associated effects on 
nucleosome occupancy (Figure 2.16). A role for CDX2 in nucleosome positioning agrees 
with previous observations of nucleosome occupancy increasing at CDX2 binding sites in 
CDX2 knockout cells (Verzi et al. 2010) but to my knowledge this is the first time that 
binding of TEAD2, involved in the hippo signalling pathway (Je et al. 2015: 2), has been 
linked to nucleosome positioning. For the vast majority of motifs their gain or loss had no 
detectable effect on nucleosome occupancy. It is unclear how representative paralogous 
regions are since paralogous regions comprise only 5% of the human genome sequence 
(Marques-Bonet et al. 2009) and thus our focus on the paralogous regions might lack the 
power to detect the effects on nucleosome occupancy of rare motifs. In addition, a number of 
proteins are expressed in a cell type restricted manner, and further study of other cell types 
using this approach may highlight further motifs whose loss is linked to nucleosome 
positioning evolution in particular cell types. 
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Table 2.4. Relative effects of DNA local sequences and chromosomal environments on positioning 
between paralogous nucleosomes by multiple linear regression. 
 
in vivo  
 
in vitro  
 Coefficient p value 
 
Coefficient p value 
Intra-chromosomal duplication
1
 -3.55e+00 2.28e-10 
 
-2.31e+00 <2.0e-16 
Average duplication length (kb) -2.43e-02 2.12e-03 
 
-1.54e-02 <2.0e-16 
Average distance to TSS (log2) -5.13e-01 1.28e-02 
 
-1.15e-01 0.229 
Difference in distance to TSS (log2) 2.79e-01 2.7e4-02 
 
6.90e-01 4.66e-12 
GC content in core (percentage)  -7.42e-01 <2.0e-16 
 
-5.85e-01 <2.0e-16 
AT content in linker (percentage)  -5.80e-01 <2.0e-16 
 
-4.25e-01 <2.0e-16 
Sequence divergence in core  
(number of changes) 
3.02e-01 3.61e-06 
 
1.48e-01 <2.0e-16 
Sequence divergence in linker  
(number of changes) 
5.56e-01 1.39e-10 
 
1.32e-01 4.67e-10 
Interaction between average  distance  
and difference in distance to TSS 
NA NA  -2.61e-02 7.53e-05 
1
The reference level being inter-chromosomal duplications. 
“NA” means variable was dropped following model selection according to AIC. 
 
 
 
Figure 2.15. Relative importance analysis of local sequence and 
chromosomal environment features on positioning divergence in vivo 
and in vitro. 
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Figure 2.16. CDX2 and TEAD2 binding motifs affect nucleosome 
positioning between paralogous regions in vivo but not in vitro. The 
mean and 95% confidence interval were plotted for the dyad 
occupancy scores at the 41 positions from -20 bp to +20bp relative 
to the midpoint of the motif and compared between paralogous 
duplicons with (Motif maintained) and without the motif (Motif lost) 
both in vivo and in vitro. Bonferroni corrected p values following a 
Mann-Whitney test were: CDX2 p= 1 for in vitro and p= 0.034 for 
in vivo; TEAD2 p=1 for in vitro and p=0.004 for in vivo. 
 
 
2.3.3 No obvious effect of the difference in mapping stringency and mapping 
software on the inference of nucleosome positions and the pattern of paralogous 
nucleosome positioning 
Due to the high sequence similarity between segmental duplicates, I used the strictest 
parameters when re-mapping paired-end reads (stringent mapping). To assess the implication 
of the mapping stringency, we also obtained the genome wide midpoint profile in the same 
in vivo sample from Gaffney et al. (2012) where default parameters were applied to map 
paired-end reads back to reference genome by BWA read mapper (Li and Durbin 2009) and 
midpoints were inferred from fragments of exact 147 bp 
(http://eqtl.uchicago.edu/nucleosomes/midpoints/mnase_mids_combined_147.wig.gz). 
Nucleosome positions were inferred exactly the same way as for in vivo nucleosomes from 
stringent mapping (no mismatch and mapped by Bowtie2 read mapper). As shown in Figure 
2.17, the positions of 93% and 94% of nucleosomes genome-wide and within segmental 
duplicates were identical between two different mapping approaches for in vivo human 
sample. In addition, the pattern of relative positioning between paralogous nucleosomes 
derived from this default mapping approach was similar as that derived from the strictest 
mapped approach discussed above (Figure 2.18). Thus I conclude that mapping stringency 
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and choice of read mappers are not an issue in comparing nucleosome positioning between 
paralogous regions at least if nucleosome positions are inferred from paired-end reads of 
exact 147 bp apart.   
 
 
 
Figure 2.17. Comparison of in vivo nucleosomes derived from 
differently mapped pair-end reads. The cumulative distribution 
was plotted from a total of 2,864,947 and 94126 reciprocally 
closest nucleosomes genome-wide (blue) and within 
duplicated segments (red) within a distance up to 100 bp.  
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Figure 2.18. Pattern of nucleosome positioning between paralogous regions derived from 
paired-end reads that mapped to the human reference genome with default parameter and 
by BWA. (A). Distribution of signed differences in positions (shift) between paralogous 
nucleosomes. (B). Observed periodicity in nucleosome positioning divergence of ~10 bp. 
The corresponding distances of 1 to 5 helical turns of 10, 21, 31, 42, and 52 are indicated, 
based on the assumption that a complete helical turn is approximately 10.4 bp. (C). Shifts 
among proximal paralogous nucleosome pairs are correlated. 
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2.4 Discussion 
In the study by Valouev et al. (2011), the involvement of the DNA sequence in placing 
nucleosomes at many genomic sites has been deduced by the observation of the consistent 
peaks of ~147 bp in the distograms and of well positioned nucleosomes at many genomic 
positions with the underlying DNA sequence features that they called “container sites” both 
in vivo and in vitro. In this chapter, I first directly compared the distance (up to 100 bp) from 
nucleosomes in vitro to their closest nucleosomes in vivo by limiting our focus on the 
reciprocally closest nucleosome pairs, as similarly done in Kaplan et al. (2008). I observed a 
mild impact of DNA sequence in the nucleosome positioning, as indicated by a median size 
of 39 bp in the divergence in translational positioning among ~2.5 million pairs of in vivo 
and in vitro nucleosomes. I speculate that the comparison of nucleosome translational 
positioning between in vivo and in vitro samples might introduce biases in detecting the 
effects of DNA sequence on nucleosome positioning, due to the variations in sample 
handling, sequencing strategies (paired-end for in vivo and single-end sequencing for in vitro 
samples respectively), and bioinformatics procedures to infer nucleosome positions in vivo 
and in vitro. Nonetheless, I have successfully demonstrated that both DNA sequence features 
and chromatin states were associated with nucleosome positioning evolution, echoing the 
claims by Schones et al. (2008) that trans-acting factors are more important in regulating 
nucleosome positioning at cis-regulatory genomic sites while DNA sequences are the 
primary determinants of nucleosome positioning at non-regulatory sites. 
To mitigate the biologically irrelevant biases, and control for the confounding effects 
from trans-acting factors, we then compared the translational positioning of nucleosomes 
between paralogous regions within the same in vivo and in vitro human samples side by side. 
By doing so, the technical biases and variations in the broad cell environments, such as the 
abundances of trans-acting binding factors, should be consistently controlled for. These 
variations may be expected to confound other studies comparing species, replicates or cell 
types (Tirosh et al. 2010; Hughes et al. 2012; Struhl and Segal 2013).  
I showed that nucleosome positioning is generally well conserved between paralogous 
regions in both datasets. Following the duplication of a region and its insertion into a new 
genomic location nucleosomes generally reassemble at the same, or similar, locations.  
The base-pair resolution of the nucleosome positioning calls in the in vivo sample enabled 
me to explore how nucleosomes relocate. As far as we are aware, it is the first time that the 
rotational positioning has been directly tested by comparing the translational positioning of 
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nucleosomes from paralogous regions. Before this study, the rotational positioning has 
usually been deduced from the ~10 bp periodicity in the dinucleotide frequencies along the 
nucleosomal DNA (Kaplan et al. 2008; Zhang et al. 2009; Valouev et al. 2011; Gaffney et al. 
2012), or in the distribution of the DNase I cleavages and the MNase fragment midpoints 
with respective to the called nucleosome dyads (Gaffney et al. 2012). I observed that 
nucleosomes do not simply drift from their location during evolution; but rather particular 
sizes of shifts are favoured, in particular multiples of around 10 bp. The DNA helix makes 
one complete turn every approximately 10 bp and matching 10 bp periodicities in AT and GC 
rich sequences have been observed to underlie nucleosomes in various studies. This has often 
been attributed to AT/AA/TT dinucleotides being periodically favoured at the minor grooves 
of the DNA double helix that face histone octamer, such that nucleosomes with this 
periodicity are stable (Albert et al. 2007; Cui and Zhurkin 2009). This observed preferential 
shift of 10 base pairs is expected to maintain these periodicities relative to the nucleosome 
dyad, suggesting DNA structural constraints restrict the evolution of nucleosome positioning.  
In addition to the strong rotational preference where nucleosome positioning has diverged, 
another feature in the nucleosome positioning evolution between paralogous regions is that 
neighbouring proximal nucleosomes (up to 1 kb) often shift by approximately the same 
distance and thus evolve as an array both in vivo and in vitro, supporting a barrier model and 
the “statistical principle” in nucleosome positioning (Kornberg and Stryer 1988; Mavrich et 
al. 2008). It has been previous shown that well positioned nucleosomes could act as the 
barrier but trans-acting factors, such as chromatin remodelling complex, are required to  
created regularly spaced nucleosome arrays  (Valouev et al. 2011; Zhang et al. 2011; 
Gaffney et al. 2012); however, the observed correlation in nucleosome positioning in vitro 
suggests a role for long range effects of intrinsic histone-DNA interaction in nucleosome 
positioning evolution. 
I go on to show that the comparison of duplicons in vitro and in vivo provide natural 
controls for the effect of DNA sequence changes and the disruption of DNA binding motifs 
on nucleosome occupancy. To further support the role of DNA sequence in the nucleosome 
positioning, features of DNA sequence including DNA composition, divergence in DNA 
composition and DNA sequence all showed significant links with divergence in nucleosome 
positioning between paralogous regions in both in vivo and in vitro samples. Although inter-
chromosomal duplications were linked to slightly higher divergences in nucleosome 
positioning than between intra-chromosomal duplicons, strong conservation in nucleosome 
positioning was still observed. This suggests that the chromosomal neighbourhood or 
broader environment a sequence is inserted into plays a more limited role in nucleosome 
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positioning in humans than the sequence itself. Not surprisingly, the relative importance 
analysis confirmed that the most important variables in nucleosome positioning between 
paralogous regions are features of DNA sequence.  
Similar to previous observations that nucleosome positioning could be regulated by the 
interaction of transcription factors with DNA sequence, I also found that the birth or death of 
certain protein binding motifs in human genome, such as CDX2 and TEAD2, are associated 
with nucleosome positioning evolution between paralogous regions (Valouev et al. 2011). 
However, it is not a universal feature of all transcription factors except a subset of proteins 
called “pioneer transcription factors” (Zaret and Carroll 2011), with the majority of motifs 
having no observable role in nucleosome repositioning between paralogous regions. Previous 
studies have shown that when genes get duplicated, one copy is constrained to keep the 
original function, and the other is free to diverge, acquiring new function or losing function 
which results in the copy that loses function evolving to pseudogene. One possible 
mechanism for acquiring or losing functions might be the birth and/or loss of functional cis-
regulatory motifs (Force et al. 1999; Stoltzfus 1999; Rastogi and Liberles 2005; Rastogi and 
Liberles 2005; Bailey and Eichler 2006; Zheng et al. 2007). However, it has been found that 
both copies of segmental duplicates experience elevated evolution (Kostka et al. 2010; 
Lorente-Galdos et al. 2013).   
 Controlling for confounding factors is a common problem when trying to determine the 
role of DNA sequence or local environment in the evolution of chromatin and epigenetic 
states. Here I have shown that the analysis of paralogous regions allows for trans-factors to 
be controlled for and can potentially provide a clearer picture of the role of DNA sequence 
and other factors in nucleosome position evolution. The results presented here and in 
particular the strong agreement between in vivo and in vitro datasets, point towards DNA 
sequence playing a primary role in determining nucleosome positioning evolution. 
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Chapter 3: Conserved Determinants of 
Nucleosome Positioning Evolution across 
Eukaryotes 
 
 
3.1 Introduction 
In Chapter 2, I have compared the nucleosome positioning evolution between paralogous 
regions in the human genome using in vivo and in vitro datasets. In this chapter, I aimed to 
directly contrast the nucleosome positioning between paralogous regions in human and yeast 
genomes simultaneously and deduce potentially conserved or divergent determinants of 
nucleosome positioning evolution across eukaryotes, by analysing another two independent 
in vivo human (10 base pair resolution, provided by James Prendergast) and yeast (base pair 
resolution, Brogaard et al. 2012) nucleosome positions maps. The side by side comparison of 
the relative nucleosome positioning between paralogous regions in both human and yeast 
genomes respectively should resolve the issue that is inevitable in the direct inter-species 
comparison of nucleosome positioning, namely that the levels of trans-acting chromatin 
binding factors are expected to vary widely between cell types, replicates and organisms. 
Particularly, I addressed the following questions: 1) To what extent is the positioning 
between paralogous nucleosome pairs conserved in human and yeast genomes following a 
duplication event? 2) Does the repositioning of proximal paralogous nucleosome pairs over 
time follow the statistical positioning principle? 3) To what extent is the underlying DNA 
sequence important in determining how nucleosome positioning evolves between paralogous 
regions? 4) Is the local chromosomal environment an important determinant of the 
positioning between paralogous nucleosomes? 5) To what extent are the determinants of 
nucleosome positioning conserved across eukaryotes? 
 
 
66 
 
3.2 Materials and Methods:  
3.2.1 Summary of datasets and software used 
3.2.1.1 Inference of paralogous regions in the yeast genome by LASTZ 
The list of paralogous segments (sequence identity ≥ 90%; length ≥ 1 kb) was obtained 
from http://humanparalogy.gs.washington.edu/, as described in Chapter 2.  
The list of duplicated regions in the yeast genome was obtained by whole genome self-
alignment: the yeast genome sequence (SGD/sacCer2 version) was downloaded from the 
UCSC genome browser (Kent et al. 2002) and LASTZ was used to align the whole genome 
sequence to itself to retrieve paralogous regions (Harris 2008). The general workflow of 
LASTZ includes: 1) build a position table of DNA oligomers from the target sequences (the 
whole yeast genome) which is loaded into memory; 2) scan each query sequence (each 
chromosome for example) against the position table to find matches in the target sequence, 
which are called seeds; 3) infer high-scoring segment pairs (HSPs) from matched seeds and 
furthered chained into anchors using syntenic information; and 4) individual anchors were 
further extended by local alignment and back-end filtering to obtain duplicated segments. 
The power of LASTZ lies in the fact that, instead of requiring parameters from end users, it 
automatically infers scoring parameters from input sequences. The command used to infer 
paralogous segments in the yeast genome is: lastz yeast.fa[multiple] yeast.fa –chain  
–notrivial format=general:name1,start1,end1,name2,start2,end2,length1,length2,strand1, 
strand2,identity,text1,text2 > yeast_duplicates.txt. 
Due to much smaller the size of the yeast genome than that of the human genome 
(Chapter 2), paralogous segments with sequence identity ≥ 80% and length ≥ 200 bp were 
selected to obtain enough data for meaningful analysis (Harris 2008). I identified a total of 
459 pairs of paralogous regions in the yeast genome, with a median average size of 746 bp. 
The size distribution is plotted in Figure 3.1. 
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Figure 3.1. Size distributions of average paralogous 
duplicons   in the human genome. 
 
 
3.2.1.2 Nucleosome positioning map in the yeast and human genomes 
The nucleosome positioning map in the yeast genome was obtained from (Brogaard et al. 
2012). In contrast to the progressive digestion of Linker DNA towards nucleosome cores by 
MNase, the authors used a chemical approach in which the cleavage selectively occurs at -1 
and +6 positions relative to the centre of engineered nucleosomes which carry a cytosine at 
serine residue of H4 core histone (H4S47C). Thus positions of nucleosomes by this method 
can be determined with base pair accuracy. DNA fragments with ends marking centres of 
neighbouring nucleosomes were selected and sequenced from six replicate experiments (four 
single-end and two paired-end replicates). The list of nucleosomes used in this analysis was 
based on the unique map in which 67,543 nucleosomes were called from the combined 
dataset of six replicate experiments such that the maximum overlap of two neighbouring 
nucleosomes is 40 base pairs, corresponding to a centre-to-centre distance of at least 107 bp. 
The in vivo human nucleosome positions data were provided by James Prendergast 
(bench supervisor). Briefly reads used to infer nucleosome positions were obtained from 
histone modification data in human H1 cells that were collated from a combination of both 
the ENCODE (T.E.P. Consortium 2012) and NIH Epi-genomics Roadmap (Bernstein et al. 
2010) projects. Reads were mapped with Bowtie allowing no mismatches and only a single 
best hit (Langmead and Salzberg 2012). Mapped reads less than 35 bp long were also 
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discarded. Nucleosome positions were determined using the NPS software by default 
parameters (Zhang et al. 2008). The reasons we used another independent in vivo human 
nucleosome positions dataset in this chapter are that we would like to use another dataset as 
a validation for what we observed in Chapter 2, and we would like sample sizes to be 
approximately balanced for yeast and human paralogous nucleosome pairs (we retrieved 
4,479 and 4,462 paralogous nucleosome pairs in the yeast and human genomes respectively). 
 
3.2.2 Analysis procedure 
Linker regions have been estimated at approximately 20bp in yeast (Brogaard et al. 2012), 
and so 20bp at each side of the core regions was annotated as linker region in yeast dataset. 
In addition, we set the maximum shift in yeast as 80bp, as done in Tirosh et al. (2010). The 
length of linker region and the maximum shift in humans were defined as described in 
Chapter 2. Unless stated explicitly, the analytic processes were similar to that described in 
Chapter 2, including defining paralogous nucleosome, permutation analysis to detect the 
correlation in positioning between proximal paralogous nucleosome pairs, and multiple 
linear regression and relative importance test. 
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3.3 Results 
3.3.1 Nucleosome positioning is well conserved following yeast and human 
duplications 
I retrieved 4,462 and 4,479 paralogous nucleosome pairs in the human and yeast 
genomes respectively. As shown in Figure 3.2, 33% (1,496 pairs) of paralogous pairs of 
nucleosomes displayed no evidence of changing position at all following a duplication event 
in yeast; whereas in human 25% (1,121 pairs) of paralogous pairs of nucleosomes were 
shifted by less than 10 bp, the approximate resolution of the algorithm used to call 
nucleosome positioning (Zhang et al. 2008). Beyond this there are heavy biases in both 
species to shifts of less than 40 bp, such that the cores of paralogous nucleosome pairs 
occupy broadly equivalent positions. I conclude that following the duplication of a region, 
nucleosomes in general assemble at similar locations on the original and duplicated copies in 
both yeast and human genomes, suggesting an important relative contribution of local DNA 
sequence to nucleosome positioning in both yeast and human genomes. 
 
3.3.2 Yeast nucleosome positioning divergence shows strong periodicity 
Similarly to the in vivo human nucleosome dataset in Chapter 2, the unusually high, base-
pair resolution of the yeast nucleosome dataset used in this study (Brogaard et al. 2012) 
allowed me to discover periodicities in shifts following a duplication event, indicating that 
particular sizes of shifts are favoured. As shown in Figure 3.2C, following a segmental 
duplication event yeast nucleosomes were observed to preferentially shift by a multiple of 
complete helical turns as observed previously in the human in vivo analysis (Figure 2.10B). 
The strong rotational preference in translational positioning between paralogous regions in 
both human (Figure 2.10B) and yeast (Figure 3.2C) in vivo datasets of base pair resolution 
suggests that this is a fundamental principle of nucleosome positioning evolution across 
eukaryotes.  
Nucleosomes were not only observed to preferentially shift a multiple of 10 bp however, 
intriguingly an additional preference for shifts of 6 bp was also observed (Figure 3.2C). This 
corresponds to the known phase shift between the maxima of AA and TT dinucleotides at 
nucleosome core regions (Ioshikhes et al. 1996) and suggests a more complex interplay 
between underlying dinucleotide frequencies and nucleosome positioning evolution. 
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Figure 3.2. Nucleosome positioning is generally conserved between paralogous regions in 
human and yeast. (A) and (B) Distribution of signed differences in positions between 
paralogous nucleosomes in human and yeast datasets respectively. Negative numbers in the X 
axis correspond to a shift 5 prime relative to the reference strand. Permutation was also carried 
out in yeast species (B) to assess whether there was conservation in positioning between 
paralogous nucleosomes. Blue lines are observed shifts between paralogous nucleosomes while 
red lines are permutated shifts (based on 1000 permutations) assuming independence between 
the positions of nucleosomes between duplicons. (C) Observed periodicity in nucleosome 
positioning divergence of ~10 bp in yeast. The corresponding distances of 1 to 5 helical turns 
of 10, 21, 31, 42, and 52 are indicated, based on the assumption that a complete helical turn is 
approximately 10.4 bp. 
 
 
3.3.3 Long range correlations in nucleosome positioning evolution in human 
and yeast genomes 
To decide whether the role of “statistical principle” in nucleosome positioning between 
paralogous regions was evolutionarily conserved, I investigated the correlations seen in 
shifts among proximal paralogous nucleosome pairs within a maximum distance of 1000 bp 
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in both human and yeast species by comparing correlations observed against that generated 
from permutations, which was carried out similarly as described in Figure 2.11A. I found a 
significant enrichment of nucleosomes within close proximity that display approximately the 
same size shifts relative to their corresponding paralogous nucleosome partners in both the 
yeast and human genomes (Figure 3.3). Thus I concluded that nucleosome positioning by the 
constraints from neighbouring nucleosomes is a general mechanism that is conserved across 
eukaryotes.  
 
 
 
Figure 3.3. Shifts among proximal paralogous nucleosome pairs are correlated. 
Detailed schematic description on the permutation procedure could be found in 
Figure 2.11A. (A) Human dataset. (B) Yeast dataset. 
 
3.3.4 The local DNA composition bias is associated with nucleosome 
positioning evolution  
The “container site” mechanism for nucleosome translational positioning has been found 
and only was directly tested in human cells; studies in Schizosaccharomyces pombe have 
found different rules for DNA sequence in nucleosome positioning and nucleosome cores are 
actually coincident with AT rich sequences, directly contradicting with that found in human 
nucleosomes which feature GC rich sequences (Lantermann et al. 2010; Valouev et al. 2011; 
Gaffney et al. 2012; Moyle-Heyrman et al. 2013). In addition, a recent study from Xing and 
He (2015) suggested that the GC content bias in core in Saccharomyces cerevisiae is a by-
product of mutation bias.  
 
72 
 
To extend our analyses of the impact of DNA composition to yeast species, while 
controlling for trans-acting factors, I investigated how various sequence features of 
duplicated regions are related to nucleosome positioning stability in both human and yeast 
genomes. I compared the GC content in core and AT content in linker regions between 
nucleosomes showing conserved positions between paralogous regions with those showing 
larger relative shifts. To balance sample sizes, I divided the nucleosomes in both human and 
yeast datasets into three, approximately equal sized groups and tested the differences among 
the three groups by Kruskall-Wallis test. The three groups in yeast being: 1) Shift: 0 bp 
(1496 nucleosome pairs); 2) Shift: 1-27 bp (1513 pairs); 3) Shift: 28-80 bp (1470 pairs) and 
in the human dataset: 1) Shift: 0-15 bp (1499 pairs); 2) Shift: 16-40 bp (1493 pairs); 3) Shift: 
41-100 bp (1470 pairs). To address the potential biases introduced by the arbitrary grouping 
of unsigned shift sizes between paralogous nucleosomes, I also performed Spearman 
correlation test between unsigned shift and DNA sequence composition. As shown in Figure 
3.4A and B, the highest GC content in core regions is associated with nucleosomes of the 
most conserved positioning between paralogous regions in both human and yeast, though the 
difference does not reach significance in humans (human, p = 0.673; yeast, p = 1.53e-11), 
which is supported by the Spearman correlation test (human, rho=-0.01, p=0.34; yeast, rho=-
0.11, p=3.72e-13). The observation is supported by further evidence in yeast. Firstly, 
paralogous nucleosomes with identical positioning are generally more stable, indicated by 
the nucleosome centre positioning score to noise ratio (Pearson's Chi-squared, p-value < 
2.2e-16; Brogaard et al. 2012). In addition, I compared the average binding and occupancy 
scores across nucleosome cores based on the model proposed by Kaplan et al. (2008), and in  
Figure 3.4E and F observed that paralogous nucleosomes with identical positioning are 
associated with the highest average binding and occupancy scores (Kruskal-Wallis test: 
binding score, p < 2.2e-16; occupancy score, p=3.386e-16. Spearman correlation test: binding score, 
rho= -0.10, p=3.28e-12; occupancy score, rho=-0.10, p=1.04e-10). This suggests that the relative 
positioning between paralogous nucleosomes is associated with the stability of nucleosome 
formation, thus confirming that the compositional bias plays an important role in nucleosome 
positioning.  
However, AT content in linker shows an intriguing contrast between species. I observed 
the expected bias in higher AT content in linkers for nucleosomes of the more conserved 
positioning between paralogous regions in human data but the opposite in yeast, a significant 
decline in AT content in linker for nucleosomes with conserved positioning (Figure 3.4C and 
D. Kruskal-Wallis test: human, p=0.044; yeast, p=7.863e-09. Spearman corelation test: human, 
rho=-0.10, p=3.28e-12; yeast, rho=-0.10, p=1.04e-10.). A plausible explanation would be that this 
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may be due to the differences in linker histone biology between species. Firstly, the 
extremely low abundance of linker histone Hho1p in yeast (1 molecule per 4 ~ 40 
nucleosomes) suggests that the role of linker region realised through linker histone is quite 
limited in nucleosome positioning (Bates and Thomas 1981; Freidkin and Katcoff 2001). 
Secondly, the effect of Hho1p is directed by the contact of “wing” domains with TT dimers 
situated at ±75 and ±76 bp relative to the dyad and bends the linker DNA around the histone 
core (Cui and Zhurkin 2009). I thus assessed the relative enrichment of the TT dimers at ±75 
and ±76 bp relative to the dyad and found that nucleosomes displaying no shift between 
paralogous nucleosomes (Shift: 0 bp) are generally more enriched with TT dimers at these 
locations (Pearson's Chi-squared Test, p=4.6e-4). 
Collectively this highlights that more conserved positioning between paralogous 
nucleosomes is associated with stronger local DNA compositional biases in both human and 
yeast genomes.  
 
 
Figure 3.4. Nucleosome positioning divergence is associated with underlying 
sequence composition. The distribution of GC content in core and AT content 
in linker were compared among three groups of nucleosome with different 
degrees of divergence in positioning between paralogous nucleosomes in 
human (A and C) and yeast (B and D). Nucleosome binding and occupancy 
scores at each site of nucleosome cores were predicted and averaged. The 
distribution of average scores for individual nucleosomes in yeast was then 
compared between the three groups (E and F). P values were obtained using 
the Kruskal-Wallis rank sum test as appropriate for each plot shown (A: p = 
0.673; B: p = 1.53e-11; C: p = 0.044; D: p = 7.863e-09; E: p < 2.2e-16; F: p = 
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3.386e-16). In addition, the correlation coefficients (rho) and p values from 
Spearman correlation tests between positioning divergence (unsigned shift) 
and DNA sequence composition are: A, rho=-0.01, p=0.34; B, rho=-0.11, 
p=3.72e-13; C, rho=-0.04, p= 0.007; D, rho=0.09, p=9.30e-10; E, rho= -0.10, 
p=3.28e-12; F, rho=-0.10, p=1.04e-10.p=1.04e-10. 
3.3.5 Sequence divergence and the nucleosome repositioning 
In addition to the role of DNA composition, I also examined whether DNA sequence 
divergence is associated with nucleosome repositioning in both human and yeast genomes. 
Overall the relative positioning of paralogous nucleosomes (unsigned distance between 
paralogous nucleosomes) is correlated with total sequence divergence (nucleosome core plus 
linker regions; Spearman’s rho = 0.10, p = 1.94e-10 in humans; rho = 0.17, p < 2.2e-16 in 
yeast). In addition, to assess whether different choices in the definition of reference dyads 
have an impact on the interpretation, I compared the divergence at the DNA sequence level 
between paralogous regions showing different degrees of nucleosome positioning 
conservation in more detail using two approaches. In the first approach, the reference dyad 
locations were defined as the dyad of a randomly selected nucleosome from each paralogous 
pair, and in the second the mid-point between dyad locations was taken as the reference dyad 
in both yeast and human datasets. The results obtained from these two approaches were 
largely consistent, and one of the possible reasons might be that the majority of nucleosomes 
have shifted relatively small distances. Sequence substitutions were separated into two 
groups: AT <=> TA or GC <=> CG, i.e. substitutions that do not alter DNA composition, 
and AT <=> GC changes that do alter sequence composition between paralogous regions 
(Figure 3.5). 
In yeast the number of both types of change was observed to be lower at pairs of 
nucleosomes conserved in their positioning. However in humans only the number of changes 
that altered DNA composition (AT <=> GC) was significantly higher across nucleosome 
cores at divergently positioned human nucleosomes (left two panels in Figure 3.5). This 
suggests that, at least in humans, only mutations that alter DNA composition are specifically 
linked to nucleosome positioning divergence. These results provide evidence of a link 
between DNA sequence divergence and nucleosome repositioning after eukaryotic 
duplication events.  
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Figure 3.5. Sequence divergence is associated with divergence in nucleosome positioning 
between paralogous regions in human and yeast. Panels are split into AT <=> GC 
sequence changes that affect local DNA composition and AT<=>TA/CG<=>GC changes 
that do not. In the ‘Randomly selected’ analysis, the reference dyad is set to the dyad of a 
randomly selected nucleosome in each paralogous pair. In the ‘Middle point’ analysis the 
reference dyad is set to the mid-point between paralogous nucleosomes. The means and 
associated 95% confidence intervals are displayed as red, green and black lines and 
associated grey regions. 
 
 
3.3.6 The local genomic environment affects positioning between paralogous 
nucleosomes 
Though DNA composition and sequence divergence appear to be key determinants of 
nucleosome repositioning, the different local chromosomal environments that duplicons 
occupy may also play important roles in divergence in positioning between paralogous 
nucleosomes. For example, the divergence in positioning between paralogous nucleosomes 
in duplications which have occurred between different chromosomes (inter-chromosome) is 
significantly higher than those on the same chromosome (intra-chromosome) in both human 
and yeast (Figure 3.6A and B). Although inter-chromosomal duplications are generally older 
and more divergent at the sequence level (Kimura 1983), changes in nucleosome positioning 
remain larger between human inter-chromosomal duplicons having accounted for any 
sequence divergence affects (Spearman partial correlation test, human adjusted rho = 0.07, 
p=1.9e-7; yeast adjusted rho = 0.03, p = 0.06).   
For most eukaryotic genes, nucleosomes are well positioned around the TSSs with the 
strength of nucleosome positioning decaying with increasing distance from the TSSs 
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(Schones et al. 2008; Valouev et al. 2011; Hughes et al. 2012). This suggests that the TSS 
acts as an influential local chromosomal environment and could potentially affect the 
positioning of nucleosomes in opposition to their broader sequence preferences. To explore 
this I examined the positioning of paralogous nucleosomes relative to their proximity to the 
closest TSS. I divided nucleosome pairs into three categories as follows. 1) Both 
nucleosomes being within 200 bp of their closest TSSs (Both proximal). 2) Both 
nucleosomes at least 1000 bp from their closest TSS (Neither proximal). 3) One nucleosome 
within 200 bp of a TSS and the other at least 1000 bp away (One proximal). As one might 
expect, the positioning of paralogous nucleosomes in which both are proximal to and under 
the strong effect of their TSSs (Both proximal) are the most conserved in both human and 
yeast datasets (Figure 3.6C and D). The positioning of paralogous nucleosomes in which only 
one is under the strong influence of a TSS is most divergent in yeast, which could reflect 
sub-functionalisation of TSS-associated nucleosomes following duplication. However, in 
humans the average divergence of positioning between paralogous nucleosomes was similar 
whether only one nucleosome is proximal to a TSS or neither. Again, as expected given the 
functional constraints of occupying an exon, nucleosome positioning was also observed to be 
significantly more conserved following a duplication event where both nucleosomes were in 
exons in both yeast and humans (Figure 3.6E and F). 
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Figure 3.6. Local chromosomal environments affect divergence in positioning 
between paralogous nucleosomes. Paralogous nucleosomes residing on the same 
chromosome are compared with nucleosomes located on different chromosomes 
in human (A) and yeast (B). Comparison of paralogous nucleosome pairs (C: 
human; D: yeast) where both nucleosomes are within 200 bp of a TSS (Both 
proximal), where one nucleosome is within 200 bp of a TSS but the other is at 
least 1000 bp away (One proximal), and where both nucleosomes are at least 
1000 bp away from their nearest TSS (Neither proximal). The effect on 
positioning is also compared (E: human; F: yeast) for pairs where both 
nucleosomes are in exons (Both exonic), where one nucleosome is in an exon 
but the other is intergenic (One exonic), and where both nucleosomes are in 
intergenic regions (Neither exonic). In each case the mean shift between 
paralogous nucleosomes is plotted in each boxplot in red (mean ± 95% 
confidence interval). The numbers at the bottom of each boxplot reflect the 
numbers of paralogous nucleosome pairs in each group. P values were obtained 
using the Mann-Whitney test (two groups) and Kruskal-Wallis rank sum test 
(more than two groups) as appropriate for each plot shown (A: p = 3.3e-06; B: p 
= 0.015; C: p = 8.6e-05; D: p = 6.08e-05; E: p = 0.03; F: p = 4.916e-09). 
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3.3.7 Integrative analysis of paralogous nucleosome divergence covariates by 
multiple linear regression and relative importance test 
Finally, to disentangle the relative contributions of several variables that might affect 
each other to nucleosome repositioning in the human and yeast lineages, I included 7 distinct 
variables in multiple linear regression models and analysed the normalized relative 
importance of each independent variable using the “lmg” method from the “relaimpo” R 
package (Table 3.1,Table 3.2; Lindeman and Merenda 1980; Ulrike 2006). Despite being 
separated by up to 1 billion years of evolution the features controlling the divergence in 
nucleosome positioning between paralogous regions were observed to be generally 
correlated between human and yeast. Not only was there a large overlap in the factors 
significantly linked to nucleosome position divergence in both species, but also the size and 
direction of their coefficients were generally similar, suggesting they have a similar impact 
on nucleosome positioning evolution in these two substantially different species. For 
example the AT<=>GC base changes that alter the DNA composition was observed to be 
significantly associated with the divergence in nucleosome positioning between paralogous 
regions in both species when accounting for these other factors, with 10 such base changes 
(in nucleosome core plus linker regions) associated with a 3bp larger shift on average in both 
humans and yeast (Table 3.1). The relative importance analysis revealed that such base 
changes were ranked the most important factor contributing to nucleosome repositioning in 
both species with the distance to TSS also ranked highly in both human and yeast (Table 3.2).  
However, one factor was found to be inconsistent between species, the relative 
contribution of AT content in linker regions. A general higher AT content in linker regions is 
linked to a significantly decreased probability of the corresponding nucleosome shifting 
following a segmental duplication event in human but an increased probability of shifting in 
yeast. Examining the correlation between nucleosome shifts and linker AT content in 
isolation from other factors captures this observed difference between species. Whereas on 
average larger AT linker contents are associated with greater nucleosome shifts in yeast, 
nucleosomes in regions of intermediate AT content show the largest shifts in humans (Figure 
3.7). A plausible explanation would be that the different sequence characteristics at these 
regions are linked to the known divergence in structure and distribution of the linker histone 
protein between these eukaryotes. Although the other core histone proteins are 
comparatively well conserved between these species the linker histone protein has shown an 
elevated rate of divergence and is not found associated with all nucleosomes in yeast unlike 
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in humans (Bates and Thomas 1981; Freidkin and Katcoff 2001; Downs et al. 2003; Cui and 
Zhurkin 2009; Osmotherly 2010). 
 
 
Table 3.1. Relative effects of DNA local sequences and chromosomal environments on positioning 
between paralogous nucleosomes according to optimised multiple linear regression models. 
1
The reference level for the Intra-chromosomal duplication is the Inter-chromosomal duplication 
2
The reference level in the distance to TSS is the Both proximal to TSS 
3
AT <=> TA or GC <=> CG: i.e. sequence divergence that does not change the local DNA 
composition 
4
AT <=> GC: i.e. sequence divergence that changes the local DNA composition 
 
Human 
 
Yeast 
 
Coefficient p value 
 
Coefficient p value 
Intra-chromosomal duplication
1
 -3.4 2.6e-5 
 
-1.9 0.08 
One proximal to TSS
2
 7.4 2.8e-3 
 
8 2.7e-4 
Neither proximal to TSS
2
 10.2 5.1e-8 
 
4.5 1.8e-4 
Average duplication length (kb) -0.04 0.02 
 
-0.22 2.0e-3 
GC content in core (percentage)  -0.289 1.5e-5 
 
-0.259 2.3e-5 
AT content in linker (percentage) -0.357 7.3e-12 
 
0.099 0.02 
AT <=> TA or GC <=> CG 
(number of changes)
3
 
0.0 0.95 
 
-0.4 0.06 
AT <=> GC  
(number of changes)
4
 
0.3 1.9e-8 
 
0.3 7.2e-5 
 
 
Table 3.2:  Relative importance analysis of DNA local sequences and chromosomal 
environments on positioning between paralogous nucleosomes. 
 Human 
 
Yeast 
AT <=> GC 0.26 0.27 
Distance to TSSs 0.20  0.17 
AT content in linker region 0.19  0.12 
Genomic distance 0.15  0.02 
Average duplication length  0.11  0.10 
GC content in core region  0.07  0.22 
AT <=> TA or GC <=> CG 0.03  0.11 
Note: the analysis has been done by the “lmg” method in R package relaimpo 
(Lindeman and Merenda 1980; Ulrike 2006) 
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Figure 3.7. The effects of linker region AT content on nucleosome repositioning in human and yeast 
genomes. The mean and 95% confidence interval of nucleosome shifts are displayed as red lines and 
grey regions after applying loess smoothing. AT content was rounded to the nearest percentage and 
percentage values with less than 10 regions were excluded. 
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3.4 Discussion 
In this chapter, I show that nucleosome positioning is generally well conserved between 
paralogous regions in both human and yeast genomes. I observed two features in nucleosome 
positioning evolution between paralogous regions. Firstly, nucleosome positioning by the 
constraints from neighbouring nucleosomes is a general mechanism that is conserved across 
eukaryotes. Secondly, the strong rotational preference in translational positioning appears to 
not only be the case in humans (Chapter 2) but also in yeast, suggesting that this is a 
fundamental principle of nucleosome positioning evolution between paralogous regions 
across eukaryotes (Hughes and Rando 2014). Intriguingly a peak at around 6 bp was also 
observed in nucleosome shifts in yeast, which corresponds to the observed phase shift 
between the AA and TT dinucleotide 10 bp periodicities underlying nucleosomes (Ioshikhes 
et al. 1996). However no similar peaks were observed at other multiples of 6 bp suggesting 
this preferential shift of 6 bp may be unrelated to such underlying, periodic patterns.  
In both yeast and humans, a greater level of sequence divergence between paralogous 
regions was associated with larger changes in the locations of corresponding nucleosomes. 
However separating changes into those that change GC content and those that do not 
highlighted that the number of changes that affect base composition (AT<=>GC) are linked 
to nucleosome repositioning when controlling for other factors, and was found to be the most 
important factor of those analysed. The total number of AT<=>TA or GC<=>CG changes 
was uncorrelated to the size of nucleosome shifts, highlighting that it is not simply higher 
mutation rates, indicative of a longer time since duplication, that is linked to nucleosome 
repositioning. This suggests certain sets of nucleosomes are more primed to evolve following 
a duplication event due to being less constrained by their underlying sequence patterns. The 
nucleosome positioning was conserved between paralogous regions irrespective of whether 
the duplicons were in close proximity or on different chromosomes, though nucleosome 
positioning was marginally less well conserved between inter-chromosomal than intra-
chromosomal duplicons in humans. This was the case even having controlled for sequence 
divergence, suggesting that the chromosomal neighbourhood or broader environment a 
sequence is inserted into plays a limited role in nucleosome positioning in humans, 
confirming what we found in Chapter 2.  
In spite of these species being separated by approximately 1 billion years of evolution, 
accounting for all other factors the contribution of individual factors to nucleosome 
positioning, as measured by their coefficients, was surprisingly well conserved between 
yeast and humans. This is especially surprising given previous reports that distinct 
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nucleosome positioning mechanisms have evolved between yeast species (Lantermann et al. 
2010). Despite the high level of conservation of core histone proteins, across eukaryotes 
linker histones have evolved comparatively rapidly (Cui and Zhurkin 2009; Osmotherly 
2010). Thus, the observed difference in the association of linker AT content with the 
positioning between paralogous nucleosomes might be a reflection of the evolution of linker 
histones and DNA sequence features between human and yeast species. In multicellular, 
eukaryotic organisms, the abundance of linker histone is approximately 1 molecule per 
nucleosome; however the abundance of linker histone Hho1p in yeast is about 1 molecule 
per 4 ~ 40 nucleosomes (Bates and Thomas 1981; Freidkin and Katcoff 2001; Downs et al. 
2003; Cui and Zhurkin 2009; Osmotherly 2010). The low abundance of the yeast linker 
histone Hho1p would suggest the stabilisation of nucleosomes by the linker histone is 
restricted to a subset of the total pool of nucleosomes. In addition, while the nucleosome core 
is extremely conserved the linker region is much shorter in yeast than human (~ 20 bp in 
yeast but ~ 50 bp in human), potentially a reflection of the linker region evolving to be more 
important in human than yeast, as supported by the relative importance analysis. 
Once again in this chapter, I have shown that the analysis of paralogous regions allows 
for trans factors to be controlled for and can potentially provide a clearer picture of the role 
of DNA sequence and other factors in nucleosome position evolution.  
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Chapter 4: Nucleosome Positioning Dynamics 
and Interplay with Mutational Spectra in 
Disease 
 
 
4.1 Introduction 
In Chapter 2 and 3, I have investigated the nucleosome positioning dynamics in evolution. 
In this chapter, I focused on directly comparing nucleosome positioning between multiple 
cancer and non-cancerous cell lines. As discussed in Chapter1, nucleosome positioning has 
been linked to the mutational spectra and several clues suggest that the positioning of 
nucleosomes and the patterns of histone modifications or variants they carry may differ 
between cancer and normal cell lines. Firstly, various histone variants (e.g. H2.A.Z) and 
modifications (e.g. H3K4me3) are enriched at promoter regions and promoter activities are 
globally altered in cancer (Barski et al. 2007; Zhang et al. 2008; Jin et al. 2009a). Secondly, 
aberrant DNA methylation, histone modification, and nucleosome positioning are 
intertwined in cancers, leading to the dysregulation of many genes including oncogenes and 
tumour suppressor genes and may also cause genome instability (Portela and Esteller 2010; 
Brait and Sidransky 2011). DNA methylation has been shown to increase nucleosome 
stability and be associated with nucleosome positioning and occupancy (Lin et al. 2007; 
Chodavarapu et al. 2010; Collings et al. 2013). Thirdly mutations in chromatin remodelling 
complexes including SWI/SNF have also been observed to be involved in cancer (Fraga et al. 
2005; Esteller 2007; Wilson and Roberts 2011). 
Previous work from different groups have shown that sequence divergence is linked with 
nucleosome positioning (Chen et al. 2012; Xing and He 2015; Prendergast and Semple 
2011), suggesting that nucleosome positioning might be a potential factor to affect 
mutational spectra. For example, Prendergast and Semple (2011) have shown that both 
mutation rates and patterns of selection observed in the human lineage are correlated with 
nucleosome positioning. Furthermore the direction and strength of selection observed was 
predicted to maintain the optimal variation in local GC content for nucleosome positioning. 
Firstly to detect whether the alterations in nucleosome positioning between cell types is a 
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possible contributor to the difference in the mutation spectra between germline and somatic 
mutations, I compared the patterns of nucleosome positioning in human cancer lines.I have 
also compared the difference between somatic and germline mutational spectra and their 
compositional biases. I was especially interested in the following questions: 
1. Are the positioning at TSSs and phasing of nucleosomes different or generally 
conserved among different cell lines? 
2. How do somatic and germline mutational spectra differ between classes of genomic 
annotations and chromatin states?  
3. Are the rates of particular types of mutation, for example transitions or transversions, 
different among germline and somatic mutations?   
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4.2 Methods and materials 
4.2.1 ENCODE source data to call nucleosome positions 
Nucleosome positioning data from 11 cell lines (Table 4.1) derived using ChIP-Seq were 
all downloaded from the Encyclopaedia of DNA Elements (ENCODE) Project. The 
ENCODE project was established in 2003 and aims to identify and annotate the cell line 
specific functional elements in the human genome, including but not limited to RNA 
transcripts, transcription factor binding sites, and chromatin structures that are both three-
dimensional, based on the chromatin interaction capturing techniques like Hi-C, and one-
dimensional, based on histone modification data by ChIP-Seq protocol (Consortium 2004; 
Ecker et al. 2012; Dekker et al. 2013; Kellis et al. 2014). I analysed and compared the 
positioning and phasing of three types of nucleosomes (Valouev et al. 2011). They were: 1) 
nucleosomes carrying a specific histone modification from a range of 11 types (Table 4.2), 
2) all nucleosomes carrying any examined modification, and 3) bulk nucleosomes not 
selected for any specific histone modification in cell lines GM12878 and K562.  
 
4.2.2 Reads mapping and nucleosome positions calling 
Reads, either from the two replicates (Replicate number 1 and 2) of each histone 
modification in each cell line or derived from bulk nucleosomes in cell lines GM12878 
(replicate number 8) and K562 (replicate number 4), were mapped to the current human 
genome assembly (hg19, NCBI37) using Bowtie2 (Langmead et al. 2009) with default 
parameters (See workflow in Figure 4.1). Nucleosome dyad positions were estimated from 
positioned nucleosomes derived using NPS (Zhang et al. 2008) by taking the midpoint of 
called nucleosomes as in the method of (Reynolds et al. 2010). Each core detected by NPS is 
given a p-value which is defined as the probability of observing that number of reads by 
chance, given the current dataset of reads and reference genome (Zhang et al. 2008). Only 
nucleosome cores predicted by NPS with p value not greater than a conservative threshold of 
1x10
-5 
were accepted. The numbers of called nucleosomes carrying a specific histone 
modification and all nucleosomes carrying any histone modification is summarized in Table 
4.2. For bulk nucleosomes not selected for any specific histone modification, we called 
179,783 and 224,275 nucleosomes in GM12878 and K562 respectively. 
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                 Table 4.1. The list of cell lines used for detecting nucleosome positioning 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Workflow to derive positions of nucleosomes carrying a specific histone modification 
and all nucleosomes carrying any examined histone modifications. 
Cell line Description 
Hela-S3  Immortalized cell line;  cervical cancer 
HepG2 Liver carcinoma 
K562  Immortalized cell line; chronic myelogenous leukemia 
Dnd41 T cell leukemia with Notch mutation 
HUVEC  Human umbilical vein endothelial cells 
GM12878 Lymphoblastoid cell line 
H1-hESC Embryonic stem cell 
HMEC Mammary epithelial cells 
HSMM Skeletal muscle myoblasts 
NHEK Epidermal keratinocytes 
NHLF Lung fibroblasts 
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Table 4.2. Summary of number of nucleosomes called from histone modifications and variants data in this study. 
 
H2A.Z H3K9ac H3K9me3 H3K27ac H3K27me3 H3K36me3 H3K4me1 H3K4me2 H3K4me3 H3K79me2 H4k20me1 Any mark 
Hela-S3  98490 106088 29535 152399 49847 114389 244838 194056 127712 252456 84814 346793 
HepG2 77918 137471 NA 139850 102621 102583 471965 285286 163771 298446 59529 510912 
K562 251118 141543 33272 149685 60063 93091 226150 191195 150696 271351 42364 437751 
Dnd41 123799 169173 98574 213895 NA 425016 302866 200360 138951 394592 152557 486488 
HUVEC  225098 125004 NA 189566 80659 52750 294139 209961 113637 427365 10771 501188 
GM12878 159392 115199 31399 169387 8698 71209 177360 225491 151106 309531 6136 411645 
H1-hESC 110318 65386 85385 48585 83188 49247 104573 198450 107143 296984 25645 341312 
HMEC 197494 98930 35135 178828 20508 53714 297577 252510 120435 457641 9091 508627 
HSMM 171338 112939 29673 187184 21099 140546 165159 237004 116769 364421 17723 473599 
NHEK 239323 125916 77122 191153 54999 41278 257842 235285 123242 492364 12611 537944 
NHLF 240826 80436 32942 NA 36314 88555 141116 188174 117787 468371 5132 472510 
“NA”: the specific histone modification data was not available in a particular cell line 
“Any mark”: all nucleosomes carrying any histone modification and variant examined  
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4.2.3 TCGA dataset and overview of variant calling 
Exome sequencing data were retrieved from The Cancer Genomic Atlas (TCGA) project 
by Alison Meynert. TCGA (http://cancergenome.nih.gov/) provides comprehensive exome 
sequencing data for tumour and matched normal tissues from the same patient. Exome 
sequencing targets the protein-coding portion of the genome (Teer and Mullikin 2010). Data 
for 997 patients covering 17 cancer types (Table 4.3) was remapped and variants (single 
nucleotide and insertions/deletions) were called using Genome Analysis Toolkit (GATK, 
McKenna et al. 2010; DePristo et al. 2011) and stored in a local MyQSL database by Alison 
Meynert. Briefly, pre-aligned BAM files were downloaded from TCGA, sequencing reads 
were extracted into FASTQ format by Picard (version 1.43, 
http://broadinstitute.github.io/picard/), and subsequently aligned to the reference human 
genome (hg19) using BWA pre-alignment (version 0.5.9, Li and Durbin 2009) followed by 
the Stampy read mapper (version 1.0.12, Lunter and Goodson 2011). Duplicated reads were 
marked by Picard (version 1.43). 
 
4.2.4 Simultaneous per-patient variant calling and mutation rate calculation 
Genotypes in both normal and tumour tissues were determined simultaneously in each 
patient. This approach calls all single nucleotide variants in tumour-normal sample pairs for 
each patient by the joint calling mode by the unified genotyper of GATK and was stored in a 
MySQL database. This was done by Alison Meynert. I limited the analysis to positions that 
were covered by at least 10 reads in both matched tumour and normal tissue. The coverage 
cut-off excluded sites without enough read depth to call variants accurately. 
For a given position meeting these criteria, variants were categorised based on the 
following sequential steps: 1) if the ratio of alternative read depth to total read depth 
(alternative plus reference read depth) in the cancer sample was ≥ 0.1, and in the matching 
normal sample it was ≤ 0.01, we called it a potential cancer specific mutation; 2) if the ratio 
in the cancer sample was ≤ 0.01 and in the matching normal sample was ≥ 0.1, we called it a 
potential somatic mutation; and 3) if both of the ratios were ≥ 0.1, we called it a potential 
germline variant. 
Conservative methods were employed to identify mutations likely to be specific to cancer, 
somatic, or germline cells. Potential cancer or normal tissue specific mutations were filtered 
against dbSNP132 variants, 1000 genome variants, and the germline specific variants called. 
In addition, for mutations that were present only in the cancer tissues (cancer specific 
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mutations), the genotype of the same position in normal matching tissue must be reference 
homozygous (0/0) and in the cancer tissue must be variant heterozygous or homozygous (0/1 
or 1/1). Correspondingly for somatic mutations, the genotype in cancer tissue must be 0/0, 
and in normal tissue must be 0/1 or 1/1. For potential germline variants that were present in 
both normal and cancer tissues, only those observed in 1000 genomes and different to the 
ancestral allele were kept. 
Due to the design of exome sequencing, regions upstream of TSS are not as well covered 
and as deeply sequenced as downstream exonic regions. To account for such sequencing 
coverage bias, we calculated the total number of patients with enough coverage at each 
position in a 2kb window across Fantom5 TSSs (1kb at each side, The FANTOM 
Consortium and the RIKEN PMI and CLST (dgt) 2014). Consequently, the mutation rate at 
each position from a given TSS was measured by dividing the observed number of patients 
carrying a variant by the total number of patients that had enough coverage at the position to 
call a variant if it existed. 
 
 
Table 4.3. List of disease in the study.  
Cancer type Patient number 
Bladder Urothelial Carcinoma (BLCA) 15 
Breast invasive carcinoma ( BRCA) 110 
Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) 14 
Colon adenocarcinoma (COAD) 9 
Glioblastoma multiforme (GBM) 208 
Head and Neck squamous cell carcinoma (HNSC) 85 
Kidney renal clear cell carcinoma (KIRC) 168 
Kidney renal papillary cell carcinoma (KIRP) 16 
Acute Myeloid Leukemia (LAML) 54 
Brain Lower Grade Glioma (LGG) 50 
Lung adenocarcinoma (LUAD) 26 
Lung squamous cell carcinoma (LUSC) 53 
Ovarian serous cystadenocarcinoma (OV) 73 
Prostate adenocarcinoma (PRAD) 40 
Stomach adenocarcinoma (STAD) 19 
Thyroid carcinoma (THCA) 19 
Uterine Corpus Endometrioid Carcinoma (UCEC) 38 
 
 
 
 
 
90 
 
4.3 Results 
4.3.1 Nucleosome phasing is well conserved among different human cell lines 
To investigate whether nucleosome positioning is relatively consistent among different 
human cell lines as described in Table 4.1, I first compared the inter-nucleosome distance of 
all nucleosomes carrying any histone modification for 11 cell lines. Most nucleosomes are 
distant to the nearest other called nucleosome (data not shown) so I confined our analysis 
only to nucleosomes within 500bp of their nearest neighbours (Figure 4.2). The pattern of 
nucleosome spacing (inter-nucleosome distance) was found to be consistent among different 
datasets (cell lines). All cell lines show a similar peak of inter-nucleosomes distances at 
~190bp, corresponding to an inter-nucleosome linker length of ~43 bp given that the length 
of nucleosome core is 147 bp.  
 
 
 
 
Figure 4.2. Nucleosome phasing is conserved among different cell lines. Inter-nucleosome 
distances were limited to 500bp. Frequency is normalised to account for the different numbers of 
nucleosomes covered by each dataset (cell line), by calculating the percentage of nucleosomes 
with each inter-nucleosome distance up to 500 bp (the frequency at each distance divided by the 
total number of nucleosomes for each dataset). Normalised frequency (percentage of dyads) is 
plotted against the distance between two successive nucleosome dyads. 
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I then calculated the average frequency for each inter-nucleosome distance across 7 
normal cell lines and 4 cancer cells respectively and the distribution of the cell line averaged 
normal and cancer inter-nucleosome distance confirmed that the nucleosome spacing was 
generally conserved between normal and cancer genomes, suggesting that the nucleosome 
organization in the cancer genome was not globally altered compared to that in the normal 
genome (Figure 4.3). The overall consistency in the global nucleosome organizations was 
also observed in a  recent study (West et al. 2014) that nucleosome positioning only changes 
locally at key regulatory regions during cell differentiation and reprogramming. It might be 
the case that the cancer genome features the local alteration in nucleosome organization, 
while global patterns are generally maintained.  
 
 
 
Figure 4.3. Nucleosome phasing is globally conserved between normal 
and cancer genomes. The normalized frequency of each inter-nucleosome 
distance was averaged across 7 normal and 4 cancer cell lines 
respectively. The averaged frequency was further normalized, such that 
the percentages of dyads with individual inter-nucleosome distances up to 
500 bp in both normal and cancer genomes sum up to 100% respectively, 
and plotted for normal and cancer genomes. 
 
 
I lastly directly compared the pattern of phasing of GM12878 to K562 based on bulk 
nucleosomes not selected for any specific histone modification (Figure 4.4). I observed two 
peaks in the inter-nucleosome distance distributions for both cell lines: a main peak at ~190 
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bp and a secondary at ~380 bp (equivalent to the distance of two regularly spaced 
nucleosomes. The phasing is also relatively conserved between GM12878 and K562 cell 
lines, except that the secondary peak in GM12878 is higher, suggesting that nucleosomes are 
slightly more regularly spaced. 
 
 
 
Figure 4.4. Global nucleosome phasing is relatively conserved between 
GM12878 normal and K562 cancer cell lines. Inter-nucleosome distances are 
limited up to 500bp. Normalised frequency (percentage) is plotted against the 
distance between two successive nucleosome dyads.  
 
 
4.3.2 Nucleosome positioning around FANTOM5 TSSs is moderately 
conserved among different human cell lines 
To further investigate whether the nucleosome organizations are conserved across 
different cell lines, I also compared the positioning of nucleosomes around FANTOM5 TSSs 
among 11 cell lines based on all nucleosomes carrying any histone modification (Figure 4.5). 
Annotation of TSSs in FANTOM5 data is based on the Cap Analysis of Gene Expression 
(CAGE) approach and provides the most precise annotation of TSSs which are used 
ubiquitously across almost all the cell types in the human body, without being confounded 
by the alternative promoter usage, due to the usage of the robust threshold to define the 5’ 
end of the full transcripts which in turn were supported by other evidence to ensure the 
identified peaks are genuine TSSs (Shiraki et al. 2003; Carninci et al. 2006; The FANTOM 
Consortium and the RIKEN PMI and CLST (dgt) 2014). The -2 and +1 nucleosomes 
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immediately flanking the TSSs are strongly positioned in each cell line, as seen at most 
eukaryotic genes (Jiang and Pugh 2009). The first nucleosome immediately upstream of a 
TSS is called the -1 nucleosome and usually lost, generating nucleosome depleted region. 
Correspondingly, the first nucleosome immediately downstream of a TSS is called the +1 
nucleosome. While the nucleosomes upstream and downstream of the -1 and +1 ones are 
called -2 and +2 nucleosomes and so on. Variable positioning to different extents can be 
observed for nucleosomes downstream of the +1 nucleosome among different cell lines 
(comparing peaks at +2, +3, and +4 nucleosome positions in Figure 4.5). It was further 
exemplified by the comparison of nucleosome positioning in Dnd41 cell line to that in H1-
hESC and K562 cell lines respectively (Figure 4.6). In Figure 4.6A, the overall positioning 
between Dnd41 and H1-hESC is correlated (rho = 0.7970706; p < 2.2e-16). When zoomed in 
to the region from -800bp to +800bp relative to the TSS, it clearly shows that the +2, +3, and 
+4 nucleosomes show shifts of different degrees while the +1 nucleosome is strongly 
positioned. Comparison between Dnd41 and K562 in Figure 4.6B shows a similar pattern. 
In addition, the nucleosome positioning was also consistent between normal (averaged 
across 7 cell lines) and cancer (averaged across 4 cell lines) genomes, based on the combined 
dataset of nucleosomes carrying any histone modification examined (Figure 4.7).   
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Figure 4.5. Nucleosome positioning around FANTOM5 TSSs. Frequency is normalised to 
account for the different numbers of nucleosomes covered by each dataset (cell line), by 
calculating the percentage of nucleosomes at each position relative to TSS (the frequency at each 
distance divided by the total number of nucleosomes for each dataset). Normalised frequency 
(percentage) is plotted against relative position from FANTOM5 TSS for 11 cell line. 
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Figure 4.6. Variable positioning of nucleosomes downstream of TSSs in different cell 
types. Although the +1 nucleosome appears tightly controlled and is consistently 
positioned between cell types, nucleosomes further downstream display variable 
positioning peaks in different cell lines. 
 
 
 
 
Figure 4.7. Nucleosome positioning around FANTOM5 TSSs in 
normal and cancer cell lines.  
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4.3.3 Mutation spectra around FANTOM5 TSSs 
To assess whether particular genomic regions around TSSs are more prone to certain 
types of mutations, I focused on the region from -500 to +500bp across TSSs and compared 
the substitution density among germline, cancer, and somatic substitutions called from 
TCGA. Figure 4.8 shows that the number of total valid sites (≥10X coverage) at regions 
upstream of FANTOM5 TSSs is lower than that at regions downstream, confirming that 
regions upstream were sparsely covered and inadequately sequenced as expected.  
 
 
 
Figure 4.8. Number of valid sites at each position relative to FANTOM5 
TSSs. The total number of valid sites for each position relative to TSS was 
calculated by adding up, across 997 patients, the number of valid sites 
(covered by ≥ 10 reads in both normal and cancer tissues) observed in the 
same relative position from each of the 39445 FANTOM5 TSSs. 
 
 
The position dependent substitution density distribution (20bp sliding window) in Figure 
4.9 shows that substitution density is higher in germline than somatic mutation across the 
region analysed. The substitution density, in both germline and cancer substitutions, is 
relatively even across the whole region. The substitution density in somatic substitutions is 
relatively higher at regions upstream of -100bp relative to TSS than at regions downstream. I 
also observed that the substitution density is higher in transitions than transversions in 
germline while it appears similar in somatic transitions. Thus the difference in the 
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substitution density seen across TSSs is mainly between the germline and somatic mutations, 
which is further supported by the investigation into the composition of substitutions of 
germline to somatic substitutions in this region as a whole, and results are presented in next 
section. 
 
 
 
 
Figure 4.9. Substitution density (original and 20bp sliding window) from 
-500bp to +500bp relative to FANTOM5 TSSs between germline and 
somatic mutations. Germline mutations whose different ancestral allele 
could be ascertained were included. Purple lines represent total 
substitutions. Blue lines transitions and red lines transversions. 
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4.3.4 Composition is distinct between germline and somatic substitutions 
around FANTOM5 TSSs 
Pearson's Chi-squared tests were applied to investigate whether the composition of 
somatic substitutions is different from that of germline substitutions across the region from -
500bp to +500bp relative to FANTOM5 TSSs as a whole. The raw data are presented in 
Table 4.4. Figure 4.10A shows that, compared to germline substitutions, transitions are 
relatively under represented (observed to expected ratios: germline, 1.01; cancer, 0.69; 
somatic, 0.74) while transversions are relatively enriched (observed to expected ratios: 
germline, 0.99; cancer, 1.67; somatic, 1.55) in somatic substitutions (chi-squared test: p < 
2.2e-16). The ratio of the observed frequency of transitions to transversions is 2.2, 0.9, and 
1.0 in germline, cancer, and normal datasets respectively. The transition/transversion bias 
observed for germline mutations was consistent with previous findings, and was mainly 
attributable to the elevated rate in C->T base change due to the deamination of methylated 
cytosine to thymine in the CpG context (Gojobori et al. 1982; Zhang and Gerstein 2003; 
Arnheim and Calabrese 2009). However, I also acknowledge the potential confounding from 
sequencing error that might contribute to the reduced transition/transversion ratio observed 
for somatic mutations, in the sense that mutation calls as a result of sequencing error would 
be in theory enriched in what appear to be transversions because possible transversions (C:G 
<=> A:T and A:T <=> T:A) are twice as many as possible transitions (C:G <=> T:A).  
I then investigated the relative contribution of different types of base changes to the 
transition and transversion biases between germline and somatic substitutions (Figure 4.10B 
and Table 4.4). The relative enrichment of transitions in germline substitutions and/or 
deprivation in somatic substitutions is mainly determined by G:C -> A:T. The enrichment 
index of G:C -> A:T transitions in germline substitutions is 1.02 while that in somatic 
transitions is much lower (cancer: 0.28; somatic: 0.41). It strongly supports a well-accepted 
observation that higher rate of transitions than transversions is a general feature of vertebrate 
evolution which is at least partly due to the relatively high rate of mutation of methylated 
cytosine to thymine due to deamination (Colot and Rossignol 1999). In contrast, A:T -> G:C 
transitions are relatively enriched in somatic rather than germline substitutions, with an 
observed to expected ratio of 0.99, 1.57, and 1.47 in germline, cancer, and somatic 
respectively. A:T -> C:G transversions are enriched in somatic substitutions, with the 
enrichment index of 0.94, 3.78, and 3.03 in germline, cancer, and somatic substitutions 
respectively. Also, A:T -> T:A transversions are enriched in somatic mutations (germline: 
0.97; cancer: 2.22; somatic: 2.37) while the difference in enrichment index in G:C -> T:A 
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and G:C -> C:G transversions is relatively smaller between germline and somatic 
substitutions.   
Collectively these analyses suggest that mutational compositions are different between 
germline and somatic mutations at regions across TSSs. 
 
Table 4.4. Observed frequency of substitutions in germline and somatic substitutions in the region 
from -500bp to +500bp relative to FANTOM5 TSSs as a whole. 
 
Note: Pearson’s chi-squared test was applied to detect whether the mutational 
composition (six types of base specific base changes, top part of table; transition vs. 
transversion, bottom part of table) is independent of mutational classes (germline, 
cancer and somatic). The null model assumes that the mutational composition is 
independent of the mutational classes. For example, the expected number of germline 
mutation that is transition under the null model is derived as: 1) the proportion of 
mutations that are germline is 
2086161
2129928
; 2) the proportion of mutations that are transition 
is 
1452908
2129928
; and 3) the expected number is 
2086161
2129928
∗   
1452908
2129928
∗ 2129928 = 1423053. In 
test between transition and transversion, X-squared = 9194.314, df = 2, and p-value < 
2.2e-16. Post-hoc tests to look for significant differences in terms of transversion vs. 
transition substitutions was done by the “chisqPostHoc” function in the R package 
“NCStats” (https://rforge.net/NCStats/), and the FDR-adjusted p values for contrasts 
Germline vs. Cancer, Germline vs. Somatic, and Cancer vs. Somatic were all equal 0. In 
tests among different types of base changes, X-squared = 37070.32, df = 10, and p-value 
< 2.2e-16. The post-hoc tests for pair-wise comparisons between different base 
substitution types (15 comparisons in total) and between germline and somatic classes (3 
comparisons) were all significant. 
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Figure 4.10. Transition and transversion biases between germline and somatic 
substitutions in the region from -500bp to +500bp relative to FANTOM5 TSSs as 
a whole. A: transition and transversion biases between somatic and germline 
substitutions. B: enrichment biases in different types of base changes between 
somatic and germline substitutions. Though theoretically there are 12 types of 
individual base changes, they are collapsed into 6 types. The logic behind this is 
that if we observe a T -> A change at a given genomic position, we cannot tell 
whether it comes from the + strand or – strand. 
 
 
4.3.5 Mutation spectra around nucleosome dyads 
To test whether the nucleosome structure is associated with the biases between germline 
and somatic substitutions, I compared the spectra of both germline substitutions against that 
of somatic mutations around nucleosome dyads. The nucleosome dyad dataset used in this 
analysis, covering 817,774 autosomal nucleosomes, was produced by Schones et al. (2008) 
and used in Prendergast and Semple (2011) where the inter-species sequence divergence and 
intra-species sequence diversity (SNPs) were found to be higher in nucleosome cores. In this 
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analysis, unlike the calculation of the position dependent substitution density across 
FANTOM5 TSSs, I directly compared the position dependent frequency (counts) of 
mutations across dyads without normalizing the frequency at each position by the total 
number of valid sites meeting the criterion of 10X coverage. Theoretically not correcting for 
the total number of valid sites at each position relative to the nucleosome dyad might 
introduce bias in the calculation of the position-dependent mutational density; however, we 
speculate that it is less of a problem since the variation in sequencing coverages across the 
nucleosomes should not be as substantial as that observed at regions across TSSs. 
Figure 4.11 shows that substitution frequency (20bp sliding window) is generally lower 
in somatic than germline across the region from -500bp to +500bp relative to the nucleosome 
dyad. Consistent with results comparing transitions and transversions across FANTOM5 
TSSs, the frequency of transitions is relatively higher than that of transversions in germline 
substitutions but the difference is not obvious in somatic substitutions.   
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Figure 4.11. Substitution frequency (original and 20bp sliding window) from -500bp to 
+500bp relative to nucleosome dyad between germline and somatic mutations. Only 
germline substitutions whose different ancestral allele could be ascertained were included. 
Purple lines represent total substitutions; blue lines indicate transitions and red 
transversions. 
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4.3.6 Composition of substitutions is distinct between germline and somatic 
substitutions around nucleosome dyads 
To statistically test the difference in the substitution frequency around the nucleosome 
dyads between germline and somatic substitutions, I adopted a similar strategy as in the 
comparison of substitutions around TSSs by comparing the observed frequency to the 
expected frequency under the null model using a Pearson's Chi-squared test. The raw data is 
presented in Table 4.5. In addition, instead of focusing on the region from -500bp to +500bp 
relative to nucleosome dyads, we limited the analysis to the region from -125bp to +125bp 
relative to dyads as it more accurately reflects the real length of a nucleosome (150bp of 
nucleosome core and 50bp of linker region at both sides).  
Figure 4.12A shows that, compared to germline substitutions, transitions are relatively 
under represented (observed/expected ratio: germline, 1.01; cancer, 1.97; somatic, 1.93) 
while transversions are relatively enriched (observed/expected ratio: germline, 0.98; cancer, 
1.67; somatic, 1.55) among somatic substitutions (p < 2.2e-16). The ratio of the observed 
frequency of transitions to transversions (Ti/Tv ratio) is 2.81, 0.89, and 0.92 in germline, 
cancer, and somatic substitutions respectively. 
Figure 4.12B shows that the enrichment of transitions in germline substitutions and/or 
deprivation of transversions is mainly by G:C -> A:T. The enrichment index of G:C -> A:T 
transitions in germline substitutions is 1.02 while that in somatic transitions is much lower 
(cancer: 0.29; somatic: 0.40). In contrast, A:T -> G:C transitions are relatively enriched in 
somatic rather than germline substitutions, with an enrichment index of 0.99, 1.38, and 1.18 
observed in germline, cancer, and somatic substitutions respectively. Results are quite 
consistent in the contradictory observations of G:C -> A:T and A:T -> G:C transitions in the 
transitions enrichment between germline and somatic substitutions, across both FANTOM 
TSSs and nucleosome dyads. A:T -> C:G transversions are enriched in somatic substitutions, 
with the enrichment index of 0.93, 3.84, and 3.10 in germline, cancer, and somatic 
substitutions respectively. Also, A:T -> T:A transversions are enriched in somatic mutations 
(germline: 0.95; cancer: 3.05; somatic: 3.97) while the difference in enrichment index in G:C 
-> T:A and G:C -> C:G transversions is relatively smaller between germline and somatic 
substitutions.   
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Table 4.5. Observed frequency of substitutions in germline and somatic substitutions on the region 
from -125bp to +125bp relative to nucleosome dyads. 
 
Note: Pearson’s chi-squared test was applied to detect whether the mutational composition (six types 
of base-specific base changes, top part of table; transition vs. transversion, bottom part of table) is 
independent of mutational classes (germline, cancer and somatic). The null model assumes that the 
mutational composition is independent of the mutational classes. For example, the expected number of 
germline mutation that is transition under the null model is derived as: 1) the proportion of mutations 
that are germline is 
3504863
3594740
; 2) the proportion of mutations that are transition is 
2626537
3594740
; and 3) the 
expected number is 
3504863
3594740
∗   
2626537
3594740
∗ 3594740 = 2560867.  In test between transitions and 
transversion, X-squared = 31610.08, df = 2, and p-value < 2.2e-16. The FDR adjusted p values in 
post-hoc tests for Germline vs. Cancer and Germline vs. Somatic equal 0 while that for Cancer vs. 
Somatic equals 0.114. In test among different types of base changes, X-squared = 80916.25, df = 10, 
and p-value < 2.2e-16. The post-hoc tests for pair-wise comparisons between different base substation 
types (15 comparisons in total) and between germline and somatic classes (3 comparisons) were all 
significant. 
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Figure 4.12. Transition and transversion biases between germline and somatic substitutions on the 
region from -125bp to +125bp relative to the nucleosome dyad. A: transition and transversion biases 
between somatic and germline substitutions. B: enrichment biases in different types of base changes 
between somatic and germline substitutions.  
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4.4 Discussion 
In this chapter, I have shown that nucleosome spacing among different human cancer and 
normal cell lines is well conserved. Overall nucleosome positioning around FANTOM5 
TSSs is consistent among cell lines. In addition, the positioning of -1 and +1 nucleosomes is 
well conserved while that of further downstream nucleosomes shows shifts of different 
degrees among different cell lines. Although the nucleosome positioning has been observed 
to alter at specific genomic loci associated with a subset of genes during cell differentiation 
and reprogramming and in cancer cells (Schones et al. 2008; Portela and Esteller 2010; Brait 
and Sidransky 2011; Hassler and Egger 2012; Plass et al. 2013; West et al. 2014), the global 
patterns of the positions of bulk nucleosomes or nucleosomes carrying specific histone 
modifications were not noticeably globally altered in cancer cells with respect to normal cell 
lines, suggesting the contrasts seen between somatic and germline mutational spectra do not 
appear to be attributable to alterations in nucleosome positioning between cell types. 
The germline and somatic substitution spectra across FANTOM5 TSSs and nucleosome 
dyads are different. Using the Pearson's Chi-squared test, we found that the composition of 
somatic substitutions is quite distinct from that of germline substitutions.  Also, the transition 
bias has been shown to be exclusively determined by the deprivation of G:C -> A:T 
transitions in somatic substitutions,  although we could not exclude the possible confounding 
from the errors in variant calling. In addition, it should not be surprising to observe the 
expected transition/transversion ratio in germline variants since I only included the germline 
variants if also seen in 1000 genomes (filtering against 1000 genomes should be expected to 
reduce the false positive germline variants detected). The biased enrichment of A:T -> C:G 
and A:T -> T:A changes are responsible for the general transversion enrichment in somatic 
mutations.  
 One limitation in the mutation spectra analysis is that when we defined somatic 
mutations at a non-polymorphic genomic site (non-SNP site), we did not take into 
consideration the effect of the loss of heterozygosity (LOH) in tumour cells and the LOH 
rate was substantial in some cancer genomes (data not shown); thus a called somatic 
mutation might be a false positive in the sense that it might be a de novo germline mutation 
but the alternate base has been lost in cancer cells due to LOH in cancer. Future study will be 
focused on comparing mutational spectra at genomic regions where no LOH was detected in 
tumour cells. 
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Chapter 5: Genetic Determinants of Somatic 
Mutation Rates in Blood Cells 
 
 
5.1 Introduction 
As discussed in Chapter 1, cancer can be regarded as a disease of the genome and is the 
result of an evolutionary process within populations of cells (Crespi and Summers 2005; 
Jones et al. 2008; Ye et al. 2009; Heng et al. 2010; Heng et al. 2011). A crucial requirement 
for the initiation and progression of cancer is the accumulation of somatically acquired DNA 
mutations in normal cells. The sources of DNA mutations are diverse, including but not 
limited to, exogenous and endogenous DNA mutagens, decreased fidelity of DNA 
replication and defects in DNA repair pathways (Salk et al. 2010).  
Genomic DNA suffers constant damage by both endogenous and exogenous mutagens 
(Salk et al. 2010). Examples of endogenous DNA damage are the oxidation of DNA by 
reactive oxygen species (ROS) such as the 8-oxo-deoxyguanosine (8-oxo-dG) (Nishimura 
2006), and the deamination of methylated cytosine at CpG sites (Helleday et al. 2014). The 
environmental mutagens can be either chemical or physical, and the DNA damage caused is 
predominantly a stochastic process and shows characteristic patterns associated with 
different sources. The non-ionizing radiation by UV light causes the covalent modification 
between neighbouring pyrimidines, resulting in CC:GG ->TT:AA mutations which are often 
predominant in skin cancers (Salk et al. 2010; Helleday et al. 2014). Another well studied 
example is that the lung cancer caused by tobacco smoke features elevated G->T mutations 
(Hecht 1999; Lee et al. 2010; Pleasance et al. 2010; Helleday et al. 2014).  
Though not perfect, DNA replication is a process of high fidelity and is associated with 
an extremely low frequency of spontaneous mutations (Salk et al. 2010). The bulk 
replication of DNA is carried out by DNA polymerases Pol δ and Pol ε (Garg and Burgers 
2005). The proofreading domains in POLD1 (the catalytic subunit of Pol δ) and POLE (the 
catalytic subunit of Pol ε) which work as exonuclease guarantee the low replication error rate. 
Thus defects in the proofreading functions can increase the mutation rates, generating 
mutator phenotypes (Lawrence A Loeb 2011; Heitzer and Tomlinson 2014). For example, 
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both germline and somatic mutations in POLD1 and POLE were discovered in the colorectal 
cancers (Briggs and Tomlinson 2013; Palles et al. 2013; Heitzer and Tomlinson 2014).  
A crucial mechanism against mutation accumulation is the DNA repair system, such as 
the involvement of the p53 in DNA repair by arresting cells at G1 phase, and mutations in 
p53 can lead to increased DNA damage (Calvert and Frucht 2002). Distinct DNA repair 
pathways involving more than 100 repair genes have been found to repair both single-strand 
breaks (SSBs) and double strand breaks (DSBs) and thus the defects in DNA repair 
pathways are often associated with increased spontaneous mutation rates (Salk et al. 2010; 
Lawrence A Loeb 2011; Dietlein et al. 2014). For example, the DNA mismatch repair 
(MMR) pathway targets and repairs the mis-incorporated bases during DNA replication, as 
well as some insertions and deletions (indels) (Dietlein et al. 2014; Helleday et al. 2014). 
Mutations in MMR genes, including MSH2 and MSH6, have been found to be associated 
with microsatellite instability (MSI) characterised by a high frequency of indels at simple 
tandem sequence repeats, and in particular linked to increased mutation rates in colorectal 
cancer (Network 2012). In addition, by assessing the single nucleotide variants in 652 
tumours, Supek and Lehner (2015) found that differential DNA mismatch repair underlies 
variations in the mutation rates of intervals measured at mega-base scale across the genome. 
Both the base excision repair (BER) and nucleotide excision repair (NER) pathways 
recognise and repair SSBs (Helleday et al. 2008; Dietlein et al. 2014). While the BER 
pathway targets and excises the single damaged base, the NER pathway usually excises a 
short stretch of ~30 nucleotides (Dietlein et al. 2014). In BER pathway, the single damaged 
base is excised by a specific DNA glycosylase, the resulting abasic site is cleaved by APEX1 
nuclease, and finally the SSB is repaired by a DNA repair complex. The defects in the BER 
pathway have been shown to have a causative role in colorectal cancer (Farrington et al. 
2005). The NER pathway is a major DNA repair pathway involved in  maintaining genome 
integrity and can be either global genome repair (GGR) or transcription-coupled repair (TCR) 
(Kamileri et al. 2012; Dietlein et al. 2014). TCR can cause strand bias in the repair efficiency 
such that the DNA damage on the transcribed strand can be repaired more efficiently 
compared to that on non-transcribed strand (Nouspikel 2009; Kamileri et al. 2012). The 
DSBs can be repaired by homologous recombination (HR) and non-homologous end-joining 
(NHEJ). The HR pathway uses the sister chromatid as the template and generally happens in 
S and G2 phases (Chapman et al. 2012); the NHEJ pathway does not need a sister chromatid 
but directly ligates broken DNA ends, and preferentially happens in the G1 phase 
(Hartlerode and Scully 2009). Heterozygous mutations in HR genes, including BRCA1, 
BRCA2 and RAD51C are associated with increased cancer risks, and homozygous mutations 
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(loss-of-function biallelic mutations) in those genes have been discovered in different 
cancers (Dietlein et al. 2014). However, NHEJ is usually error prone and has been shown to 
be involved in the formation of translocations, representing a source of genome instability 
and a variant in NHEJ gene Ligase IV has been found to be associated with a decrease in 
breast cancer  risk (Kuschel et al. 2002; Dietlein et al. 2014).  
The rate of the accumulation of somatic mutations is therefore affected by many genetic 
and  genomic factors (Salk et al. 2010; Hodgkinson and Eyre-Walker 2011; Dietlein et al. 
2014; Helleday et al. 2014). There are likely many further genes that directly or indirectly 
affect somatic mutation rates and potentially play an important role in the emergence of 
diseases such as cancer (Lawrence A Loeb 2011; Network 2012; Supek and Lehner 2015).  
In addition to the discovery of germline mutations that predispose individuals to diseases, 
genome-wide association study (GWAS) has also been successful in understanding the 
genetic architecture of quantitative trait phenotypes (like blood pressure and height) affected 
by multiple loci where each locus has only a moderate effect (Cho et al. 2009; Stranger et al. 
2011; Visscher et al. 2012). For example, GWAS has been applied to successfully identify 
the loci that affect blood pressure (ICBP 2011), lipid levels (Global Lipids Genetics 
Consortium 2013), adult human height (Wood et al. 2014), and body mass index (Speliotes 
et al. 2010). 
In this chapter, I focused on the somatic mutation rate of single nucleotide variants 
(SNVs) in blood derived normal cells. I tested whether an individual’s age is associated with 
the number of somatic mutations they carry in their normal tissue and searched for potential 
genetic determinants of somatic mutation rate using GWAS.  
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5.2 Methods 
5.2.1 Patient selection and raw variant calling 
Data used in this chapter are somatic mutations from normal blood derived cells, a subset 
of the TCGA dataset used in Chapter 4. The rates of loss of heterozygosity (LOH) in cancers 
can be substantial, and the LOH events in cancer tissues can confound the somatic mutations 
called in blood derived normal cells, as a called normal cells specific SNV might be a false 
positive in the sense that it might be a germline mutation but the alternate base has been lost 
in the cancer cells due to the LOH. We thus only analysed SNVs in normal blood samples 
where the overall LOH rates in corresponding tumour tissue were low (arbitrarily chosen as 
≤ 0.11 to maximize the number of cases). The list of overall LOH rate and LOH regions in 
cancer tissues was detected by ExomeCNV (Sathirapongsasuti et al. 2011) and provided by 
Alison Meynert. The ExomeCNV detects the LOH in cancer tissues, based on contrasts in 
depth-of-coverage and minor allele frequency between cancer and paired normal tissues at 
known SNP sites (1000 genomes) across the genome (Sathirapongsasuti et al. 2011). In total, 
372 out of 997 patients were selected (the list of included patient numbers per cancer is 
summarised in Table 5.1) where the control (non-cancer) tissue sample sequenced was blood. 
Varscan (version 2.3.5, Koboldt et al. 2012) was used to detect SNVs specific to normal 
somatic cells and also germline SNVs based on the normal-cancer sample pairs. 
To call somatic and germline SNVs in normal blood cells using Varscan, the analysis 
protocol was reversed from that traditionally used to call somatic mutations in tumour 
samples, i.e. the pre-aligned BAM files from primary tumour tissues were used as the control 
files. The general workflow is depicted in Figure 5.1. For each patient, pileup inputs that 
summarize the base calls at the reads mapping to each genomic position were generated 
respectively for normal blood cells and primary tumour tissue by Samtools (version 0.1.19, 
Li et al. 2009) from Stampy realigned BAM files (by Alison Meynert, Lunter and Goodson 
2011). At a given position, bases were only included if the base quality was ≥ 20 (-Q 20) 
and the minimum mapping quality of the containing read was ≥ 1 (-q 1), to exclude reads 
that mapped to multiple genomic regions. Normal cells specific somatic mutations and 
germline variants were called by Varscan with default parameters.  
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Table 5.1:  List of patient numbers whose control tissues are from blood derived normal cells. 
Cancer type Patient number 
Bladder Urothelial Carcinoma (BLCA) 4 
Breast invasive carcinoma ( BRCA) 45 
Cervical squamous cell carcinoma and endocervical 
adenocarcinoma (CESC) 
6 
Colon adenocarcinoma (COAD) 7 
Glioblastoma multiforme (GBM) 89 
Head and Neck squamous cell carcinoma (HNSC) 37 
Kidney renal clear cell carcinoma (KIRC) 35 
Kidney renal papillary cell carcinoma (KIRP) 4 
Brain Lower Grade Glioma (LGG) 43 
Lung adenocarcinoma (LUAD) 10 
Lung squamous cell carcinoma (LUSC) 7 
Ovarian serous cystadenocarcinoma (OV) 1 
Prostate adenocarcinoma (PRAD) 28 
Stomach adenocarcinoma (STAD) 4 
Thyroid carcinoma (THCA) 19 
Uterine Corpus Endometrioid Carcinoma (UCEC) 33 
 
 
5.2.2 Variants filtering and mutation rate calculation 
To exclude the possibility that a given genomic position is well sequenced in some 
patients but not others, only genomic positions that were covered by at least 10 reads in both 
cancer and normal blood cells for all 372 patients were included and analysed. This was 
done to reduce the bias, such as hypermutated regions represented in one sample but not 
another. To exclude the impact of LOH in cancer, any genomic positions which were located 
in the regions defined as LOH in the cancer were discarded. Somatic mutations are rare 
events and are unlikely to occur multiple times at the same position. Therefore any normal 
cells specific mutations that were seen in another patient were excluded. In addition, 
potential normal cells specific mutations were further filtered against dbSNP135 variants, 
1000 genome variants, and germline variants from 372 patients. 
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The overall somatic mutation rate in each patient was calculated as the ratio of the 
number of normal cells specific somatic mutations to the total number of valid sites passing 
the above filters. 
 
 
 
Figure 5.1. Work flow for calling normal cells specific somatic variants and germline 
variants.  
 
 
5.2.3 Genome-wide association study (GAWS) for genetic determinants of 
normal cells specific somatic mutation rates 
The quantitative trait association between the overall normal cells specific somatic 
mutation rates and germline variants (mean and median number of called variants per 
individual are 91438 and 86068 respectively) called by Varscan was tested by PLINK 
(Purcell et al. 2007) with adaptive permutations on a per-SNP basis with default parameters 
except that the maximum number of permutations per SNP was set as 100000000 (--aperm 
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10 100000000 0.0001 0.01 5 0.001) instead of the default 1000000, where the phenotype is 
the overall normal cells specific somatic mutation rates (for more information please see 
"Quantitative trait association" section in the PLINK manual: 
http://pngu.mgh.harvard.edu/~purcell/plink/anal.shtml#qt)). The command used was: plink --
lfile germline --allow-no-sex --assoc --aperm 10 100000000 0.0001 0.01 5 0.001 --qt-means 
–out germline_aperm. 
To account potential confounders, I also did a post-GWAS quality control analysis. To 
only keep SNPs with high quality, a given SNP must meet the following criteria: the 
proportion of patients with missing genotypes was <0.05, minor allele frequency (MAF) 
was >0.01, and Hardy-Weinberg Equilibrium (p>0.001) must be met. The command used 
was: plink --lfile germline --noweb --allow-no-sex --maf 0.01 --geno 0.05 --hwe 0.001 --out 
germline.filtered --make-bed. 
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5.3 Results and discussions 
5.3.1 The overall somatic mutation rate and age 
The variation in the somatic mutation rates in blood cells was considerable across 372 
individuals, ranging from ~1.3 per 10
6
 to ~6.3 per 10
4
 bases with a median rate of ~3.8 per 
10
6
 bases (Figure 5.2). Age has been shown to have a linear relationship with the germline 
mutation rates (Crow 2000; Hodgkinson and Eyre-Walker 2011; Ségurel et al. 2014), such 
that  Kong et al. (2012) noted an increase of ~2 de novo germline mutations per year while 
Michaelson et al. (2012) noted a rate of ~1.02 de novo mutations per year. In order to 
investigate whether the somatic mutations accumulate in the normal blood cells as a function 
of age, I performed a correlation test but failed to find a significant relationship across the 
372 individuals (Pearson's product-moment correlation test: p=0.1546 and rho=0.07). 
However, examination of Figure 5.2 highlights that 7 individuals showed evidence of a 
mutator phenotype, i.e. they exhibited a substantially higher somatic mutation rate than the 
other individuals in this dataset. Intriguingly 6 out of 7 of these individuals were colon 
adenocarcinoma patients. Deficient DNA repair is a common feature of colon cancer, 
germline mutations in mismatch repair genes being linked to several of the major heritable 
colorectal cancer syndromes (Peltomäki 2001). Age and mutation numbers in these “hyper-
mutated” individuals did show a significant positive correlation with an average rate of ~4.8 
per 10
6
 bases per year. The higher mutational load in these individuals potentially leading to 
the relationship between age and mutation number being easier to detect, however the 
numbers are small and further investigation is required to follow up this result.  
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Figure 5.2. Relationship between age and the somatic mutation rates in blood derived normal cells in 
372 TCGA patients. Individuals with colon adenocarcinoma (COAD) were displayed as blue while 
others as red points. The linear relationship between age and mutation rate (represented by black 
line) was based on a subset of 7 individuals with substantially higher somatic mutation rate: p = 
0.004 and adjusted R-squared = 0.80.  
 
 
5.3.2 Genetic determinants of somatic mutation rate  
 To search for genetic determinants of these human somatic mutation rates, I performed a 
quantitative trait association using PLINK with per-SNP based adaptive permutations (see 
Methods). I obtained a total of 601 germline variants whose genotype was significantly 
correlated with mutation rate at a p value of ~1.0e-08 which is approximately the level for a 
genome-wide significant result. The effects of 601 germline variants were annotated using 
the ANNOVAR program (Wang et al. 2010). Out of 601 significant germline variants, 108 
were either nonsynonymous or stop gaining mutations affecting 41 genes in total, and 44 
were de novo in the sense that they were not seen in 1000 genomes (T. 1000 G.P. 
Consortium 2012), esp6500 (https://esp.gs.washington.edu/drupal/) and dbSNP135 
databases. The summary of genes harbouring significant germline variants is in Table 5.2. 
Some of these genes are already associated to cancer associated pathways. CDC27 encodes a 
component of the anaphase-promoting complex and is associated with cell cycle regulation, 
and has been linked to lung and prostate adenocarcinoma (Gonzalez-Perez et al. 2013; Ahn 
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et al. 2014; Rubio-Perez et al. 2015). BCLAF1 encodes a transcriptional repressor and can 
induce apoptosis, and has been shown to regulate the tumorigenic potential of colon cancer 
cells (Lee et al. 2012; Zhou et al. 2014). CTDSP2 involves in the metabolism pathway which 
is the major source of reactive oxidative species and associates with diseases including 
glioblastoma (GBM) (Ping et al. 2015). However, many of the genes in the list seem unlikely 
to affect the accumulation of mutations in somatic tissues, including OR4C3 and MUC6 
(Table 5.2). Although it is possible these variants are tagging causative variants nearby, 
MUC6 has several similar paralogs and therefore variants in these genes are at greater risk of 
being false positives (Treangen and Salzberg 2012).  
No evidence of population structure was found. However after applying quality control to 
filter putative false positive variants and linkage disequilibrium pruning, the number of 
significant germline variants dropped from 601 to 44, mainly due to the genotype 
information missing. Out of 44 significant germline variants, 13 were nonsynonymous 
mutations affecting seven genes in total: AK2 (1), CNN2 (3), MAP1B (1), OR4C3 (4), 
PLIN4 (1), PRB4 (1), and ZNF141 (2).  
Though number of significant germline variants dropped markedly due to the 5% 
threshold applied to missing genotypes, this approach so far shows promise for detecting 
candidate variants and genes linked to somatic mutation rates. Expanding this preliminary 
analysis to more individuals represented in the TCGA and other cohorts has the potential to 
enable the first comprehensive study of the genetic determinants of somatic mutation rates.  
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Table 5.2. Summary of genes harbouring germline variants associated with variation in somatic 
mutation rates. 
Genes  
Germline variants 
(count)  Summary 
 All de novo  
AK2 
 
1 0 
 
Adenylate kinase 2  
AKAP13 
 
1 0 
 
A kinase (PRKA) anchor protein 13  
ANKRD36 
 
10 3 
 
Ankyrin Repeat Domain-Containing Protein 36 
BCLAF1 
 
2 0 
 
BCL2-associated transcription factor 1  
CDC27 
 
13 4 
 
Cell Division Cycle 27 
CNN2 
 
5 5 
 
Calponin H2, Smooth Muscle 
CPEB3 
 
1 1 
 
Cytoplasmic polyadenylation element binding protein3  
CTBP2 
 
4 2 
 
C-terminal binding protein 2  
CTDSP2 
 
6 6 
 
CTD (carboxy-terminal domain) small phosphatase 2  
DUX2 
 
1 0 
 
Double homeobox 2  
GPR89B 
 
1 1 
 
G protein-coupled receptor 89B  
HNRNPCL1 
 
4 0 
 
Heterogeneous nuclear ribonucleoprotein C-like 1  
ITPR1 
 
1 1 
 
Inositol 1,4,5-Trisphosphate Receptor, Type 1 
KRT18 
 
4 2 
 
Keratin 18  
KRT8 
 
1 1 
 
Keratin 8  
LOC440563 
 
6 0 
 
Heterogeneous nuclear ribonucleoprotein C-like  
LOC649330 
 
4 0 
 
Heterogeneous nuclear ribonucleoprotein C-like  
LST1 
 
1 1 
 
Leukocyte specific transcript 1  
MAP1B 
 
1 1 
 
Microtubule-associated protein 1B  
MTCH2 
 
1 0 
 
Mitochondrial carrier 2  
MUC16 
 
2 2 
 
Mucin 16, cell surface associated  
MUC2 
 
3 1 
 
Mucin 2, oligomeric mucus/gel-forming  
MUC6 
 
6 1 
 
Mucin 6, oligomeric mucus/gel-forming  
MYH7B 
 
1 1 
 
Myosin, heavy chain 7B, cardiac muscle, beta  
OR4C3 
 
5 0 
 
Olfactory receptor, family 4, subfamily C, member 3  
OR8U1 
 
1 0 
 
Olfactory receptor, family 8, subfamily U, member 1  
OTOP1 
 
2 1 
 
Otopetrin 1 
PCMTD1 
 
3 0 
 
Protein-L-isoaspartate (D-aspartate) O-
methyltransferase domain containing 1 
PLIN4 
 
1 0 
 
Perilipin 4  
POTED 
 
1 1 
 
POTE ankyrin domain family, member D  
PRB4 
 
1 0 
 
Proline-rich protein BstNI subfamily 4  
PRSS3 
 
4 4 
 
Protease, serine, 3  
PSMB10 
 
1 1 
 
Proteasome subunit, beta type, 10  
RPS20 
 
1 1 
 
Ribosomal protein S20 
SHANK3 
 
1 1 
 
SH3 and multiple ankyrin repeat domains 3  
TNC 
 
1 0 
 
Tenascin C 
TRPM6 
 
1 0 
 
Transient Receptor Potential Cation Channel, 
Subfamily M, Member 6 
ZNF141 
 
2 0 
 
zinc finger protein 141 
ZNF585A 
 
1 1 
 
Zinc finger protein 585A  
ZNF585B 
 
1 1 
 
 Zinc finger protein 585B 
ZNF717 
 
1 0 
 
Zinc Finger Protein 717 
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Note: only significant nonsynonymous or stop-gaining germline variants (p value ~1.0e-08) were 
included.    
“De novo” means germline variants not exist in 1000 genomes, ESP6500 and dbSNP135. 
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Chapter 6: Discussion 
 
 
In this thesis, I have investigated nucleosome positioning dynamics in evolution and 
cancer, the interplay between mutational spectra and nucleosome structure, and also the role 
of age and genetic determinants in the rate of accumulation of somatic mutations in blood 
derived normal cells. 
In Chapter 2 and 3, I found that nucleosome positioning is generally well conserved 
between paralogous regions in both the human and yeast genomes: following the duplication 
of a region and its insertion into a new genomic location nucleosomes generally reassemble 
at the same, or similar, locations, supporting the importance of the cis-acting DNA sequence 
in nucleosome positioning (Kaplan et al. 2008). I have also observed strong rotational 
preference and constraints from neighbouring nucleosomes in nucleosome positioning 
evolution where nucleosome positioning has diverged in both species (Chapter 2 and 3), 
consistent with previous studies (Albert et al. 2007; Zhang et al. 2009; Struhl and Segal 2013; 
Hughes and Rando 2014). As far as I am aware, it is the first time that the rotational 
positioning has been directly tested by comparing the translational positioning of 
nucleosomes from paralogous regions. Although there are clues suggesting that the 
positioning of nucleosomes might differ between cancer and normal cell lines (Fraga et al. 
2005; Barski et al. 2007; Esteller 2007; Zhang et al. 2008; Jin et al. 2009b; Portela and 
Esteller 2010; Brait and Sidransky 2011; Wilson and Roberts 2011; Collings et al. 2013), I 
have shown that global nucleosome organization is broadly conserved across cancer and 
non-cancerous cell lines, as suggested by the conserved positioning across FANTOM5 TSSs 
and strongly conserved global phasing (Chapter 4). The local change in nucleosome 
positioning has been also observed during cell differentiation and reprogramming (West et al. 
2014). 
As well as the chromosomal environment, both the DNA composition and sequence 
divergence have been found to be associated with shifts in nucleosome positioning during 
evolution in both yeast and human genomes. The GC content at the nucleosome core is 
inversely related to the nucleosome positioning divergence in both species; while showing an 
inverse relationship in the human genome, the AT content in linker has been observed to be 
positively correlated with nucleosome positioning divergence in the yeast genome (Chapter 2 
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and 3), suggesting that the observed difference might be a reflection of the evolution of 
linker histones and DNA sequence features between human and yeast species (Bates and 
Thomas 1981; Freidkin and Katcoff 2001; Downs et al. 2003; Cui and Zhurkin 2009; 
Osmotherly 2010). I have also found, in both yeast and human genomes, that DNA sequence 
features appear to be more important than local chromosomal environments in nucleosome 
positioning evolution, while controlling for trans-acting factors that can potentially confound 
inter-species comparisons. 
The observed correlation between nucleosome positioning evolution between paralogous 
regions and sequence divergence (Chapter 2 and 3), suggests that nucleosome structure 
might be associated with mutational spectra (Prendergast and Semple 2011; Chen et al. 
2012). I also investigated the interplay between chromatin structure and DNA sequence 
variation, with a particular focus on the spectra of (germline and somatic) substitutions in 
Chapter 4. Based upon a set of 997 patients covering 17 cancer types, I observed that both 
somatic and germline substitutions are enriched at sequences coinciding with nucleosome 
cores. This is consistent with a previous study where nucleosome positioning has been 
shown to influence the types and rates of substitutions across the genome during human 
evolution (Prendergast and Semple 2011). In addition, transitions appear to be enriched in 
germline relative to somatic substitutions at nucleosome core regions; this difference in 
transition to transversion ratio is also seen at transcription start sites (TSSs) genome wide. 
The contrasts seen between somatic and germline mutational spectra do not appear to be 
attributable to alterations in nucleosome positioning between cell types, since I have shown 
that the global nucleosome organizations have been broadly conserved across cancer and 
non-cancerous cell lines. Instead the particular mutational profiles seen for somatic and 
germline cells occur upon a common landscape of conserved chromatin structure. However 
there are some potential drawbacks in the analysis in this chapter: 1) somatic substitutions 
called were filtered based on the number of reads in paired cancer and normal tissues but 
variants were not called by programs specifically designed for somatic mutation detection 
(e.g. Varscan), possibly compromising accuracy. 2) I was not able to take into consideration 
co-founding factors such as LOH in cancer tissues, and thus the substitutions called may 
contain false positives. Future work will be focused on addressing those potential drawbacks.  
In Chapter 5, I also found that the somatic mutation rates in blood derived normal cells 
varied considerably across 372 individuals. Although no correlation was detected between 
age and overall somatic mutation rates, the linear dependency of the rate of somatic mutation 
on age was observed in a subset of individuals that carry colon adenocarcinoma and show 
elevated mutation rates (mutator phenotype). The mutator phenotype is considered to be an 
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important initiating event during the initiation and progression of most of the sporadic 
cancers (Lawrence A. Loeb 2011). In addition, I identified a list of candidate germline 
variants that potentially predispose to increased somatic mutation rates. However, I failed to 
discover any gene that has been previously shown to be directly involved in the DNA repair 
pathways and most of these germline variants are expected to be false positives. Since this 
analysis was quite coarse and preliminary, future improvements, such as the inclusion of 
covariates and the detection of germline variants based on pooled data of 372 normal blood 
samples by GATK, which has been designed specifically for the detection of germline 
variants, should improve the power. 
The observed mutational landscapes in different tumours are thought to be the result of 
the differential exposures to individual mutational processes operating in different cellular 
lineages (Nik-Zainal et al. 2012; Stephens et al. 2012; Alexandrov et al. 2013; Helleday et al. 
2014), and the exposure rates of certain (but not all) mutational processes appear to show a 
linear association with age in cancer genomes (Alexandrov et al. 2013). Future work will 
focus on defining the particular mutational processes operating in the blood derived normal 
cells, their association with age, and further searches for genetic determinants of somatic 
mutation rates. 
Together these analyses contribute to an integrated view of genome evolution, 
encompassing the divergence of DNA sequence and chromatin structure, and initial 
explorations of how they may interact in human disease. 
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Appendix 
 
 
The divergence in the occupancy of dyads around 242 motifs in human genome 
Motif Dataset 
Motif maintained 
 
Motif lost 
 
Student’s t-test 
(p value)  
Mann-Whitney test 
(p value) 
Mean 95% CI 
 
Mean 95% CI 
 
Raw Adjusted 
 
Raw Adjusted 
AMYB (HTH) in vitro 0.049 [-0.113, 0.21]  0.071 [-0.017, 0.159]  0.82152 1.00000  0.89670 1.00000 
AMYB (HTH) in vivo -0.359 [-0.684, -0.034]  -0.148 [-0.294, -0.002]  0.24442 1.00000  0.14094 1.00000 
AP-1 (bZIP) in vitro -0.369 [-0.648, -0.09]  -0.074 [-0.189, 0.042]  0.04454 1.00000  0.01454 1.00000 
AP-1 (bZIP) in vivo -0.333 [-0.668, 0.003]  -0.21 [-0.443, 0.023]  0.56150 1.00000  0.27542 1.00000 
AP-2alpha (AP2) in vitro 0.291 [0.042, 0.539]  0.252 [0.125, 0.379]  0.78916 1.00000  0.50042 1.00000 
AP-2alpha (AP2) in vivo -0.15 [-0.497, 0.198]  0.161 [-0.061, 0.383]  0.11871 1.00000  0.17668 1.00000 
AP-2gamma (AP2) in vitro 0.256 [0.033, 0.48]  0.213 [0.112, 0.315]  0.70431 1.00000  0.56097 1.00000 
AP-2gamma (AP2) in vivo -0.3 [-0.645, 0.045]  0.15 [-0.107, 0.408]  0.01227 1.00000  0.01936 1.00000 
Ap4 (bHLH) in vitro -0.243 [-0.563, 0.077]  0.075 [-0.113, 0.264]  0.10440 1.00000  0.14094 1.00000 
Ap4 (bHLH) in vivo -0.259 [-0.546, 0.028]  -0.022 [-0.269, 0.224]  0.22201 1.00000  0.21568 1.00000 
AR-halfsite (NR)  in vitro 0.164 [0.023, 0.304]  0.151 [0.033, 0.27]  0.89868 1.00000  0.91919 1.00000 
AR-halfsite (NR)  in vivo -0.522 [-0.872, -0.171]  -0.09 [-0.284, 0.104]  0.03135 1.00000  0.02965 1.00000 
ARE (NR) in vitro 0.012 [-0.374, 0.399]  0.24 [0.088, 0.391]  0.27213 1.00000  0.06840 1.00000 
ARE (NR) in vivo 0.42 [0.046, 0.793]  0.452 [0.201, 0.704]  0.88149 1.00000  0.44418 1.00000 
Arnt:Ahr (bHLH) in vitro 0.242 [0.094, 0.39]  0.105 [0.008, 0.203]  0.14617 1.00000  0.03165 1.00000 
Arnt:Ahr (bHLH) in vivo 0.047 [-0.221, 0.316]  -0.015 [-0.203, 0.174]  0.70088 1.00000  0.76786 1.00000 
Atf1 (bZIP) in vitro -0.064 [-0.305, 0.177]  -0.08 [-0.242, 0.082]  0.91861 1.00000  0.93385 1.00000 
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Atf1 (bZIP) in vivo -0.194 [-0.588, 0.199]  -0.176 [-0.399, 0.047]  0.92122 1.00000  0.81763 1.00000 
Atf3 (bZIP) in vitro 0.573 [0.259, 0.887]  0.609 [0.376, 0.843]  0.84802 1.00000  0.49540 1.00000 
Atf3 (bZIP) in vivo 1.637 [1.474, 1.8]  1.739 [1.557, 1.92]  0.38986 1.00000  0.35599 1.00000 
Atf4 (bZIP) in vitro -0.142 [-0.342, 0.058]  -0.106 [-0.228, 0.015]  0.77484 1.00000  0.41116 1.00000 
Atf4 (bZIP) in vivo -0.338 [-0.637, -0.04]  -0.188 [-0.434, 0.057]  0.38865 1.00000  0.16503 1.00000 
Atoh1 (bHLH) in vitro 0.03 [-0.199, 0.258]  0.287 [0.17, 0.403]  0.05916 1.00000  0.03568 1.00000 
Atoh1 (bHLH) in vivo 0.102 [-0.159, 0.362]  0.034 [-0.173, 0.24]  0.66798 1.00000  0.77728 1.00000 
Bach1 (bZIP) in vitro 0.338 [0.069, 0.607]  0.303 [0.106, 0.5]  0.85245 1.00000  0.92979 1.00000 
Bach1 (bZIP) in vivo 0.946 [0.635, 1.257]  0.964 [0.744, 1.184]  0.91649 1.00000  0.51021 1.00000 
Bach2 (bZIP) in vitro -0.11 [-0.349, 0.128]  0 [-0.157, 0.157]  0.44459 1.00000  0.19257 1.00000 
Bach2 (bZIP) in vivo -0.033 [-0.386, 0.32]  0.432 [0.172, 0.692]  0.05666 1.00000  0.01165 1.00000 
BATF (bZIP) in vitro -0.044 [-0.35, 0.261]  -0.054 [-0.295, 0.187]  0.96198 1.00000  0.63623 1.00000 
BATF (bZIP) in vivo 0.239 [-0.02, 0.499]  0.38 [0.129, 0.632]  0.48220 1.00000  0.64951 1.00000 
Bcl6 (Zf) in vitro -0.418 [-0.618, -0.219]  -0.181 [-0.288, -0.074]  0.03169 1.00000  0.03397 1.00000 
Bcl6 (Zf) in vivo -0.6 [-0.87, -0.33]  -0.387 [-0.624, -0.15]  0.23560 1.00000  0.16702 1.00000 
bHLHE40 (bHLH) in vitro 0.319 [0.049, 0.589]  0.438 [0.261, 0.615]  0.47067 1.00000  0.31208 1.00000 
bHLHE40 (bHLH) in vivo 0.693 [0.295, 1.092]  0.851 [0.59, 1.111]  0.50268 1.00000  0.54354 1.00000 
BMAL1 (bHLH) in vitro 0.108 [-0.186, 0.402]  0.015 [-0.182, 0.211]  0.60107 1.00000  0.62963 1.00000 
BMAL1 (bHLH) in vivo 0.106 [-0.226, 0.437]  0.591 [0.377, 0.805]  0.02043 1.00000  0.00435 1.00000 
BMYB (HTH) in vitro -0.003 [-0.156, 0.15]  0.023 [-0.042, 0.088]  0.76260 1.00000  0.80333 1.00000 
BMYB (HTH) in vivo -0.345 [-0.616, -0.073]  -0.208 [-0.37, -0.047]  0.38823 1.00000  0.14348 1.00000 
BORIS (Zf) in vitro 0.083 [-0.214, 0.38]  0.363 [0.149, 0.577]  0.15898 1.00000  0.22218 1.00000 
BORIS (Zf) in vivo -0.038 [-0.427, 0.351]  0.273 [-0.025, 0.572]  0.14986 1.00000  0.31386 1.00000 
Brachyury (T-box) in vitro -0.101 [-0.395, 0.193]  0.218 [0.093, 0.343]  0.05249 1.00000  0.01105 1.00000 
Brachyury (T-box) in vivo -0.064 [-0.403, 0.276]  0.138 [-0.133, 0.41]  0.42587 1.00000  0.22572 1.00000 
bZIP:IRF (bZIP,IRF) in vitro -0.665 [-0.859, -0.471]  -0.27 [-0.381, -0.159]  0.00133 0.64429  0.00007 0.03591 
bZIP:IRF (bZIP,IRF) in vivo -0.816 [-1.178, -0.455]  -0.468 [-0.625, -0.312]  0.09921 1.00000  0.04278 1.00000 
c-Jun-CRE (bZIP) in vitro -0.014 [-0.312, 0.284]  0.087 [-0.093, 0.266]  0.54191 1.00000  0.61181 1.00000 
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c-Jun-CRE (bZIP) in vivo -0.081 [-0.51, 0.348]  -0.055 [-0.369, 0.259]  0.91721 1.00000  0.70033 1.00000 
c-Myc (bHLH) in vitro 0.064 [-0.164, 0.292]  0.042 [-0.064, 0.148]  0.84510 1.00000  0.91187 1.00000 
c-Myc (bHLH) in vivo 0.105 [-0.223, 0.432]  0.15 [-0.052, 0.351]  0.82233 1.00000  0.56216 1.00000 
CArG (MADS) in vitro -0.384 [-0.658, -0.11]  0.014 [-0.139, 0.168]  0.02435 1.00000  0.00416 1.00000 
CArG (MADS) in vivo -0.364 [-0.71, -0.018]  0.104 [-0.124, 0.332]  0.04127 1.00000  0.00488 1.00000 
Cdx2 (Homeobox) in vitro -0.522 [-0.753, -0.291]  -0.437 [-0.591, -0.283]  0.51742 1.00000  0.62483 1.00000 
Cdx2 (Homeobox) in vivo -1.141 [-1.433, -0.85]  -0.327 [-0.561, -0.093]  0.00006 0.02755  0.00007 0.03442 
CEBP:AP1 (bZIP) in vitro -0.244 [-0.427, -0.062]  -0.072 [-0.191, 0.047]  0.13748 1.00000  0.07960 1.00000 
CEBP:AP1 (bZIP) in vivo -0.603 [-0.946, -0.261]  -0.13 [-0.306, 0.045]  0.00873 1.00000  0.03165 1.00000 
CEBP:CEBP (bZIP) in vitro -0.253 [-0.52, 0.014]  -0.235 [-0.367, -0.102]  0.89122 1.00000  0.19737 1.00000 
CEBP:CEBP (bZIP) in vivo -0.569 [-0.934, -0.205]  -0.128 [-0.397, 0.142]  0.03895 1.00000  0.05728 1.00000 
CEBP (bZIP) in vitro -0.315 [-0.508, -0.121]  -0.084 [-0.196, 0.028]  0.06099 1.00000  0.12643 1.00000 
CEBP (bZIP) in vivo -0.718 [-1.095, -0.341]  -0.227 [-0.424, -0.03]  0.01397 1.00000  0.01240 1.00000 
Chop (bZIP) in vitro -0.379 [-0.615, -0.143]  -0.141 [-0.261, -0.022]  0.06842 1.00000  0.12186 1.00000 
Chop (bZIP) in vivo -0.386 [-0.785, 0.013]  0.059 [-0.235, 0.352]  0.03674 1.00000  0.04041 1.00000 
CLOCK (bHLH) in vitro -0.241 [-0.499, 0.018]  0.176 [0.032, 0.32]  0.00575 1.00000  0.00282 1.00000 
CLOCK (bHLH) in vivo 0.244 [-0.105, 0.592]  0.251 [-0.024, 0.525]  0.97297 1.00000  0.94455 1.00000 
CRE (bZIP) in vitro -0.16 [-0.509, 0.189]  0.183 [-0.008, 0.374]  0.02980 1.00000  0.13662 1.00000 
CRE (bZIP) in vivo 0.28 [-0.083, 0.642]  0.329 [0.048, 0.609]  0.82677 1.00000  0.86742 1.00000 
CRX (Homeobox) in vitro -0.089 [-0.307, 0.128]  -0.164 [-0.297, -0.032]  0.54821 1.00000  0.36047 1.00000 
CRX (Homeobox) in vivo -0.123 [-0.53, 0.285]  -0.15 [-0.373, 0.073]  0.89800 1.00000  0.95587 1.00000 
CTCF-SatelliteElement in vitro 0.383 [0.073, 0.693]  0.873 [0.637, 1.108]  0.00695 1.00000  0.00004 0.02040 
CTCF-SatelliteElement in vivo 1.405 [1.295, 1.515]  1.821 [1.631, 2.012]  0.00022 0.10550  0.00000 0.00000 
CTCF (Zf) in vitro -0.099 [-0.496, 0.298]  0.208 [-0.083, 0.499]  0.23466 1.00000  0.23887 1.00000 
CTCF (Zf) in vivo 0.011 [-0.409, 0.43]  0.175 [-0.186, 0.536]  0.50680 1.00000  0.61000 1.00000 
E-box (bHLH) in vitro 0.516 [0.182, 0.849]  0.424 [0.198, 0.65]  0.66408 1.00000  0.50430 1.00000 
E-box (bHLH) in vivo 0.67 [0.43, 0.91]  0.904 [0.667, 1.141]  0.18125 1.00000  0.26376 1.00000 
E2A (bHLH) in vitro 0.24 [-0.006, 0.487]  0.25 [0.12, 0.38]  0.94722 1.00000  0.84642 1.00000 
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E2A (bHLH) in vivo 0.181 [-0.14, 0.501]  0.346 [0.074, 0.618]  0.47217 1.00000  0.30766 1.00000 
E2A (bHLH), near_PU.1 in vitro 0.247 [0.123, 0.37]  0.188 [0.098, 0.277]  0.47432 1.00000  0.61000 1.00000 
E2A (bHLH), near_PU.1 in vivo -0.162 [-0.481, 0.157]  0.379 [0.187, 0.57]  0.00242 1.00000  0.00540 1.00000 
E2F1 (E2F) in vitro -0.134 [-0.375, 0.108]  0.287 [0.158, 0.416]  0.00184 0.88995  0.00156 0.75715 
E2F1 (E2F) in vivo -0.041 [-0.414, 0.332]  0.388 [0.154, 0.623]  0.06215 1.00000  0.00993 1.00000 
E2F4 (E2F) in vitro -0.364 [-0.604, -0.124]  -0.031 [-0.165, 0.102]  0.02040 1.00000  0.04576 1.00000 
E2F4 (E2F) in vivo -0.497 [-0.852, -0.142]  -0.072 [-0.359, 0.215]  0.06355 1.00000  0.05001 1.00000 
E2F6 (E2F) in vitro -0.147 [-0.369, 0.075]  0.222 [0.123, 0.321]  0.00245 1.00000  0.00172 0.83276 
E2F6 (E2F) in vivo -0.018 [-0.384, 0.348]  0.177 [-0.031, 0.384]  0.39337 1.00000  0.08453 1.00000 
E2F7 (E2F) in vitro -0.423 [-0.687, -0.159]  -0.035 [-0.248, 0.179]  0.01045 1.00000  0.02541 1.00000 
E2F7 (E2F) in vivo 0.001 [-0.286, 0.287]  0.435 [0.176, 0.694]  0.05183 1.00000  0.00113 0.54827 
E2F (E2F) in vitro -0.257 [-0.592, 0.079]  0.02 [-0.213, 0.253]  0.18753 1.00000  0.03369 1.00000 
E2F (E2F) in vivo 0.569 [0.365, 0.773]  0.897 [0.695, 1.099]  0.02480 1.00000  0.00142 0.68757 
EBF1 (EBF) in vitro -0.118 [-0.349, 0.112]  0.235 [0.078, 0.392]  0.01507 1.00000  0.02364 1.00000 
EBF1 (EBF) in vivo -0.639 [-0.963, -0.316]  0.075 [-0.17, 0.32]  0.00047 0.22956  0.00134 0.65092 
EBF (EBF) in vitro 0.13 [-0.227, 0.487]  0.43 [0.18, 0.679]  0.17407 1.00000  0.09784 1.00000 
EBF (EBF) in vivo 0.091 [-0.25, 0.433]  0.329 [0.074, 0.584]  0.17524 1.00000  0.12144 1.00000 
EBNA1 (EBV_virus) in vitro 1.487 [1.256, 1.718]  1.79 [1.594, 1.986]  0.02962 1.00000  0.00002 0.00974 
EBNA1 (EBV_virus) in vivo 2.826 [2.752, 2.901]  3.038 [2.932, 3.144]  0.00277 1.00000  0.00000 0.00003 
Egr1 (Zf) in vitro 0.219 [0.066, 0.373]  0.246 [0.141, 0.351]  0.76190 1.00000  0.70526 1.00000 
Egr1 (Zf) in vivo 0.013 [-0.295, 0.321]  0.104 [-0.108, 0.316]  0.57855 1.00000  0.75380 1.00000 
Egr2 (Zf) in vitro 0.21 [-0.008, 0.427]  0.311 [0.15, 0.471]  0.39318 1.00000  0.22796 1.00000 
Egr2 (Zf) in vivo 0.085 [-0.297, 0.466]  0.251 [-0.033, 0.535]  0.44527 1.00000  0.16702 1.00000 
EHF (ETS) in vitro -0.162 [-0.28, -0.044]  -0.083 [-0.166, 0.001]  0.29888 1.00000  0.17668 1.00000 
EHF (ETS) in vivo -0.525 [-0.806, -0.245]  -0.352 [-0.541, -0.163]  0.32325 1.00000  0.28367 1.00000 
EKLF (Zf) in vitro -0.194 [-0.442, 0.053]  0.085 [-0.06, 0.23]  0.04512 1.00000  0.07126 1.00000 
EKLF (Zf) in vivo -0.137 [-0.46, 0.185]  0.195 [-0.02, 0.41]  0.06592 1.00000  0.08793 1.00000 
ELF1 (ETS) in vitro -0.161 [-0.401, 0.079]  0.046 [-0.067, 0.16]  0.11434 1.00000  0.06753 1.00000 
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ELF1 (ETS) in vivo -0.519 [-0.918, -0.121]  0.063 [-0.215, 0.342]  0.00768 1.00000  0.00942 1.00000 
ELF5 (ETS) in vitro -0.356 [-0.562, -0.15]  -0.119 [-0.217, -0.02]  0.03559 1.00000  0.06613 1.00000 
ELF5 (ETS) in vivo -0.382 [-0.682, -0.083]  -0.273 [-0.444, -0.103]  0.45162 1.00000  0.37526 1.00000 
Elk1 (ETS) in vitro -0.219 [-0.506, 0.069]  0.009 [-0.109, 0.127]  0.12408 1.00000  0.37830 1.00000 
Elk1 (ETS) in vivo -0.608 [-0.983, -0.232]  -0.028 [-0.276, 0.219]  0.01136 1.00000  0.01112 1.00000 
Elk4 (ETS) in vitro -0.308 [-0.546, -0.071]  -0.037 [-0.171, 0.098]  0.04601 1.00000  0.11524 1.00000 
Elk4 (ETS) in vivo -0.469 [-0.808, -0.13]  -0.054 [-0.279, 0.172]  0.02598 1.00000  0.01616 1.00000 
Eomes (T-box) in vitro -0.077 [-0.232, 0.078]  -0.041 [-0.115, 0.032]  0.63429 1.00000  0.75604 1.00000 
Eomes (T-box) in vivo -0.002 [-0.315, 0.312]  0.014 [-0.148, 0.175]  0.92781 1.00000  0.92243 1.00000 
ERE (NR), IR3 in vitro 0.161 [-0.113, 0.435]  0.429 [0.235, 0.623]  0.09658 1.00000  0.10686 1.00000 
ERE (NR), IR3 in vivo -0.101 [-0.481, 0.279]  0.074 [-0.154, 0.301]  0.46430 1.00000  0.39040 1.00000 
ERG (ETS) in vitro 0.013 [-0.143, 0.169]  -0.09 [-0.2, 0.019]  0.25922 1.00000  0.18272 1.00000 
ERG (ETS) in vivo -0.529 [-0.805, -0.253]  -0.231 [-0.417, -0.046]  0.08823 1.00000  0.10660 1.00000 
Erra (NR) in vitro 0.099 [-0.06, 0.258]  0.107 [0.009, 0.205]  0.93282 1.00000  0.64286 1.00000 
Erra (NR) in vivo -0.007 [-0.334, 0.321]  0.11 [-0.124, 0.344]  0.52505 1.00000  0.60352 1.00000 
Esrrb (NR) in vitro 0.153 [-0.015, 0.32]  0.061 [-0.041, 0.163]  0.30231 1.00000  0.40391 1.00000 
Esrrb (NR) in vivo -0.05 [-0.407, 0.308]  0.233 [-0.032, 0.497]  0.16943 1.00000  0.17371 1.00000 
ETS:E-box (ETS, bHLH) in vitro -0.128 [-0.443, 0.187]  0.117 [-0.108, 0.342]  0.24408 1.00000  0.14033 1.00000 
ETS:E-box (ETS, bHLH) in vivo -0.028 [-0.328, 0.272]  0.232 [-0.053, 0.518]  0.19101 1.00000  0.12942 1.00000 
ETS:RUNX (ETS, Runt) in vitro 0.183 [-0.145, 0.511]  0.302 [0.082, 0.523]  0.50447 1.00000  0.38842 1.00000 
ETS:RUNX (ETS, Runt) in vivo 0.09 [-0.208, 0.388]  0.681 [0.417, 0.946]  0.00532 1.00000  0.00370 1.00000 
Ets1-distal (ETS) in vitro -0.179 [-0.423, 0.065]  -0.175 [-0.339, -0.01]  0.97538 1.00000  0.88268 1.00000 
Ets1-distal (ETS) in vivo -0.356 [-0.651, -0.06]  -0.141 [-0.421, 0.14]  0.30514 1.00000  0.40591 1.00000 
ETS1 (ETS) in vitro 0.061 [-0.118, 0.241]  -0.008 [-0.111, 0.095]  0.53927 1.00000  0.19207 1.00000 
ETS1 (ETS) in vivo -0.421 [-0.632, -0.209]  -0.18 [-0.34, -0.019]  0.05883 1.00000  0.12413 1.00000 
ETS (ETS) in vitro -0.119 [-0.407, 0.169]  0.055 [-0.085, 0.194]  0.25976 1.00000  0.07960 1.00000 
ETS (ETS) in vivo -0.521 [-0.975, -0.067]  0.169 [-0.096, 0.435]  0.00506 1.00000  0.01020 1.00000 
ETV1 (ETS) in vitro 0.022 [-0.117, 0.161]  -0.04 [-0.133, 0.053]  0.40099 1.00000  0.44901 1.00000 
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ETV1 (ETS) in vivo -0.531 [-0.864, -0.199]  -0.217 [-0.43, -0.004]  0.08745 1.00000  0.02548 1.00000 
EWS:ERG-fusion (ETS) in vitro -0.457 [-0.631, -0.284]  -0.249 [-0.357, -0.142]  0.05815 1.00000  0.05458 1.00000 
EWS:ERG-fusion (ETS) in vivo -0.81 [-1.164, -0.457]  -0.336 [-0.564, -0.108]  0.03013 1.00000  0.03018 1.00000 
EWS:FLI1-fusion (ETS) in vitro -0.247 [-0.447, -0.046]  -0.163 [-0.308, -0.019]  0.51885 1.00000  0.27135 1.00000 
EWS:FLI1-fusion (ETS) in vivo -0.563 [-0.918, -0.207]  -0.122 [-0.372, 0.128]  0.04610 1.00000  0.03319 1.00000 
Fli1 (ETS) in vitro -0.121 [-0.309, 0.067]  -0.013 [-0.116, 0.089]  0.26347 1.00000  0.30942 1.00000 
Fli1 (ETS) in vivo -0.389 [-0.677, -0.1]  -0.116 [-0.311, 0.079]  0.11924 1.00000  0.05341 1.00000 
Fox:Ebox (Forkhead, bHLH) in vitro -0.001 [-0.13, 0.127]  0.086 [-0.013, 0.185]  0.19297 1.00000  0.35613 1.00000 
Fox:Ebox (Forkhead, bHLH) in vivo -0.317 [-0.579, -0.056]  -0.376 [-0.591, -0.161]  0.69734 1.00000  0.85649 1.00000 
FOXA1:AR (Forkhead,NR) in vitro -0.961 [-1.281, -0.64]  -0.669 [-0.871, -0.467]  0.10316 1.00000  0.01840 1.00000 
FOXA1:AR (Forkhead,NR) in vivo -0.744 [-1.178, -0.31]  -0.397 [-0.641, -0.152]  0.20515 1.00000  0.00250 1.00000 
FOXA1 (Forkhead) in vitro -0.279 [-0.706, 0.148]  -0.184 [-0.384, 0.016]  0.68783 1.00000  0.87472 1.00000 
FOXA1 (Forkhead) in vivo 0.083 [-0.245, 0.411]  0.157 [-0.087, 0.401]  0.72906 1.00000  0.38586 1.00000 
Foxa2 (Forkhead) in vitro -0.264 [-0.444, -0.083]  -0.053 [-0.18, 0.073]  0.05788 1.00000  0.01494 1.00000 
Foxa2 (Forkhead) in vivo -0.464 [-0.73, -0.199]  -0.562 [-0.771, -0.353]  0.55200 1.00000  0.35563 1.00000 
Foxh1 (Forkhead) in vitro -0.073 [-0.262, 0.116]  -0.097 [-0.2, 0.007]  0.81633 1.00000  0.81763 1.00000 
Foxh1 (Forkhead) in vivo -0.608 [-0.907, -0.31]  -0.472 [-0.671, -0.273]  0.38317 1.00000  0.41178 1.00000 
Foxo1 (Forkhead) in vitro 0.027 [-0.143, 0.196]  0.045 [-0.028, 0.118]  0.83821 1.00000  0.40070 1.00000 
Foxo1 (Forkhead) in vivo -0.17 [-0.477, 0.137]  -0.159 [-0.317, -0.002]  0.95214 1.00000  0.94852 1.00000 
FOXP1 (Forkhead) in vitro -0.149 [-0.353, 0.055]  -0.152 [-0.244, -0.06]  0.98113 1.00000  0.80946 1.00000 
FOXP1 (Forkhead) in vivo -0.602 [-0.892, -0.311]  -0.503 [-0.749, -0.257]  0.52577 1.00000  0.40914 1.00000 
FXR (NR),IR1 in vitro 0.351 [0.102, 0.599]  0.356 [0.172, 0.541]  0.97348 1.00000  0.44145 1.00000 
FXR (NR),IR1 in vivo 0.17 [-0.193, 0.532]  0.302 [0.04, 0.565]  0.52262 1.00000  0.21056 1.00000 
GABPA (ETS) in vitro 0.068 [-0.135, 0.272]  0.006 [-0.094, 0.105]  0.56104 1.00000  0.87541 1.00000 
GABPA (ETS) in vivo -0.411 [-0.756, -0.065]  0.002 [-0.171, 0.175]  0.02497 1.00000  0.02808 1.00000 
GATA:SCL (Zf, bHLH) in vitro -0.077 [-0.4, 0.247]  0.054 [-0.099, 0.207]  0.46227 1.00000  0.20841 1.00000 
GATA:SCL (Zf, bHLH) in vivo -0.244 [-0.679, 0.192]  0.194 [-0.048, 0.435]  0.05727 1.00000  0.01260 1.00000 
Gata1 (Zf) in vitro -0.288 [-0.437, -0.139]  0.037 [-0.058, 0.131]  0.00010 0.04740  0.00021 0.10001 
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Gata1 (Zf) in vivo -0.615 [-0.955, -0.274]  -0.221 [-0.445, 0.002]  0.03790 1.00000  0.03692 1.00000 
Gata2 (Zf) in vitro -0.368 [-0.517, -0.219]  0.005 [-0.094, 0.104]  0.00003 0.01441  0.00007 0.03442 
Gata2 (Zf) in vivo -0.72 [-1.068, -0.371]  -0.215 [-0.367, -0.062]  0.00631 1.00000  0.01174 1.00000 
GATA3 (Zf) in vitro -0.415 [-0.611, -0.219]  -0.185 [-0.277, -0.092]  0.03759 1.00000  0.00670 1.00000 
GATA3 (Zf) in vivo -0.442 [-0.81, -0.073]  -0.22 [-0.401, -0.04]  0.28866 1.00000  0.17871 1.00000 
GATA3 (Zf), DR4 in vitro -0.723 [-1.014, -0.433]  -0.387 [-0.616, -0.158]  0.09280 1.00000  0.09153 1.00000 
GATA3 (Zf), DR4 in vivo -0.358 [-0.683, -0.033]  0.303 [0.064, 0.542]  0.00044 0.21183  0.00022 0.10420 
GATA3 (Zf), DR8 in vitro -0.737 [-1.033, -0.44]  -0.011 [-0.17, 0.148]  0.00017 0.08220  0.00001 0.00431 
GATA3 (Zf), DR8 in vivo -0.157 [-0.523, 0.209]  -0.163 [-0.422, 0.096]  0.97957 1.00000  0.68323 1.00000 
Gata4 (Zf) in vitro -0.421 [-0.603, -0.239]  -0.103 [-0.192, -0.015]  0.00403 1.00000  0.00019 0.09239 
Gata4 (Zf) in vivo -0.623 [-0.928, -0.317]  -0.149 [-0.326, 0.028]  0.00214 1.00000  0.01112 1.00000 
GATA (Zf), IR3 in vitro -0.452 [-0.74, -0.163]  -0.005 [-0.24, 0.231]  0.01768 1.00000  0.01244 1.00000 
GATA (Zf), IR3 in vivo 0.272 [-0.036, 0.58]  0.16 [-0.111, 0.43]  0.64031 1.00000  0.91506 1.00000 
GATA (Zf), IR3 in vitro 0.034 [-0.261, 0.33]  0.341 [0.105, 0.576]  0.11561 1.00000  0.04319 1.00000 
GATA (Zf), IR3 in vivo 0.82 [0.639, 1]  1.102 [0.904, 1.3]  0.04030 1.00000  0.00867 1.00000 
Gfi1b (Zf) in vitro -0.006 [-0.172, 0.16]  0.196 [0.097, 0.295]  0.05314 1.00000  0.04132 1.00000 
Gfi1b (Zf) in vivo -0.203 [-0.543, 0.136]  -0.261 [-0.465, -0.058]  0.74648 1.00000  0.71902 1.00000 
GFY-Staf (?, Zf) in vitro -0.156 [-0.433, 0.12]  0.203 [-0.071, 0.477]  0.08798 1.00000  0.03733 1.00000 
GFY-Staf (?, Zf) in vivo 0.682 [0.512, 0.852]  1.16 [0.952, 1.368]  0.00042 0.20210  0.00015 0.07325 
GLI3 (Zf) in vitro -0.072 [-0.364, 0.221]  0.189 [0.034, 0.344]  0.12019 1.00000  0.12368 1.00000 
GLI3 (Zf) in vivo -0.143 [-0.514, 0.229]  0.196 [-0.038, 0.43]  0.12498 1.00000  0.07199 1.00000 
GRE (NR), IR3 in vitro -0.256 [-0.54, 0.029]  0.125 [-0.04, 0.29]  0.03633 1.00000  0.01694 1.00000 
GRE (NR), IR3 in vivo -0.036 [-0.397, 0.325]  0.212 [-0.056, 0.481]  0.24659 1.00000  0.08621 1.00000 
GRHL2 (CP2) in vitro -0.224 [-0.468, 0.02]  -0.04 [-0.19, 0.111]  0.17676 1.00000  0.06429 1.00000 
GRHL2 (CP2) in vivo -0.302 [-0.639, 0.035]  -0.069 [-0.278, 0.14]  0.27308 1.00000  0.13844 1.00000 
HIF-1a (bHLH) in vitro 0.21 [-0.047, 0.467]  0.214 [0.101, 0.327]  0.97240 1.00000  0.75380 1.00000 
HIF-1a (bHLH) in vivo 0.119 [-0.121, 0.358]  -0.04 [-0.248, 0.167]  0.31185 1.00000  0.30503 1.00000 
HIF2a (bHLH) in vitro 0.097 [-0.109, 0.304]  0.175 [0.07, 0.28]  0.49485 1.00000  0.43256 1.00000 
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HIF2a (bHLH) in vivo -0.199 [-0.517, 0.118]  -0.02 [-0.201, 0.162]  0.35242 1.00000  0.39040 1.00000 
Hnf1 (Homeobox) in vitro -0.993 [-1.265, -0.721]  -0.566 [-0.765, -0.367]  0.01469 1.00000  0.00778 1.00000 
Hnf1 (Homeobox) in vivo -0.83 [-1.192, -0.467]  -0.511 [-0.785, -0.236]  0.16979 1.00000  0.02965 1.00000 
HNF4a (NR), DR1 in vitro -0.034 [-0.237, 0.169]  -0.054 [-0.17, 0.062]  0.87253 1.00000  0.57791 1.00000 
HNF4a (NR), DR1 in vivo -0.602 [-0.939, -0.265]  -0.093 [-0.305, 0.119]  0.03387 1.00000  0.00277 1.00000 
HNF6 (Homeobox) in vitro -0.547 [-0.72, -0.373]  -0.307 [-0.418, -0.196]  0.03673 1.00000  0.02451 1.00000 
HNF6 (Homeobox) in vivo -0.741 [-1.006, -0.477]  -0.26 [-0.488, -0.032]  0.00809 1.00000  0.00605 1.00000 
HOXA2 (Homeobox) in vitro -0.575 [-0.839, -0.311]  -0.113 [-0.281, 0.056]  0.01098 1.00000  0.01120 1.00000 
HOXA2 (Homeobox) in vivo -0.332 [-0.671, 0.006]  0.319 [0.07, 0.569]  0.00143 0.69103  0.00319 1.00000 
HOXA9 (Homeobox) in vitro -0.38 [-0.603, -0.157]  -0.102 [-0.183, -0.022]  0.01318 1.00000  0.02364 1.00000 
HOXA9 (Homeobox) in vivo -0.775 [-1.015, -0.535]  -0.271 [-0.477, -0.064]  0.00247 1.00000  0.00170 0.82388 
Hoxb4 (Homeobox) in vitro -0.341 [-0.582, -0.1]  0.073 [-0.056, 0.201]  0.00632 1.00000  0.00034 0.16561 
Hoxb4 (Homeobox) in vivo -0.748 [-1.082, -0.414]  0.047 [-0.173, 0.267]  0.00015 0.07466  0.00010 0.04660 
Hoxc9 (Homeobox) in vitro -0.493 [-0.652, -0.334]  -0.323 [-0.444, -0.202]  0.09782 1.00000  0.05823 1.00000 
Hoxc9 (Homeobox) in vivo -0.973 [-1.266, -0.68]  -0.404 [-0.62, -0.188]  0.00077 0.37418  0.00221 1.00000 
HOXD13 (Homeobox) in vitro -0.66 [-0.884, -0.436]  -0.462 [-0.602, -0.322]  0.11352 1.00000  0.03478 1.00000 
HOXD13 (Homeobox) in vivo -0.978 [-1.337, -0.619]  -0.346 [-0.649, -0.043]  0.00685 1.00000  0.00441 1.00000 
HRE (HSF) in vitro -0.77 [-1.119, -0.422]  -0.207 [-0.383, -0.032]  0.00532 1.00000  0.01020 1.00000 
HRE (HSF) in vivo -0.28 [-0.627, 0.067]  0.014 [-0.249, 0.277]  0.18658 1.00000  0.05974 1.00000 
IRF1 (IRF) in vitro -0.773 [-1.016, -0.531]  -0.304 [-0.469, -0.139]  0.00425 1.00000  0.00046 0.22050 
IRF1 (IRF) in vivo -0.958 [-1.233, -0.683]  -0.435 [-0.703, -0.168]  0.00735 1.00000  0.00640 1.00000 
IRF2 (IRF) in vitro -0.786 [-1.086, -0.486]  -0.056 [-0.234, 0.121]  0.00023 0.11187  0.00004 0.02139 
IRF2 (IRF) in vivo -0.428 [-0.709, -0.146]  -0.076 [-0.339, 0.188]  0.03645 1.00000  0.03369 1.00000 
IRF4 (IRF) in vitro -0.313 [-0.521, -0.105]  -0.151 [-0.272, -0.029]  0.20399 1.00000  0.23292 1.00000 
IRF4 (IRF) in vivo -0.417 [-0.803, -0.031]  -0.153 [-0.398, 0.091]  0.17239 1.00000  0.28619 1.00000 
Isl1 (Homeobox) in vitro -0.251 [-0.417, -0.085]  -0.089 [-0.211, 0.033]  0.12856 1.00000  0.07040 1.00000 
Isl1 (Homeobox) in vivo -0.475 [-0.764, -0.187]  -0.124 [-0.332, 0.084]  0.02561 1.00000  0.06840 1.00000 
ISRE (IRF) in vitro -0.528 [-0.801, -0.256]  -0.219 [-0.458, 0.019]  0.07510 1.00000  0.07199 1.00000 
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ISRE (IRF) in vivo -0.032 [-0.248, 0.185]  0.178 [-0.049, 0.404]  0.13342 1.00000  0.11487 1.00000 
Jun-AP1 (bZIP) in vitro 0.592 [0.279, 0.905]  0.653 [0.415, 0.892]  0.73291 1.00000  0.38076 1.00000 
Jun-AP1 (bZIP) in vivo 1.628 [1.383, 1.872]  1.767 [1.547, 1.987]  0.36983 1.00000  0.14529 1.00000 
JunD (bZIP) in vitro -0.182 [-0.517, 0.152]  0.429 [0.178, 0.681]  0.01427 1.00000  0.00404 1.00000 
JunD (bZIP) in vivo 0.997 [0.709, 1.286]  1.088 [0.872, 1.304]  0.61654 1.00000  0.19096 1.00000 
Klf4 (Zf) in vitro -0.171 [-0.41, 0.067]  0.142 [0.024, 0.26]  0.02545 1.00000  0.00844 1.00000 
Klf4 (Zf) in vivo -0.099 [-0.375, 0.177]  -0.055 [-0.335, 0.226]  0.79688 1.00000  0.56844 1.00000 
KLF5 (Zf) in vitro 0.265 [0.09, 0.44]  0.201 [0.097, 0.305]  0.47658 1.00000  0.85365 1.00000 
KLF5 (Zf) in vivo -0.213 [-0.539, 0.113]  -0.136 [-0.36, 0.088]  0.64945 1.00000  0.53026 1.00000 
Lhx2 (Homeobox) in vitro -0.38 [-0.603, -0.157]  -0.267 [-0.396, -0.138]  0.37169 1.00000  0.42178 1.00000 
Lhx2 (Homeobox) in vivo -0.574 [-0.918, -0.231]  -0.421 [-0.646, -0.196]  0.44719 1.00000  0.23520 1.00000 
Lhx3 (Homeobox) in vitro -0.518 [-0.731, -0.305]  -0.202 [-0.362, -0.042]  0.03648 1.00000  0.01747 1.00000 
Lhx3 (Homeobox) in vivo -0.406 [-0.707, -0.105]  -0.117 [-0.373, 0.139]  0.15287 1.00000  0.12596 1.00000 
LXRE (NR), DR4 in vitro 0.135 [-0.214, 0.485]  0.063 [-0.149, 0.276]  0.71704 1.00000  0.61000 1.00000 
LXRE (NR), DR4 in vivo 0.241 [-0.079, 0.561]  0.215 [-0.038, 0.469]  0.88984 1.00000  0.62305 1.00000 
MafA (bZIP) in vitro 0.179 [0.019, 0.34]  0.164 [0.057, 0.27]  0.86051 1.00000  0.91187 1.00000 
MafA (bZIP) in vivo 0.071 [-0.181, 0.324]  0.443 [0.215, 0.672]  0.04503 1.00000  0.05458 1.00000 
MafF (bZIP) in vitro -0.585 [-0.808, -0.361]  -0.03 [-0.171, 0.111]  0.00041 0.19851  0.00018 0.08833 
MafF (bZIP) in vivo -0.721 [-1.07, -0.372]  -0.308 [-0.596, -0.02]  0.05614 1.00000  0.06910 1.00000 
MafK (bZIP) in vitro -0.069 [-0.34, 0.202]  -0.041 [-0.218, 0.137]  0.86305 1.00000  0.69690 1.00000 
MafK (bZIP) in vivo 0.05 [-0.256, 0.355]  0.327 [0.074, 0.58]  0.10987 1.00000  0.10262 1.00000 
Max (bHLH) in vitro -0.013 [-0.283, 0.256]  0.066 [-0.07, 0.201]  0.61250 1.00000  0.21226 1.00000 
Max (bHLH) in vivo 0.077 [-0.241, 0.394]  0.186 [-0.08, 0.451]  0.61818 1.00000  0.35131 1.00000 
Maz (Zf) in vitro 0.184 [0.011, 0.356]  0.108 [0, 0.215]  0.46168 1.00000  0.47149 1.00000 
Maz (Zf) in vivo -0.267 [-0.577, 0.044]  0.156 [-0.05, 0.361]  0.02025 1.00000  0.05112 1.00000 
Mef2a (MADS) in vitro -0.426 [-0.631, -0.221]  -0.411 [-0.511, -0.31]  0.89401 1.00000  0.82481 1.00000 
Mef2a (MADS) in vivo -0.91 [-1.216, -0.604]  -0.635 [-0.838, -0.432]  0.15501 1.00000  0.13844 1.00000 
Mef2c (MADS) in vitro -0.823 [-1.005, -0.642]  -0.645 [-0.796, -0.493]  0.13934 1.00000  0.08707 1.00000 
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Mef2c (MADS) in vivo -1.036 [-1.325, -0.746]  -0.951 [-1.197, -0.706]  0.66670 1.00000  0.95587 1.00000 
Meis1 (Homeobox) in vitro -0.054 [-0.222, 0.114]  0.129 [0.02, 0.238]  0.08125 1.00000  0.02451 1.00000 
Meis1 (Homeobox) in vivo -0.077 [-0.406, 0.252]  0.006 [-0.211, 0.222]  0.66317 1.00000  0.97041 1.00000 
MITF (bHLH) in vitro 0.105 [-0.067, 0.277]  0.172 [0.063, 0.28]  0.52448 1.00000  0.32285 1.00000 
MITF (bHLH) in vivo -0.331 [-0.582, -0.08]  0.062 [-0.137, 0.261]  0.01634 1.00000  0.02145 1.00000 
MYB (HTH) in vitro -0.085 [-0.256, 0.086]  0.065 [-0.034, 0.164]  0.13151 1.00000  0.11068 1.00000 
MYB (HTH) in vivo -0.28 [-0.526, -0.034]  -0.321 [-0.464, -0.179]  0.77170 1.00000  0.90456 1.00000 
Myf5 (bHLH) in vitro 0.379 [0.15, 0.609]  0.311 [0.194, 0.428]  0.62664 1.00000  0.25940 1.00000 
Myf5 (bHLH) in vivo 0.15 [-0.237, 0.537]  0.203 [-0.041, 0.447]  0.80153 1.00000  0.64457 1.00000 
MyoD (bHLH) in vitro 0.563 [0.347, 0.778]  0.346 [0.166, 0.525]  0.11559 1.00000  0.14094 1.00000 
MyoD (bHLH) in vivo 0.064 [-0.364, 0.492]  0.241 [-0.073, 0.554]  0.41915 1.00000  0.39870 1.00000 
MyoG (bHLH) in vitro 0.45 [0.271, 0.628]  0.321 [0.192, 0.451]  0.28859 1.00000  0.36536 1.00000 
MyoG (bHLH) in vivo 0.062 [-0.211, 0.335]  0.087 [-0.117, 0.29]  0.88820 1.00000  0.66966 1.00000 
n-Myc (bHLH) in vitro -0.2 [-0.483, 0.082]  0.013 [-0.135, 0.16]  0.16125 1.00000  0.07336 1.00000 
n-Myc (bHLH) in vivo 0.186 [-0.149, 0.52]  0.214 [-0.013, 0.442]  0.88921 1.00000  0.89303 1.00000 
Nanog (Homeobox) in vitro 0.076 [-0.141, 0.293]  0.16 [-0.031, 0.351]  0.53457 1.00000  0.56843 1.00000 
Nanog (Homeobox) in vivo 0.298 [0.023, 0.573]  0.127 [-0.088, 0.343]  0.33046 1.00000  0.51023 1.00000 
NeuroD1 (bHLH) in vitro 0.059 [-0.105, 0.223]  0.126 [0.036, 0.216]  0.47883 1.00000  0.18478 1.00000 
NeuroD1 (bHLH) in vivo 0.018 [-0.282, 0.318]  0.199 [0.021, 0.377]  0.31113 1.00000  0.12368 1.00000 
NF-E2 (bZIP) in vitro 0.121 [-0.21, 0.451]  0.292 [0.064, 0.521]  0.43137 1.00000  0.16139 1.00000 
NF-E2 (bZIP) in vivo 0.959 [0.697, 1.222]  1.057 [0.795, 1.319]  0.60769 1.00000  0.55592 1.00000 
NF1-halfsite (CTF) in vitro 0.085 [-0.099, 0.269]  0.159 [0.054, 0.265]  0.46672 1.00000  0.97793 1.00000 
NF1-halfsite (CTF) in vivo 0.277 [0.01, 0.545]  0.164 [-0.024, 0.351]  0.46441 1.00000  0.54859 1.00000 
NF1:FOXA1 (CTF,Forkhead) in vitro -0.582 [-1.116, -0.048]  0.078 [-0.248, 0.404]  0.04598 1.00000  0.02511 1.00000 
NF1:FOXA1 (CTF,Forkhead) in vivo -0.253 [-0.649, 0.143]  -0.004 [-0.359, 0.35]  0.35949 1.00000  0.41178 1.00000 
NF1 (CTF) in vitro 0.153 [-0.179, 0.484]  0.435 [0.278, 0.593]  0.11268 1.00000  0.05975 1.00000 
NF1 (CTF) in vivo -0.019 [-0.343, 0.305]  0.453 [0.23, 0.677]  0.02123 1.00000  0.04320 1.00000 
NFAT:AP1 (RHD,bZIP) in vitro -0.968 [-1.3, -0.636]  -0.446 [-0.595, -0.296]  0.00535 1.00000  0.00274 1.00000 
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NFAT:AP1 (RHD,bZIP) in vivo -0.809 [-1.139, -0.48]  -0.372 [-0.621, -0.122]  0.04045 1.00000  0.00716 1.00000 
NFAT (RHD) in vitro -0.665 [-0.875, -0.455]  -0.415 [-0.517, -0.314]  0.02738 1.00000  0.00677 1.00000 
NFAT (RHD) in vivo -0.69 [-1.01, -0.37]  -0.135 [-0.35, 0.081]  0.00345 1.00000  0.00613 1.00000 
NFkB-p50,p52 (RHD) in vitro -0.411 [-0.765, -0.056]  -0.177 [-0.362, 0.008]  0.21984 1.00000  0.46377 1.00000 
NFkB-p50,p52 (RHD) in vivo -0.457 [-0.802, -0.111]  -0.228 [-0.47, 0.013]  0.18187 1.00000  0.12254 1.00000 
NFkB-p65-Rel (RHD) in vitro -0.388 [-0.772, -0.003]  0.064 [-0.18, 0.309]  0.06598 1.00000  0.01590 1.00000 
NFkB-p65-Rel (RHD) in vivo 0.115 [-0.126, 0.356]  0.521 [0.264, 0.777]  0.02394 1.00000  0.09052 1.00000 
NFkB-p65 (RHD) in vitro -0.013 [-0.253, 0.227]  -0.009 [-0.165, 0.148]  0.97819 1.00000  0.84642 1.00000 
NFkB-p65 (RHD) in vivo -0.756 [-1.124, -0.388]  -0.093 [-0.398, 0.213]  0.01204 1.00000  0.01455 1.00000 
NFY (CCAAT) in vitro -0.017 [-0.211, 0.177]  0.187 [0.09, 0.284]  0.06957 1.00000  0.03018 1.00000 
NFY (CCAAT) in vivo -0.532 [-0.812, -0.252]  -0.163 [-0.348, 0.022]  0.03196 1.00000  0.04667 1.00000 
Nkx2.1 (Homeobox) in vitro 0.058 [-0.107, 0.223]  0.045 [-0.068, 0.157]  0.89872 1.00000  0.88570 1.00000 
Nkx2.1 (Homeobox) in vivo -0.47 [-0.753, -0.187]  -0.022 [-0.219, 0.175]  0.01347 1.00000  0.00710 1.00000 
Nkx2.5 (Homeobox) in vitro 0.144 [-0.009, 0.297]  0.172 [0.077, 0.267]  0.77708 1.00000  0.82026 1.00000 
Nkx2.5 (Homeobox) in vivo -0.336 [-0.622, -0.05]  -0.085 [-0.26, 0.09]  0.15222 1.00000  0.16419 1.00000 
Nkx3.1 (Homeobox) in vitro -0.006 [-0.216, 0.204]  0.176 [0.088, 0.264]  0.13742 1.00000  0.04929 1.00000 
Nkx3.1 (Homeobox) in vivo -0.335 [-0.605, -0.065]  -0.117 [-0.302, 0.067]  0.18726 1.00000  0.12368 1.00000 
Nkx6.1 (Homeobox) in vitro -0.671 [-0.953, -0.388]  -0.23 [-0.429, -0.03]  0.00720 1.00000  0.01550 1.00000 
Nkx6.1 (Homeobox) in vivo -0.355 [-0.663, -0.048]  -0.107 [-0.418, 0.203]  0.27218 1.00000  0.21914 1.00000 
NPAS2 (bHLH) in vitro 0.029 [-0.12, 0.178]  0.101 [0.027, 0.175]  0.41174 1.00000  0.23156 1.00000 
NPAS2 (bHLH) in vivo -0.051 [-0.319, 0.218]  0.025 [-0.146, 0.196]  0.60662 1.00000  0.78199 1.00000 
Nr5a2 (NR) in vitro -0.011 [-0.265, 0.243]  -0.02 [-0.17, 0.13]  0.95676 1.00000  0.78084 1.00000 
Nr5a2 (NR) in vivo 0.273 [-0.12, 0.666]  0.058 [-0.202, 0.319]  0.38289 1.00000  0.44697 1.00000 
NRF1 (NRF) in vitro 0.523 [0.194, 0.852]  0.862 [0.582, 1.142]  0.06852 1.00000  0.20887 1.00000 
NRF1 (NRF) in vivo 1.134 [0.957, 1.311]  1.534 [1.247, 1.822]  0.01648 1.00000  0.77724 1.00000 
Nrf2 (bZIP) in vitro 0.039 [-0.329, 0.407]  0.41 [0.167, 0.654]  0.10407 1.00000  0.02541 1.00000 
Nrf2 (bZIP) in vivo 0.944 [0.68, 1.208]  1.143 [0.932, 1.353]  0.17175 1.00000  0.06294 1.00000 
NRF (NRF) in vitro 0.068 [-0.253, 0.389]  0.479 [0.247, 0.71]  0.02881 1.00000  0.04566 1.00000 
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NRF (NRF) in vivo 0.64 [0.313, 0.967]  0.788 [0.492, 1.083]  0.50298 1.00000  0.29464 1.00000 
Nur77 (NR) in vitro -0.491 [-0.735, -0.247]  -0.297 [-0.446, -0.149]  0.20031 1.00000  0.08124 1.00000 
Nur77 (NR) in vivo -0.648 [-1.014, -0.283]  -0.103 [-0.33, 0.123]  0.02743 1.00000  0.00056 0.27137 
Oct2 (POU,Homeobox) in vitro -0.491 [-0.69, -0.293]  -0.43 [-0.552, -0.308]  0.61269 1.00000  0.41178 1.00000 
Oct2 (POU,Homeobox) in vivo -0.617 [-0.945, -0.29]  -0.359 [-0.61, -0.107]  0.21300 1.00000  0.11813 1.00000 
OCT4-SOX2-TCF-NANOG 
(POU,Homeobox,HMG) 
in vitro -0.732 [-0.949, -0.516]  -0.458 [-0.616, -0.3]  0.01841 1.00000  0.00942 1.00000 
OCT4-SOX2-TCF-NANOG 
(POU,Homeobox,HMG) 
in vivo -1.216 [-1.564, -0.869]  -0.715 [-0.968, -0.461]  0.01530 1.00000  0.00156 0.75719 
Oct4:Sox17 
(POU,Homeobox,HMG) 
in vitro -0.322 [-0.609, -0.035]  -0.142 [-0.271, -0.013]  0.27151 1.00000  0.20389 1.00000 
Oct4:Sox17 
(POU,Homeobox,HMG) 
in vivo -0.488 [-0.845, -0.131]  -0.388 [-0.666, -0.111]  0.66326 1.00000  0.48874 1.00000 
Oct4 (POU,Homeobox) in vitro -0.533 [-0.733, -0.333]  -0.305 [-0.437, -0.173]  0.04269 1.00000  0.02252 1.00000 
Oct4 (POU,Homeobox) in vivo -0.71 [-1.088, -0.332]  -0.418 [-0.661, -0.176]  0.11107 1.00000  0.24403 1.00000 
Olig2 (bHLH) in vitro -0.059 [-0.227, 0.11]  -0.008 [-0.108, 0.092]  0.59276 1.00000  0.38027 1.00000 
Olig2 (bHLH) in vivo -0.343 [-0.629, -0.056]  -0.119 [-0.317, 0.078]  0.16862 1.00000  0.07126 1.00000 
p53 (p53) in vitro 0.339 [-0.161, 0.839]  0.66 [0.399, 0.922]  0.23023 1.00000  0.01260 1.00000 
p53 (p53) in vivo 1.364 [1.208, 1.521]  1.309 [1.146, 1.472]  0.59800 1.00000  0.21562 1.00000 
p63 (p53) in vitro -0.08 [-0.347, 0.188]  0.287 [0.084, 0.49]  0.02654 1.00000  0.04929 1.00000 
p63 (p53) in vivo 0.566 [0.251, 0.88]  0.62 [0.375, 0.864]  0.77513 1.00000  0.42781 1.00000 
PAX3:FKHR-fusion 
(Paired,Homeobox) 
in vitro -0.195 [-0.429, 0.04]  -0.15 [-0.356, 0.056]  0.79548 1.00000  0.99264 1.00000 
PAX3:FKHR-fusion 
(Paired,Homeobox) 
in vivo -0.673 [-1.056, -0.291]  -0.111 [-0.412, 0.19]  0.02000 1.00000  0.00891 1.00000 
PAX5 (Paired,Homeobox) in vitro 0.325 [0.105, 0.544]  0.291 [0.188, 0.394]  0.77283 1.00000  0.56097 1.00000 
PAX5 (Paired,Homeobox) in vivo -0.146 [-0.521, 0.229]  0.12 [-0.085, 0.324]  0.15349 1.00000  0.37830 1.00000 
PAX5 (Paired, Homeobox), 
condensed 
in vitro 0.22 [-0.1, 0.541]  0.455 [0.316, 0.594]  0.20294 1.00000  0.10361 1.00000 
PAX5 (Paired, Homeobox), 
condensed 
in vivo 0.195 [-0.175, 0.566]  0.604 [0.355, 0.852]  0.04133 1.00000  0.03369 1.00000 
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Pax7 (Paired,Homeobox) in vitro -0.467 [-0.808, -0.125]  -0.122 [-0.401, 0.158]  0.15941 1.00000  0.11962 1.00000 
Pax7 (Paired,Homeobox) in vivo -1.119 [-1.47, -0.768]  -0.271 [-0.614, 0.073]  0.00224 1.00000  0.00066 0.32186 
Pax7 (Paired, Homeobox),  
long 
in vitro 0.009 [-0.242, 0.259]  0.266 [0.015, 0.516]  0.15104 1.00000  0.15181 1.00000 
Pax7 (Paired, Homeobox),  
long 
in vivo 1.144 [1, 1.289]  1.193 [1.051, 1.335]  0.65497 1.00000  0.50387 1.00000 
Pax7 (Paired, Homeobox),  
longest 
in vitro -0.267 [-0.595, 0.061]  -0.063 [-0.276, 0.15]  0.20725 1.00000  0.02171 1.00000 
Pax7 (Paired, Homeobox),  
longest 
in vivo 0.919 [0.752, 1.086]  0.936 [0.791, 1.082]  0.88358 1.00000  0.05086 1.00000 
Pax8 (Paired, Homeobox) in vitro 0.593 [0.406, 0.779]  0.533 [0.447, 0.62]  0.58047 1.00000  0.52422 1.00000 
Pax8 (Paired, Homeobox) in vivo 0.39 [-0.009, 0.788]  0.409 [0.23, 0.589]  0.92498 1.00000  0.86742 1.00000 
PBX1 (Homeobox) in vitro 0.057 [-0.274, 0.387]  0.277 [0.009, 0.544]  0.33128 1.00000  0.10760 1.00000 
PBX1 (Homeobox) in vivo 0.589 [0.261, 0.918]  0.648 [0.361, 0.934]  0.77305 1.00000  0.53741 1.00000 
Pbx3 (Homeobox) in vitro -0.018 [-0.285, 0.248]  0.077 [-0.083, 0.236]  0.51900 1.00000  0.29895 1.00000 
Pbx3 (Homeobox) in vivo -0.4 [-0.771, -0.03]  0.151 [-0.157, 0.46]  0.01149 1.00000  0.03995 1.00000 
Pdx1 (Homeobox) in vitro -0.431 [-0.607, -0.255]  -0.135 [-0.237, -0.033]  0.00907 1.00000  0.00221 1.00000 
Pdx1 (Homeobox) in vivo -0.649 [-0.89, -0.408]  -0.116 [-0.29, 0.058]  0.00037 0.17905  0.00026 0.12652 
Phox2a (Homeobox) in vitro -0.483 [-0.736, -0.231]  -0.508 [-0.712, -0.304]  0.88476 1.00000  0.97057 1.00000 
Phox2a (Homeobox) in vivo -0.612 [-0.991, -0.232]  -0.63 [-0.86, -0.399]  0.93751 1.00000  0.39040 1.00000 
Pitx1 (Homeobox) in vitro 0.115 [-0.197, 0.426]  0.115 [-0.102, 0.332]  0.99904 1.00000  0.86742 1.00000 
Pitx1 (Homeobox) in vivo 0.089 [-0.225, 0.402]  0.672 [0.426, 0.917]  0.00326 1.00000  0.00024 0.11831 
PPARE (NR), DR1 in vitro 0.143 [-0.029, 0.314]  0.084 [-0.003, 0.17]  0.54311 1.00000  0.25163 1.00000 
PPARE (NR), DR1 in vivo -0.261 [-0.519, -0.004]  0.028 [-0.12, 0.176]  0.05921 1.00000  0.00736 1.00000 
PRDM14 (Zf) in vitro 0.126 [-0.123, 0.374]  0.092 [-0.013, 0.198]  0.80661 1.00000  0.73287 1.00000 
PRDM14 (Zf) in vivo -0.622 [-0.847, -0.397]  -0.257 [-0.523, 0.01]  0.01874 1.00000  0.02336 1.00000 
PRDM1 (Zf) in vitro -0.366 [-0.518, -0.214]  -0.257 [-0.36, -0.154]  0.20208 1.00000  0.17078 1.00000 
PRDM1 (Zf) in vivo -0.75 [-1.065, -0.436]  -0.41 [-0.647, -0.173]  0.10161 1.00000  0.11922 1.00000 
PRDM9 (Zf) in vitro -0.028 [-0.271, 0.214]  0.228 [0.11, 0.346]  0.06155 1.00000  0.01381 1.00000 
PRDM9 (Zf) in vivo 0.083 [-0.26, 0.426]  0.261 [0.041, 0.481]  0.41153 1.00000  0.20555 1.00000 
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PR (NR) in vitro -0.042 [-0.191, 0.108]  -0.01 [-0.14, 0.121]  0.75398 1.00000  0.40591 1.00000 
PR (NR) in vivo -0.422 [-0.745, -0.1]  -0.124 [-0.348, 0.101]  0.13319 1.00000  0.27135 1.00000 
Ptf1a (bHLH) in vitro 0.339 [0.055, 0.624]  0.227 [0.048, 0.406]  0.50650 1.00000  0.45813 1.00000 
Ptf1a (bHLH) in vivo 0.313 [-0.028, 0.654]  0.427 [0.187, 0.667]  0.58229 1.00000  0.49839 1.00000 
PU.1-IRF (ETS:IRF) in vitro -0.381 [-0.533, -0.229]  -0.218 [-0.298, -0.138]  0.06816 1.00000  0.00892 1.00000 
PU.1-IRF (ETS:IRF) in vivo -0.457 [-0.737, -0.177]  -0.311 [-0.491, -0.131]  0.40213 1.00000  0.40591 1.00000 
PU.1 (ETS) in vitro -0.216 [-0.402, -0.03]  -0.108 [-0.232, 0.015]  0.37055 1.00000  0.46581 1.00000 
PU.1 (ETS) in vivo -0.345 [-0.64, -0.05]  -0.165 [-0.339, 0.008]  0.33459 1.00000  0.11922 1.00000 
RARg (NR) in vitro 0.324 [0.026, 0.621]  0.486 [0.224, 0.748]  0.43376 1.00000  0.20060 1.00000 
RARg (NR) in vivo 1.316 [1.034, 1.598]  1.26 [1.042, 1.478]  0.74977 1.00000  0.98150 1.00000 
REST-NRSF (Zf) in vitro 1.484 [1.295, 1.673]  2.026 [1.805, 2.247]  0.00039 0.18771  0.00000 0.00184 
REST-NRSF (Zf) in vivo 3.222 [3.036, 3.407]  2.997 [2.914, 3.08]  0.02660 1.00000  0.21880 1.00000 
Reverb (NR), DR2 in vitro 0.282 [0.054, 0.511]  0.226 [0.022, 0.43]  0.68777 1.00000  0.94118 1.00000 
Reverb (NR), DR2 in vivo 0.378 [0.056, 0.7]  0.443 [0.211, 0.674]  0.72867 1.00000  0.94455 1.00000 
Rfx1 (HTH) in vitro 0.05 [-0.231, 0.331]  0.093 [-0.097, 0.283]  0.80527 1.00000  0.78797 1.00000 
Rfx1 (HTH) in vivo -0.328 [-0.772, 0.116]  -0.064 [-0.317, 0.19]  0.24105 1.00000  0.08287 1.00000 
Rfx2 (HTH) in vitro 0.649 [0.286, 1.011]  0.645 [0.391, 0.898]  0.98383 1.00000  0.35609 1.00000 
Rfx2 (HTH) in vivo 1.33 [1.145, 1.515]  1.49 [1.3, 1.681]  0.18616 1.00000  0.04035 1.00000 
Rfx5 (HTH) in vitro 0.199 [-0.034, 0.432]  0.389 [0.233, 0.546]  0.23739 1.00000  0.35372 1.00000 
Rfx5 (HTH) in vivo -0.345 [-0.704, 0.014]  -0.041 [-0.334, 0.252]  0.19625 1.00000  0.02741 1.00000 
RFX (HTH) in vitro 0.016 [-0.371, 0.403]  0.648 [0.405, 0.891]  0.00654 1.00000  0.00218 1.00000 
RFX (HTH) in vivo 0.721 [0.429, 1.012]  0.908 [0.654, 1.162]  0.32994 1.00000  0.28408 1.00000 
RORgt (NR) in vitro -0.262 [-0.496, -0.028]  -0.032 [-0.251, 0.186]  0.14385 1.00000  0.07054 1.00000 
RORgt (NR) in vivo -0.332 [-0.64, -0.024]  0.177 [-0.129, 0.483]  0.00646 1.00000  0.01472 1.00000 
RUNX-AML (Runt) in vitro 0.068 [-0.123, 0.259]  0.09 [0.001, 0.179]  0.84005 1.00000  0.40591 1.00000 
RUNX-AML (Runt) in vivo -0.047 [-0.315, 0.222]  0.063 [-0.144, 0.269]  0.47630 1.00000  0.42178 1.00000 
RUNX1 (Runt) in vitro 0.009 [-0.178, 0.196]  -0.076 [-0.17, 0.017]  0.40526 1.00000  0.56097 1.00000 
RUNX1 (Runt) in vivo -0.335 [-0.642, -0.028]  -0.03 [-0.189, 0.128]  0.07861 1.00000  0.06632 1.00000 
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RUNX2 (Runt) in vitro 0.037 [-0.149, 0.224]  0.032 [-0.053, 0.117]  0.95866 1.00000  0.73982 1.00000 
RUNX2 (Runt) in vivo -0.276 [-0.521, -0.03]  0.03 [-0.188, 0.248]  0.06028 1.00000  0.05578 1.00000 
RUNX (Runt) in vitro -0.067 [-0.301, 0.166]  0.048 [-0.067, 0.163]  0.36354 1.00000  0.29636 1.00000 
RUNX (Runt) in vivo -0.317 [-0.644, 0.009]  0.156 [-0.058, 0.369]  0.00700 1.00000  0.01659 1.00000 
RXR (NR), DR1 in vitro 0.236 [0.074, 0.398]  0.188 [0.11, 0.267]  0.61042 1.00000  0.43256 1.00000 
RXR (NR), DR1 in vivo -0.317 [-0.624, -0.01]  0.013 [-0.185, 0.21]  0.07016 1.00000  0.04516 1.00000 
SCL (bHLH) in vitro 0.128 [-0.119, 0.375]  0.182 [-0.031, 0.395]  0.74517 1.00000  0.83833 1.00000 
SCL (bHLH) in vivo -0.043 [-0.321, 0.235]  0.246 [-0.086, 0.577]  0.14405 1.00000  0.25398 1.00000 
Six1 (Homeobox) in vitro -0.47 [-0.726, -0.214]  -0.165 [-0.269, -0.061]  0.05660 1.00000  0.14284 1.00000 
Six1 (Homeobox) in vivo -0.476 [-0.863, -0.089]  -0.353 [-0.613, -0.092]  0.59593 1.00000  0.57159 1.00000 
Smad2 (MAD) in vitro 0.104 [-0.061, 0.27]  0.125 [0.027, 0.222]  0.83537 1.00000  0.78909 1.00000 
Smad2 (MAD) in vivo -0.131 [-0.368, 0.107]  0.088 [-0.083, 0.259]  0.14762 1.00000  0.15130 1.00000 
Smad3 (MAD) in vitro 0.13 [0.009, 0.252]  0.006 [-0.096, 0.109]  0.11036 1.00000  0.12413 1.00000 
Smad3 (MAD) in vivo -0.252 [-0.462, -0.043]  0.025 [-0.165, 0.214]  0.05154 1.00000  0.03820 1.00000 
Smad4 (MAD) in vitro 0.221 [0.08, 0.362]  0.142 [0.068, 0.216]  0.32581 1.00000  0.37029 1.00000 
Smad4 (MAD) in vivo -0.022 [-0.225, 0.182]  0.058 [-0.11, 0.226]  0.47833 1.00000  0.64457 1.00000 
Sox2 (HMG) in vitro -0.195 [-0.369, -0.022]  -0.245 [-0.332, -0.157]  0.62044 1.00000  0.88268 1.00000 
Sox2 (HMG) in vivo -0.703 [-1.018, -0.389]  -0.267 [-0.449, -0.085]  0.01126 1.00000  0.00484 1.00000 
Sox3 (HMG) in vitro -0.073 [-0.237, 0.09]  -0.195 [-0.31, -0.08]  0.18879 1.00000  0.21179 1.00000 
Sox3 (HMG) in vivo -0.553 [-0.838, -0.267]  -0.14 [-0.298, 0.019]  0.01232 1.00000  0.01986 1.00000 
Sox6 (HMG) in vitro -0.339 [-0.498, -0.179]  -0.097 [-0.2, 0.006]  0.00941 1.00000  0.01534 1.00000 
Sox6 (HMG) in vivo -0.334 [-0.695, 0.028]  -0.162 [-0.328, 0.003]  0.40469 1.00000  0.19099 1.00000 
Sp1 (Zf) in vitro 0.146 [-0.24, 0.532]  0.246 [0.012, 0.479]  0.68028 1.00000  0.44421 1.00000 
Sp1 (Zf) in vivo 0.037 [-0.279, 0.353]  0.38 [0.098, 0.663]  0.08756 1.00000  0.09596 1.00000 
SPDEF (ETS) in vitro -0.104 [-0.296, 0.087]  -0.022 [-0.097, 0.054]  0.40740 1.00000  0.38334 1.00000 
SPDEF (ETS) in vivo -0.128 [-0.403, 0.148]  0.068 [-0.099, 0.236]  0.23306 1.00000  0.07187 1.00000 
Srebp1a (bHLH) in vitro 0.285 [0.044, 0.526]  0.359 [0.223, 0.495]  0.57864 1.00000  0.57349 1.00000 
Srebp1a (bHLH) in vivo -0.099 [-0.52, 0.323]  0.033 [-0.215, 0.28]  0.59241 1.00000  0.96671 1.00000 
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Srebp2 (bHLH) in vitro 0.378 [0.132, 0.623]  0.418 [0.266, 0.57]  0.78733 1.00000  0.56844 1.00000 
Srebp2 (bHLH) in vivo -0.182 [-0.522, 0.158]  0.237 [-0.019, 0.494]  0.03673 1.00000  0.04929 1.00000 
STAT1 (Stat) in vitro -1.093 [-1.404, -0.781]  -0.367 [-0.693, -0.04]  0.00186 0.89803  0.00833 1.00000 
STAT1 (Stat) in vivo -0.172 [-0.533, 0.189]  -0.066 [-0.366, 0.234]  0.62385 1.00000  0.97411 1.00000 
Stat3+il21 (Stat) in vitro -0.174 [-0.46, 0.112]  -0.107 [-0.291, 0.077]  0.67140 1.00000  0.61830 1.00000 
Stat3+il21 (Stat) in vivo -0.31 [-0.617, -0.002]  -0.275 [-0.545, -0.006]  0.86472 1.00000  0.95562 1.00000 
Stat3 (Stat) in vitro -0.429 [-0.722, -0.137]  -0.114 [-0.281, 0.053]  0.08833 1.00000  0.04929 1.00000 
Stat3 (Stat) in vivo -0.404 [-0.782, -0.026]  -0.276 [-0.566, 0.013]  0.56847 1.00000  0.44144 1.00000 
STAT4 (Stat) in vitro -0.391 [-0.695, -0.086]  -0.419 [-0.636, -0.201]  0.86645 1.00000  0.81665 1.00000 
STAT4 (Stat) in vivo -0.201 [-0.504, 0.101]  -0.103 [-0.343, 0.136]  0.59445 1.00000  0.20388 1.00000 
STAT5 (Stat) in vitro -0.789 [-1.176, -0.402]  -0.442 [-0.781, -0.103]  0.18954 1.00000  0.09505 1.00000 
STAT5 (Stat) in vivo 0.211 [-0.161, 0.584]  0.303 [-0.072, 0.679]  0.72376 1.00000  0.38585 1.00000 
STAT6 (Stat) in vitro -0.802 [-1.099, -0.506]  -0.64 [-0.88, -0.4]  0.38470 1.00000  0.33946 1.00000 
STAT6 (Stat) in vivo -0.384 [-0.755, -0.013]  -0.466 [-0.866, -0.065]  0.77267 1.00000  0.33479 1.00000 
T1ISRE (IRF) in vitro -0.016 [-0.209, 0.177]  0.359 [0.111, 0.608]  0.03204 1.00000  0.01844 1.00000 
T1ISRE (IRF) in vivo 1.45 [1.36, 1.539]  1.666 [1.502, 1.831]  0.02561 1.00000  0.02917 1.00000 
TATA-Box (TBP) in vitro -0.287 [-0.463, -0.111]  -0.207 [-0.334, -0.08]  0.48532 1.00000  0.56844 1.00000 
TATA-Box (TBP) in vivo -0.915 [-1.256, -0.573]  -0.601 [-0.799, -0.403]  0.12006 1.00000  0.11596 1.00000 
Tbet (T-box) in vitro -0.144 [-0.299, 0.012]  -0.033 [-0.113, 0.047]  0.25038 1.00000  0.05975 1.00000 
Tbet (T-box) in vivo -0.319 [-0.577, -0.06]  -0.201 [-0.414, 0.013]  0.48184 1.00000  0.44901 1.00000 
Tbox:Smad (T-box, MAD) in vitro 0.084 [-0.179, 0.347]  0.343 [0.212, 0.473]  0.09166 1.00000  0.06341 1.00000 
Tbox:Smad (T-box, MAD) in vivo -0.052 [-0.368, 0.264]  0.378 [0.135, 0.622]  0.01302 1.00000  0.01363 1.00000 
Tbx20 (T-box) in vitro 0.135 [-0.137, 0.407]  0.126 [-0.027, 0.279]  0.95066 1.00000  0.47720 1.00000 
Tbx20 (T-box) in vivo -0.177 [-0.541, 0.187]  0.344 [0.133, 0.556]  0.02853 1.00000  0.08453 1.00000 
Tbx5 (T-box) in vitro 0.196 [0.009, 0.383]  0.062 [-0.084, 0.209]  0.32002 1.00000  0.22975 1.00000 
Tbx5 (T-box) in vivo -0.12 [-0.426, 0.186]  0.039 [-0.181, 0.26]  0.41434 1.00000  0.42512 1.00000 
Tcf12 (bHLH) in vitro 0.349 [0.125, 0.572]  0.233 [0.088, 0.377]  0.42003 1.00000  0.31833 1.00000 
Tcf12 (bHLH) in vivo 0.295 [-0.057, 0.647]  0.41 [0.164, 0.657]  0.60550 1.00000  0.51622 1.00000 
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Tcf3 (HMG) in vitro -0.345 [-0.571, -0.12]  -0.153 [-0.285, -0.021]  0.13234 1.00000  0.19737 1.00000 
Tcf3 (HMG) in vivo -0.495 [-0.909, -0.08]  -0.221 [-0.517, 0.075]  0.18196 1.00000  0.18580 1.00000 
Tcf4 (HMG) in vitro -0.197 [-0.389, -0.005]  -0.143 [-0.254, -0.032]  0.62701 1.00000  0.28410 1.00000 
Tcf4 (HMG) in vivo -0.503 [-0.845, -0.161]  -0.062 [-0.299, 0.175]  0.02120 1.00000  0.04875 1.00000 
Tcfcp2l1 (CP2) in vitro 0.19 [-0.136, 0.517]  0.422 [0.162, 0.683]  0.29213 1.00000  0.25940 1.00000 
Tcfcp2l1 (CP2) in vivo 0.2 [-0.142, 0.542]  0.616 [0.336, 0.897]  0.10186 1.00000  0.00510 1.00000 
TCFL2 (HMG) in vitro -0.331 [-0.646, -0.016]  -0.186 [-0.406, 0.035]  0.39463 1.00000  0.14283 1.00000 
TCFL2 (HMG) in vivo 0.022 [-0.338, 0.381]  0.164 [-0.086, 0.414]  0.54297 1.00000  0.11276 1.00000 
TEAD2 (TEA) in vitro -0.009 [-0.182, 0.165]  -0.055 [-0.131, 0.021]  0.61807 1.00000  0.35613 1.00000 
TEAD2 (TEA) in vivo -0.64 [-0.874, -0.406]  0.057 [-0.134, 0.248]  0.00000 0.00052  0.00001 0.00426 
TEAD4 (TEA) in vitro -0.102 [-0.269, 0.066]  -0.131 [-0.228, -0.034]  0.73158 1.00000  0.59891 1.00000 
TEAD4 (TEA) in vivo -0.541 [-0.778, -0.304]  -0.133 [-0.329, 0.062]  0.01978 1.00000  0.00300 1.00000 
TEAD (TEA) in vitro -0.05 [-0.223, 0.123]  -0.071 [-0.182, 0.04]  0.82600 1.00000  0.93385 1.00000 
TEAD (TEA) in vivo -0.754 [-1.114, -0.394]  -0.239 [-0.52, 0.042]  0.02057 1.00000  0.01082 1.00000 
THRa (NR) in vitro 0.182 [-0.002, 0.367]  0.27 [0.153, 0.388]  0.42632 1.00000  0.12643 1.00000 
THRa (NR) in vivo -0.166 [-0.573, 0.242]  0.122 [-0.082, 0.326]  0.19743 1.00000  0.43800 1.00000 
Tlx (NR) in vitro 0.037 [-0.185, 0.26]  0.364 [0.255, 0.473]  0.00687 1.00000  0.00126 0.60798 
Tlx (NR) in vivo 0.125 [-0.264, 0.513]  0.29 [0.071, 0.509]  0.51833 1.00000  0.24825 1.00000 
TR4 (NR), DR1 in vitro -0.296 [-0.661, 0.069]  -0.012 [-0.235, 0.21]  0.19267 1.00000  0.17426 1.00000 
TR4 (NR), DR1 in vivo -0.286 [-0.66, 0.088]  0.263 [-0.059, 0.584]  0.03094 1.00000  0.00640 1.00000 
USF1 (bHLH) in vitro 0.181 [-0.027, 0.389]  0.145 [0.001, 0.288]  0.76862 1.00000  0.91875 1.00000 
USF1 (bHLH) in vivo 0.098 [-0.257, 0.452]  0.277 [0.046, 0.509]  0.38053 1.00000  0.34134 1.00000 
Usf2 (bHLH) in vitro 0.183 [-0.057, 0.423]  0.171 [0.059, 0.283]  0.93624 1.00000  0.97780 1.00000 
Usf2 (bHLH) in vivo 0.039 [-0.245, 0.323]  0.308 [0.096, 0.519]  0.09742 1.00000  0.09505 1.00000 
VDR (NR), DR3 in vitro -0.078 [-0.332, 0.177]  0.189 [0.053, 0.325]  0.04284 1.00000  0.06166 1.00000 
VDR (NR), DR3 in vivo -0.173 [-0.53, 0.184]  0.268 [0.055, 0.48]  0.03122 1.00000  0.01793 1.00000 
X-box (HTH) in vitro -0.201 [-0.612, 0.209]  0.354 [0.178, 0.531]  0.02559 1.00000  0.01590 1.00000 
X-box (HTH) in vivo 0.079 [-0.353, 0.511]  0.282 [-0.078, 0.642]  0.25354 1.00000  0.19736 1.00000 
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YY1 (Zf) in vitro -0.921 [-1.341, -0.502]  -0.595 [-0.973, -0.216]  0.23605 1.00000  0.20506 1.00000 
YY1 (Zf) in vivo -0.196 [-0.683, 0.291]  -0.476 [-0.745, -0.207]  0.28838 1.00000  0.35854 1.00000 
ZBTB33 (Zf) in vitro 0.997 [0.75, 1.244]  1.068 [0.881, 1.255]  0.65650 1.00000  0.07382 1.00000 
ZBTB33 (Zf) in vivo 2.266 [2.181, 2.352]  2.554 [2.387, 2.721]  0.00100 0.48545  0.00030 0.14449 
ZFX (Zf) in vitro 0.194 [-0.012, 0.4]  0.459 [0.331, 0.588]  0.04352 1.00000  0.03907 1.00000 
ZFX (Zf) in vivo -0.322 [-0.617, -0.028]  0.271 [-0.004, 0.545]  0.00244 1.00000  0.01703 1.00000 
ZNF143|STAF (Zf) in vitro 0.195 [0.004, 0.386]  0.168 [0.023, 0.312]  0.82206 1.00000  0.73149 1.00000 
ZNF143|STAF (Zf) in vivo -0.163 [-0.507, 0.181]  -0.015 [-0.265, 0.235]  0.45913 1.00000  0.64952 1.00000 
Znf263 (Zf) in vitro 0.322 [0.169, 0.476]  0.304 [0.212, 0.396]  0.78664 1.00000  0.92652 1.00000 
Znf263 (Zf) in vivo -0.148 [-0.4, 0.103]  -0.011 [-0.229, 0.207]  0.40457 1.00000  0.33201 1.00000 
ZNF711 (Zf) in vitro 0.334 [0.136, 0.532]  0.434 [0.269, 0.599]  0.46335 1.00000  0.63138 1.00000 
ZNF711 (Zf) in vivo -0.227 [-0.573, 0.12]  -0.148 [-0.406, 0.109]  0.67821 1.00000  0.84558 1.00000 
 
